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Abstract
Plasma cells are central to an effective immune response, being the sole producers of
the antibodies, yet they can cause severe disease in autoimmunity and multiple
myeloma. Therefore their differentiation and survival must be tightly regulated. In
this work I investigated some of the mechanisms regulating plasma cell
differentiation and life span. The differentiation of a long lived B cell to a short lived
plasma cell entails a profound structural and functional metamorphosis finalized to
the massive production of immunoglobulins (Ig). Exuberant Ig synthesis causes
several types of stress in differentiating plasma cells. My work deals with the
characterization of the C/EBP transcription factor CHOP in plasma cell
differentiation. Comparing differentiation of B cells harvested from chop t mice to wt
cells I found a mild phenotype, consisting in an increased accumulation of
intracellular IgMaggregates and a decreased secretion of this antibody class, in vitro
and in vivo. These findings reveal a novel role for CHOP in ensuring optimal
functionality of the secretory pathway in the course of plasma cell differentiation.
CHOP is involved in the differentiation of various cell types, where it interacts with
other members of the C/EBP family favoring or impeding differentiation and it is an
important factor in the ER stress response named unfolded protein response (UPR),
in which it plays a pro-apoptotic role in most of the systems tested. I extended my
investigation on the functions of CHOP in B cells by examining the resistance to ER
stress-induced apoptosis in wt and in chop t: cells. Surprisingly, I observed that in B
cells CHOP expression in the UPR plays an anti-apoptotic function. Altogether my
data suggest a cell-type specific role for CHOP in B cells and add information on the
multi-faceted role ofthis transcription factor.
Most plasma cells exhibit a short life span. The mechanisms at the basis of plasma
cell apoptosis are still obscure. I propose that multiple forms of stress, linked to the
massive antibody production, contribute to plasma cell death.
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Frequently used abbreviations
Most of the abbreviations below and those less frequently used are stated in the text
at the first encounter.
ASC
BCR
CSR
DUOX
ER
ERAD
ERSE
Gp
GSH
GSSG
HC
Ig
Le
LPS
NADP(H)
!fADP+
!fOX
Pm
PTK
PTP
QC
ROS
SOD
aXBPl
TLR
UPR
UPRE
uXBPl
Antigen secreting cell
B cell receptor
Class switch recombination
Dual oxidase
Endoplasmic reticulum
ER associated degradation
ER stress response element
Glutathione peroxidase
Reduced glutathione
Oxidized glutathione
Immunoglobulin heavy chain
Immunglobulin
Immunoglobulin light chain
Bacterial lipopolysaccharide
Nicotinamide adenine dinucleotide phophate (reduced)
Nicotinamide adenine dinucleotide phophate (oxidised)
NADPHoxidase
Peroxiredoxin
Protein tyrosin kinase
Protein tyrosin phosphatase
Quality control
Reactive oxigen species
Superoxide dismutase
spliced form of X-Box binding protein-l
Toll-like receptor
Unfolded protein response
UPR response element
un-spliced form of X-Box binding protein-l
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1. Introduction
1.1 The plasma cell
To recognize and fight the wide range of pathogens that can infect the organism the
lymphocytes of the adaptive immune system have evolved to recognize a great variety
of different antigens from bacteria, viruses and other disease-causing organisms. The
antigen-recognition molecules are the antibodies, or immunoglobulins (Ig). These
proteins are produced by cells of the B lineage in a vast range of specificities, each B
cell and its descendents producing Ig of a single specificity. Plasma cell mature from
B lymphocytes which are small, resting cells patrolling the body for foreign agents.
They recognize the antigen via the B cell receptor (BCR),which is a membrane bound
form of the antibody that the B cell will secrete after activation and differentiation to
plasma cell.
Hence, plasma cells are crucial for an effective immune response. Yet they can cause
severe pathology in autoimmunity and multiple myeloma. So, activation of mature B
cells, secretion of antibody and survival of plasma cells need to be tightly controlled.
1.1.1 Theantibody
Antibodies have two separate functions: one is to bind specifically to molecules from
the pathogen, the other is to recruit other cells and molecules to destroy the
pathogen once it is bound to it. These functions are structurally separated in the
antibody molecule, one part of which specifically recognizes and binds antigen
whereas the other engages different effector mechanisms. The antigen-binding region
varies extensively among Ig and thus is known as the variable region (V region). The
region of the antibody that engages the effector function of the immune system does
not vary in the same way and is thus defined constant region (C region). Many forms
of it exist (isotypes), which are specialized for activating different effector
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mechanisms and define the Ig classes. The membrane bound BCR does not have
effector functions as the C region remains inserted in the plasma membrane of the B
cell. Its function is to recognize and bind the antigens by the V regions exposed on
the cell surface, thus transmitting the signals that eventually lead to B cell activation
and plasma cell differentiation. An antibody is identical to the BCR of the cell that
secretes it except for a small portion of the C-terminus of the heavy chain C region
that in the BCR is a hydrophobic membrane-anchoring sequence and in the antibody
is a hydrophilic sequence that allows secretion. The membrane and secreted forms
are generated by alternative processing of the heavy chain transcripts.
The core structure of the antibody molecule is composed by two different kinds of
polypeptide chains, one of higher and one of lower molecular weight, thus termed
heavy (HC) and light chain (LC) respectively. Each HC is tightly bound to a LC
(generally by disulphide bonds) in a structure that in the immunological jargon is
defined "hemimer" (HL).Two hemimers are bound via disulphide bonds between the
HC forming the immunoglobulin "monomer" (H2k2).
Fig.I 1Antibodies are made up of four protein chains.
There are two types of chain in an antibodymolecule:a larger chain called the heavy chain
(green),and a smallerone calledthe light chain (yellow).Each chain has both a variableand a
constant region, and there are two identical light chains and two identical heavy chains in
each antibodymolecule.
There are two different types of LCnamed lambda (A)and kappa (K) but, owing to the
phenomenon of allelic exclusion, a single antibody molecule possesses either Aor K
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chains. No functional differences have been described between antibodies
constituted by A. or K chains, and either type of Le may be found in the different
immunoglobulin classes. The ratio of the two types of Le varies from species to
species. In the mouse, the average K to A. ratio is 20: 1 whereas in humans it is 2: 1.
By contrast, the class, and thus the effector function, of an antibody, is defmed by
the structure of its heavy chain. There are five main heavy-chain classes or isotypes,
some of which have several subtypes, and these determine the functional properties
of an antibody molecule. The five major classes are immunoglobulin M (IgM), D (IgD),
G (IgG), A (IgA), and E (IgE). Their distinctive properties are conferred by the carboxy-
terminal part of the heavy chain, where it is not associated with the light chain.
The amino acid sequences of many immunoglobulin heavy and light chains have
been determined and reveal two important features of antibody molecules. First,
each chain consists of a series of similar, although not identical, sequences, each
about 110 amino acids long. Each of these repeats corresponds to a discrete domain.
The light chain is made up of two such immunoglobulin domains, whereas the heavy
chain of the IgG antibody contains four. This suggests that the immunoglobulin
chains have evolved by repeated duplication of an ancestral gene corresponding to a
single domain.
Fig. I 2 Structure of an antibody molecule.
The figure illustrates a ribbon diagram based on the X-ray crystallographic structure of an IgG
antibody, showing the course of the backbones of the polypeptide chains. Three globular
regions form a Y. The two antigen-binding sites are at the tips of the arms, which are tethered
to the trunk of the Y by a flexible hinge region.
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The second important feature revealed by comparisons of amino acid sequences is
that the amino-terminal sequences of both the heavy and light chains vary greatly
between different antibodies. The variability in sequence is limited to approximately
the first 110 amino acids, corresponding to the first domain, whereas the remaining
domains are constant between immunoglobulin chains of the same isotype. The
amino-terminal variable or V domains of the heavy and light chains (VH and VL,
respectively) together make up the V region of the antibody and confer on it the
ability to bind specific antigen, while the constant domains CH and CLrespectively,
make up the C region. The multiple heavy-chain C domains are numbered from the
amino-terminal end to the carboxy terminus, CHI, CH2, and so on.
variable
region
N-terminus
costant
region
Cvterrnlnus
Fig.!3 Schematic representation of the antibody structure.
Thevariableand constant domainsofthe lightand heavychains are labeled.
The V regions of any given antibody molecule differ from those of every other.
Sequence variability is not, however, distributed evenly throughout the V regions but
is concentrated in certain segments of the V region. Three segments of particular
variability can be identified in both the VH and VL domains. They are designated
hypervariable regions and are denoted HVI, HV2, and HV3.The most variable part of
the domain is in the HV3 region. The regions between the hypervariable regions,
which comprise the rest of the V domain, show less variability and are termed the
framework regions. There are four such regions in each V domain, designated FRI,
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FR2, FR3, and FR4. Not only is sequence diversity concentrated in particular parts of
the V domain but it is localized to a particular region on the surface of the molecule.
When the VHand VLdomains are paired in the antibody molecule, the hypervariable
loops from each domain are brought together, creating a single hypervariable site at
the tip of each arm of the molecule. This is the binding site for antigen. The three
hypervariable loops determine antigen specificity by forming a surface
complementary to the antigen, and are more commonly termed the complementarity-
determining regions, or CORs (COR!, COR2, and COR3). Because CORs from both
VH and VL domains contribute to the antigen-binding site, it is the combination of
the H and the L chain, and not either alone, that determines the final antigen
specificity. Thus, one way in which the immune system is able to generate antibodies
of different specificities is by generating different combinations of Hand L chain V
regions. This means of producing variability is known as combinatorial diversity.
Virtually any substance can elicit an antibody response. Furthermore, the response
even to a simple antigen bearing a single antigenic determinant is diverse,
comprising many different antibody molecules each with a unique affinity, or binding
strength, for the antigen and a subtly different specificity. The total number of
antibody specificities available to an individual is known as the antibody repertoire,
or immunoglobulin repertoire, and in humans is at least 1011,perhaps more. The
number of antibody specificities present at anyone time is, however, limited by the
total number of B cells in an individual, as well as by each individual's encounters
with antigens. The antibody repertoire is generated by DNArearrangements during
B-cell development: a DNAsequence encoding a V region is assembled at each locus
by selection from a relatively small group of inherited gene segments.
The V domain of an immunoglobulin H or L chain is encoded by more than one gene
segment. For the light chain, the V domain is encoded by two separate DNA
segments. The first segment encodes the first 95-101 amino acids of the light chain
and is termed a V gene segment because it encodes most of the V domain. The
second segment encodes the remainder of the V domain (up to 13 amino acids) and
is termed a joining or J gene segment. The joining of a V and a J gene segment
creates a continuous exon that encodes the whole of the light-chain V region. In the
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un-rearranged DNA,the V gene segments are located relatively far away from the C
region. The J gene segments are located close to the C region, however, and joining of
a V segment to a J gene segment also brings the V gene close to a C-region sequence.
The J gene segment of the rearranged V region is separated from a C-region
sequence only by an intron. To make a complete Ig L messenger RNA,the V-region
exon is joined to the C-region sequence by RNAsplicing after transcription.
A heavy-chain V region is encoded in three gene segments. In addition to the V and J
gene segments (denoted VHand JH to distinguish them from the light-chain VLand
JL), there is a third gene segment called the diversity or DBgene segment, which lies
between the VHand JH gene segments. The process of recombination that generates a
complete heavy-chain V region occurs in two separate stages. In the first, a DHgene
segment is joined to a JB gene segment; then a VHgene segment rearranges to DJHto
make a complete Vwregion exon. As with the light-chain genes, RNAsplicing joins
the assembled V-region sequence to the neighboring C-region gene.
,v J
::t:-=:=DF=II.
c
Ug"'_ Hnvy dill.
_ v cJ
.~ .. ~.
v OJ.~~--~~~ ..
Fig. f 4 V·region genes are constructedjrom gene segments.
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Light-chain V-region genes are constructed from two segments (center panel). A variable M
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V-region exon. Immunoglobulin chains are extra-cellular proteins and the V gene segment is
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preceded by an exon encoding a leader peptide (Ll, which directs the protein into the cell's
secretorypathways and is then cleaved.The light-chain C region is encoded in a separate exon
and is joined to the V-regionexon by splicingof the light-chain RNA to removethe L-to-Vand
the J-to-C introns. Heavy-chainV regions are constructed from three gene segments (right
panel). First, the diversity (D)and J gene segments join, then the V gene segment joins to the
combinedDJ sequence, forminga completeVHexon. Aheavy-chain C-regiongene is encoded
by several exons. The C-regionexons, together with the leader sequence, are spliced to the V-
domain sequence during processing of the heavy-chain RNA transcript. The leader sequence is
removedafter translation and the disulfidebonds that link the polypeptidechains are formed.
The hinge regionis shown in purple.
There are multiple copies of all of the gene segments in germline DNA. It is the
random selection of just one gene segment of each type to assemble a V region that
makes possible the great diversity of V regions among immunoglobulins.
The immunoglobulin gene segments are organized into three clusters or genetic loci,
the K, A, and heavy-chain loci. These are on different chromosomes and each is
organized slightly differently for humans. At the A IgL locus, located on chromosome
22, a cluster of VI.gene segments is followed by four sets of J;. gene segments each
linked to a single C;. gene. In the K IgL locus, on chromosome 2, the cluster of V, gene
segments is followed by a cluster of JK gene segments, and then by a single CK gene.
The organization of the IgH locus, on chromosome 14, resembles that of the K locus,
with separate clusters of VH,OH, and JH gene segments and of CHgenes. The IgH
locus differs in one important way: instead of a single C-region, it contains a series of
C regions arrayed one after the other, each of which corresponds to a different
isotype. Generally, a cell expresses only one at a time, beginning with IgM. The
expression of other isotypes, such as IgO, can occur through isotype switching, a
process that will be discussed shortly below.
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Fig. I 5 The germline organization of the immunoglobulin heavy- and light-
chain loci in the human genome.
The genetic locus for the ), light chain (chromosome 22) has about 30 functional VA. gene
segments and four pairs of functional J).. gene segments and CA.genes. The K locus
(chromosome 2) is organized in a similar way, with about 40 functional VK gene segments
accompanied by a cluster of fiveJK gene segments but with a single CK gene. In approximately
50% of individuals, the entire cluster of K V gene segments has undergone an increase by
duplication (not shown for simplicity). The heavy-chain locus (chromosome 14) has about 65
functional VB gene segments and a cluster of around 27 D segments lying between these VB
gene segments and six JH gene segments. The heavy-chain locus also contains a large cluster
of CH genes. For simplicity it is shown only a single CH gene in this diagram without
illustrating its separate exons, pseudogenes have been omitted, and all V gene segments have
been shown in the same orientation. L, leader sequence. This diagram is not to scale: the total
length of the heavy-chain locus is over 2 megabases (2 million bases), whereas some of the D
segments are only six bases long.
Although each B lymphocyte has multiple allelic loci for the different antibody chains,
clonally derived mature B lymphocyte expresses a single species of antibody with a
unique specificity via a process termed allelic exclusion (Fig.6). Despite some
progress, the precise mechanism of allelic exclusion remains an enigma. In B cell
development, IgH gene assembly generally precedes that of IgL genes. For IgH genes,
D to JH rearrangements occur on both allelic chromosomes before appendage of a VH
to DJH. In addition, rearrangement of Ig). occurs mostly in cells that have already
rearranged or deleted both IgKloci (isotype exclusion). The regulated model of allelic
exclusion propose that IgL chain V gene assembly must proceed one chromosome at
a time and that protein products from a functional IgL rearrangement mediates
allelic exclusion through feedback inhibition of further IgL rearrangement (the same
model applies to IgH).
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See text for details
from (Mostoslavsky et al., 2004)
Two further processes add greatly to repertoire diversity, imprecise joining of V, D,
and J gene segments and somatic hypermutation. Of the three hypervariable loops
in the protein chains of immunoglobulins, two are encoded within the V gene
11
segment DNA.The third (HV3or CDR3)falls at the joint between the V gene segment
and the J gene segment, and in the heavy chain is partially encoded by the D gene
segment. In both heavy and light chains, the diversity of CDR3 is significantly
increased by the addition and deletion of nuc1eotides in the formation of the
junctions between gene segments.
The mechanisms for generating diversity described so far all take place during the
rearrangement of gene segments in the initial development of B cells in the central
lymphoid organs. There is an additional mechanism that generates diversity
throughout the V region and that operates on B cells in peripheral lymphoid organs
after functional immunoglobulin genes have been assembled. This process, known as
somatic hypermutatioD, introduces point mutations into the V regions of the
rearranged heavy- and light-chain genes at a very high rate, giving rise to mutant B-
cell receptors on the surface of the B cells. Some of the mutant immunoglobulin
molecules bind antigen better than the original B-cell receptors, and B cells
expressing them are preferentially selected to mature into antibody secreting cells.
This gives rise to a phenomenon called affinity maturation of the antibody population.
Somatic hypennutation occurs when B cells respond to antigen along with signals
from activated T cells. The immunoglobulin C-region gene, and other genes
expressed in the B cell, are not affected, whereas the rearranged VHand VLgenes are
mutated.
Where not indicated references and figures are from the textbook "lmmunobioloqu" Sh
edition, Janeway CA et al., Garland Sience Publishing.
1.1.2 The immunoglobulin isotypes
The five main isotypes of immunoglobulin are IgM, IgD, IgG, 19E, and 19A. Their
heavy chains are denoted by the corresponding lower-case Greek letter (11,b, y, E, and
a respectively). In humans, IgG antibodies can be further subdivided into four
subclasses (IgGl, IgG2, IgG3, and IgG4),whereas 19Aantibodies are found as two
subclasses (lgAl and 19A2).IgG is by far the most abundant immunoglobulin in the
serum. IgMis present in the extracellular fluids as pentamers and hexamers, which
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accounts for its high molecular weight. Secreted 19Acan occur as either a monomer
or as a dimer. Different isotypes and subtypes also differ in their ability to engage
various effector functions.
IlI1IIIInoglobulin
IgG1 19G2 IgG3 IgG4 IgiA IgAt IgA2 IgO IgE
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Fig.17 The properties of the human immunoglobulin isotypes.
Sequence differences between immunoglobulin heavy chains cause the various isotypes to
differ in several characteristic respects. These include the number and location of interchain
disulfide bonds, the number of attached oligosaccharide moieties, the number of C domains,
and the length of the hinge region. JgMand IgE heavy chains contain an extra C domain that
replaces the hinge region found in y, 0, and Cl. chains.
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Fig. ! 8 The structural organization of the main human immunoglobulin
isotype monomers.
Both IgMand IgE lack a hinge region but each contains an extra heavy-chain domain. Note
the differences in the numbers and locations of the disulfide bonds (black lines) linking the
chains. The isotypes also differ in the distribution of N-llnked carbohydrate groups, shown as
turquoise hexagons.
The V-region exons expressed by any given B cell are determined during its early
differentiation in the bone marrow. They may subsequently be modified by somatic
hypermutation, and possibly by secondary V(D)J recombination outside the bone
marrow (receptor editing). All the progeny of that B cell will therefore express the
same assembled V genes. By contrast, several different C-region genes can be
expressed in the B cell's progeny as the cells mature and proliferate in the course of
an immune response. Every B cell begins by expressing IgM as its B-cell receptor,
and the first antibody produced in an immune response is always IgM. Later in the
immune response, however, the same assembled V region may be expressed in IgG,
19A,or 19Eantibodies. This change is known as isotype switching. It is stimulated in
the course of an immune response by external signals such as cytokines released by
T cells or mitogenic signals delivered by pathogens.
The immunoglobulin CHgenes form a large cluster spanning about 200 kb to the 3'
side of the JH gene segments. Each CH gene is split into several exons, each
corresponding to an individual immunoglobulin domain in the folded C region.
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Fig.! 9 The organization of the immunoglobulin heavy-chain C-region genes in
mice and humans.
(not to scale) In humans, the cluster shows evidenceof evolutionaryduplication of a unit
consistingoftwo y genes, an E gene and an a gene.One of the E genes has becomeinactivated
and is nowa pseudogene (1jI); hence onlyone subtype of IgEis expressed.For simplicity,other
pseudogenesare not illustrated, and the exon details within each C gene are not shown.The
classes of immunoglobulinsfound in mice are called IgM,IgD,IgGl, IgG2a,IgG2b,IgG3,IgA,
and IgE.
The gene encoding the Il C region lies closest to the JH gene segments, and therefore
closest to the assembled V-region exon after DNA rearrangement. A complete Il
heavy-chain transcript is produced from the newly rearranged gene. Any JH gene
segments remaining between the assembled V gene and the CIl gene are removed
during RNAprocessing to generate the mature mRNA. Il heavy chains are therefore
the first to be expressed and IgM is the first immunoglobulin isotype to be expressed
during B-cell development. Immediately 3' to the Il gene lies the 6 gene, which
encodes the C region of the IgD heavy chain. IgD is coexpressed with IgM on the
surface of almost all mature B celis, although this isotype is secreted in only small
amounts and its function is unknown. B cells expressing IgM and IgD have not
undergone isotype switching, which entails an irreversible change in the DNA.
Instead, these cells produce a long primary transcript that is differentially cleaved
and spliced to yield one of two distinct mRNAmolecules. In one of these, the VDJ
exon is linked to the CIl exons to encode a !l heavy chain, and in the other the VDJ
exon is linked to the C6 exons to encode a 6 heavy chain. The differential processing
of the long mRNA transcript is developmentally regulated, with immature B celis
making mostly the Il transcript and mature B cells making mostly the 6 form along
with some of the Il transcript.
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Fig. 110 Co-expression of IgD and IgM is regulated by RNAprocessing.
In mature B cells, transcription initiated at the VHpromoter extends through both CIland Cli
exons. This long primary transcript is then processed by cleavage and polyadenylation (AAA),
and by splicing. Cleavage and polyadenylation at the 11site (PAl) and splicing between CIl
exons yields an mRNAencoding the 11heavy chain (leftpanel). Cleavage and polyadenylation at
the Ii site (pA2)and a different pattern of splicing that removes the CIl exons yields mRNA
encoding the Ii heavy chain (right panel). For simplicity I have not shown all the individual C-
region exons.
Switching to other isotypes occurs primarly after B cells have been stimulated by
antigen. It occurs through a specialized non-homologous DNA recombination
mechanism guided by stretches of repetitive DNAknown as switch regions. Switch
regions lie in the intron between the JH gene segments and the ell gene, and at
equivalent sites upstream of the genes for each of the other heavy-chain isotypes,
with the exception of the I) gene. This recombination event is mediated by the
enzyme activation-induced cytidine deaminase (AID) and involves germline
transcription, DNAdouble strand breaks at switch regions and DNArepair. At the
end of this process the Ig heavy chain constant region is rearranged and the
intervening DNAis deleted.
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Fig. I 11Class switch recombination.
Once the V(D)J exon is assembled a Ii heavy chain is synthesized. Transcription across this
region is mediated by a promoter located upstream of the V(D)J exon. Upon activation different
effector heavy chains are produced by class switch recombination (CSR) to a down stream
isotypes (CSR to 19A is shown). This recombination event is mediated by the enzyme
activation-induced cytidine deaminase (AID)and involves germ line transcription; DNA double
strand breaks at switch regions and DNA repair. At the end of this process the Ig heavy chain
constant region is rearranged and the intervening DNA is deleted.
from (Edry and Melamed, 2007)
Where not indicated references and figures are from the textbook "Immunobiology" 5th
edition, Janeway CA et al., Garland Sience Publishing.
1.1.3 The distribution and functions of immunoglobulin isotypes
Pathogens most commonly enter the body across the epithelial barriers of the
mucosa lining the respiratory, digestive, and urogenital tracts, or through damaged
skin, and can then establish infections in the tissues. The body's mucosal surfaces,
tissues, and blood are all protected by antibodies from such infections; these
antibodies serve to neutralize the pathogen or promote its elimination before it can
establish a significant infection. Antibodies of different isotypes are adapted to
function in different compartments of the body. Because a givenV region can become
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associated with any C region through isotype switching, the progeny of a single B cell
can produce antibodies, all specific for the same eliciting antigen, that provide all of
the protective functions appropriate for each body compartment.
The first antibodies to be produced in a humoral immune response are always IgM,
because IgMcan be expressed without isotype switching. These early IgMantibodies
are produced before B cells have undergone somatic hypermutation and therefore
tend to be of low affmity. IgMmolecules, however, form pentamers whose 10 antigen-
binding sites can bind simultaneously to multivalent antigens such as bacterial
capsular polysaccharides. This compensates for the relatively low affinity of the IgM
monomers by multipoint binding that confers high overall avidity. As a result of the
large size of the polymers, IgM is mainly found in the blood and, to a lesser extent,
the lymph. The pentameric structure of IgMmakes it especially effective in activating
the complement system, as it will be discussed below. Infection of the bloodstream
has serious consequences unless it is controlled quickly, and the rapid production of
IgMand its efficient activation of the complement system are important in controlling
such infections. Some IgMis also produced in secondary and subsequent responses,
and after somatic hypermutation, although other isotypes dominate the later phases
of the antibody response.
Antibodies of the other isotypes, IgO, 19A,and IgE, are smaller in size and diffuse
easily out of the blood into the tissues. While 19Acan form dimers and higher order
assembly, IgO and IgE are always monomeric. The affinity of the individual antigen-
binding sites for their antigen is therefore critical for the effectiveness of these
antibodies, and most of the B cells expressing these isotypes have been selected for
increased affmity of antigen binding in germinal centers. IgO is the principal isotype
in the blood and extracellular fluid, whereas 19Ais the principal isotype in secretions,
the most important being those of the mucus epithelium of the intestinal and
respiratory tracts. Whereas IgO efficiently opsonizes pathogens for engulfment by
phagocytes and activates the complement system, 19Ais a less potent opsonin and a
weak activator of complement. This distinction is not surprising, as IgO operates
mainly in the body tissues, where accessory cells and molecules are available,
whereas 19A operates mainly on epithelial surfaces where complement and
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phagocytes are not normally present, and therefore functions chiefly as a
neutralizing antibody. Finally, IgE antibody is present only at very low levels in blood
or extracellular fluid, but is bound avidly by receptors on mast cells that are found
just beneath the skin and mucosa, and along blood vessels in connective tissue.
Antigen binding to IgE triggers mast cells to release powerful chemical mediators
that induce reactions, such as coughing, sneezing, and vomiting, that can expel
infectious agents, and engage effector functions.
Many bacteria cause disease by secreting protein toxins, which damage or disrupt
the function of the host's cells. To have an effect, a toxin must interact specifically
with a receptor on the surface of the target cell. Antibodies that bind to the receptor-
binding site preventing the toxin from binding to the cell are referred to as
neutralizing antibodies. The ability of IgG antibodies to diffuse easily throughout the
extracellular fluid and their high affmity make these the principal neutralizing
antibodies for toxins found in tissues. 19Aantibodies similarly neutralize toxins at
the mucosal surfaces of the body. Many antibodies that neutralize viruses do so by
directly blocking viral binding to surface receptors. Such antibodies are called virus-
neutralizing antibodies and, as with the neutralization of toxins, high-affmity 19Aand
IgG antibodies are particularly important. Many bacteria have cell-surface molecules
that enable them to bind to the surface of host cells. This adherence is critical to the
ability of these bacteria to cause disease, whether they subsequently enter the cell,
or remain attached to the cell surface as extracellular pathogens. 19Aantibodies
secreted onto the mucosal surfaces of the intestinal, respiratory, and reproductive
tracts are particularly important in fighting infections by preventing the adhesion of
bacteria, viruses, or other pathogens to the epithelial cells lining these surfaces. The
adhesion of bacteria to cells within tissues can also contribute to pathogenesis, and
IgG antibodies can protect from damage much as IgAantibodies protect at mucosal
surfaces.
Another way in which antibodies can protect against infection is by activation of the
cascade of complement proteins. Complement activation proceeds via a series of
proteolytic cleavage reactions, in which inactive components, present in plasma, are
cleaved to form proteolytic enzymes that attach covalently to the pathogen surface.
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All known pathways of complement activation converge to generate the same set of
effector actions: the pathogen surface or immune complex is coated with covalently
attached fragments that act as opsonins to promote uptake and removal by
phagocytes. At the same time, small peptides with inflammatory and chemotactic
activity are released so that phagocytes are recruited to the site. In addition, the
terminal complement components can form a membrane-attack complex that
damages some bacteria
1.1.4 Polymeric immunoglobulins, IgA and IgJll
The joining (J) chain is a small polypeptide, which regulates polymer formation of IgA
and IgM. J chain incorporation into polymeric 19A (pIgA, mainly dimers) and
pentameric IgM endows these antibodies with several salient features. First, a high
valency of antigen-binding sites, which makes them suitable for agglutinating
bacteria and viruses and, most importantly, only J chain containing polymers show
high affmity for the polymeric Ig receptor (pIgR), also known as transmembrane
secretory component (SC). This epithelial glycoprotein mediates active external
transfer of pIgAand pentameric IgMto exocrine secretions. Thus, secretory IgA(SIgA)
and SIgM, as well as free se, are generated by endoproteolytic cleavage of the pIgR
extracellular domain. The secretory antibodies form the first line of defence against
pathogens and noxious substances that favor the mucosa as their portal of entry.
The J chain is involved in creating the binding site for pIgR/ se in the Ig polymers,
not only by determining the polymeric quaternary structure but apparently also by
interacting directly with the receptor protein. Therefore, both the J chain and the
pIgR/Se are key proteins in secretory immunity (Johansen et al., 2000). The J chain
has been characterized in a range of species including mammals (human, mouse,
bovine, rabbit), birds (chicken), reptiles (turtle), amphibians (Xenopus laevis and
Rana catesbeiana), and cartilaginous fish (nurse shark and cleamose skate). A recent
study demonstrated that J chain from several different tetrapod species is capable of
inducing polymerization of human IgA and that the resulting pIgA binds human
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pIgRjSC and amphibian pIgR pIg-binding domain is capable of binding human pIgA
revealing a remarkable conservation of protein-protein interaction sites in secretory
Ig from different species. These observations evidence the evolutionary significance of
this first-line defense system (Braathen et al., 2007).
Fig.112 The IgMand IgA molecules can form multimers.
IgM and 19A are usually synthesized as multimers in association with an additional
polypeptide chain, the J chain. In pentameric IgM, the monomers are cross-linked by disulfide
bonds to each other and to the J chain. The bottom left panel shows an electron micrograph of
an IgM pentamer, showing the arrangement of the monomers in a flat disc. IgM can also form
hexamers that lack a J chain but are more efficient in complement activation. In dimeric IgA,
the monomers have disulfide bonds to the J chain as well as to each other. The top left panel
shows an electron micrograph of dirneric IgA.
IgA-secreting plasma cells are found predominantly in the connective tissue called
the lamina propria, which lies immediately below the basement membrane of many
surface epithelia. 19Ais the predominant Ig class in the secretions on the mucosal
surfaces and the second most prevalent antibody in the serum after IgG. However,
since IgA are metabolized around five times faster than IgG the production rates of
IgAand IgGmust be similar and indeed the daily production of IgAexceeds that of
all the other antibody classes combined (Woofand Kerr, 2006). Serum 19Aare mainly
monomeric while SIgA, as discussed above, are polymeric. SIgA are essential to
protect the wide area occupied by the mucosal surface of the respiratory,
gastrointestinal and genitourinary apparatuses. Furthermore IgA antibodies are
secreted in breast milk and are thereby transferred to the gut of the newborn infant,
21
where they provide protection from newly encountered bacteria until the infant can
synthesize its own protective antibody.
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Fig. I 13 Transcytosis of 19A antibody across epithelia is mediated by the poly-Ig
receptor, a specialized transport protein.
Most IgA antibody is synthesized in plasma cells lying just beneath epithelial basement
membranes of the gut, the respiratory epithelia, the tear and salivary glands, and the lactating
mammary gland. The IgAdimer bound to a J chain diffuses across the basement membrane
and is bound by the poly-Ig receptor on the basolateral surface of the epithelial cell. The
bound complex undergoes transcytosis in which it is transported in a vesicle across the cell to
the apical surface, where the poly-Ig receptor is cleaved to leave the extracellular IgA-binding
component bound to the IgA molecule as the so-called secretory component. The residual
piece of the poly-Ig receptor is nonfunctional and is degraded. In this way, IgAis transported
across epithelia into the lumens of several organs that are in contact with the external
environment.
IgM are the first antibodies produced in primary immune responses and the
predominant isotype secreted in T cell-independent immune responses. IgM are
secreted by plasma cells only in the polymeric form, as will be discussed in greater
details below. Secreted IgM is predominantly found as pentameric molecules ((!-l2k)s-
22
J), but IgMcan also be secreted as hexamers (1!2L2)6 by B cell lines. Murine hexamers
activate the complement cascade 15-20 fold more efficiently than pentamers.
Although hexameric IgM is not abundant in vivo, normal B cells are capable of
producing significant amounts of IgM hexamers in vitro. IgM pentamers and
hexamers exhibit very similar half-lives in vivo, suggesting that the predominance of
circulating IgM pentamers in normal animals reflects the relative levels of assembly
of the two types of polymers by IgM-secreting cells. However, hexameric IgM can be
found at significant levels in the serum IgM autoantibodies of a number of patients
with an IgM-mediated autoimmune condition (Hughey et al., 1998).
In plasma, the pentameric IgM molecule has a planar conformation that does not
bind the initial factor for complement activation (C1q); however, binding to the
surface of a pathogen deforms the IgM pentamer so that it looks like a staple, and
this distortion exposes binding sites for the Clq heads. Although Clq binds with low
affinity to some subclasses of IgG in solution, the binding energy required for CLq
activation is achieved only when a single molecule of C1q can bind two or more IgG
molecules that are held within 30-40 nm of each other as a result of binding antigen.
This requires many molecules of IgG to be bound to a single pathogen. For this
reason, IgMis much more efficient in activating complement than is IgG. The binding
of Clq to a single bound IgMmolecule, or to two or more bound IgGmolecules, leads
to the activation of an enzymatic activity in C1r, triggering the complement cascade
translating antibody binding into the activation of the complement cascade.
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Fig.114 The two conformations oflgM.
The left panel shows the planar conformation of soluble IgM; the right panel shows the staple
conformation ofIgM bound to a bacterial flagellum. Photographs r- 760,000)
Where not indicated references and figures are from the textbook "Immunobiology" Sh
edition, Janeway CA et al., Garland Sience Publishing.
1.1.5 The B ceII receptor
The antigen-binding portion of the B-cell receptor complex is a cell-surface
immunoglobulin that has the same antigen specificity as the secreted antibodies that
the B cell will eventually produce. Indeed, it is identical to a secreted monomeric
immunoglobulin, except that it is attached to the membrane through the carboxy
termini of the paired heavy chains. The mRNA for the cell-surface heavy chain is
spliced in such a way that the carboxy terminus of the protein is made up of a
transmembrane domain and a very short cytoplasmic tail. One Iga chain and one Igl3
chain associates with each surface immunoglobulin molecule. Thus the complete B-
cell receptor is a complex of six chains, two identical light chains, two identical heavy
chains, one Iga, and one Igl3.
The cytoplasmic tail of Iga and Igl3 carries an immunoreceptor tyrosine-based
activation motif (ITAM)characterized by a consensus sequence that includes two
tyrosines that become phosphorylated upon BCR activation. Three P'I'Ks (Lyn, Syk
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and Btk) and one PTP (SHP-l) are involved in signal transduction from the BCR. The
generation of a doubly phosphorylated ITAMallows the two amino-terminal SH2
domains of Syk to bind to the BCR. This activates the kinase to phosphorylate
neighboring ITAMsequences, which results in more Syk recruitment and activation
and thus in the amplification of the BCR signal. The cytosolic phosphatase SHP-I is
one of the PTPs counteracting Syk activity in B cells. In the past few years hydrogen
peroxide has been identified as a second messenger molecule for BCR activation
(Reth, 2002). In the presence of active SHP-l, the ITAMtyrosines are more rapidly
dephosphorylated than they are phosphorylated by Syk. Therefore, no amplification
of Syk activity can occur when the BCRis in a resting state. Upon exposure of B cells
to H202 or upon stimulation of the H202-generating enzymes in B cells, the PTPs are
inhibited and lose their negative regulatory power on the BCR. This results in rapid
Syk activation and increased tyrosine phosphorylation.
An important aspect of ligand-dependent BCR activation may be rapid translocation
of the receptor to a source of H202production (like the NADPHoxidases, NOX)or,
vice versa, translocation of the source to the receptor. Indeed in the reducing
environment of the cytosol, H202has only a short half-life and can act only close to
its site of production.
BCR expression is indispensable for B cell survival even in the absence of antigen,
implying that basal signals are generated and deciphered (Kraus et al., 2004; Meffre
and Nussenzweig, 2002). Oxidants and Ca++act in a cooperative manner to regulate
the strength and duration of BCR signalling (Singh et al., 2005), crucial parameters
for determining the subtype of B cell generated from transitional, immature B cells
(Casola, 2007). It is still unclear what the source of the basal BCR signalling is and
how the strength of the signals could be achieved and interpreted.
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Fig.! 15Model oj the redox regulation ojBCR signaling.
(Leftpanel) In the resting state of the BCR (a complex between membrane IgM(mIgM)and the
Iga~heterodimer), the signal-transducing kinase Syk cannot become activated at the lTAM,as
any ITAMphosphorylation is prevented by dominant PTP activity. (Right panel) Upon antigen
(Ag)binding, the BCR is localized closed to a ROS-producing NADPHoxidase. The increased
H202 production generates around the BCR an oxidizing environment or domain (dashed
circle) that inhibits PTP, thus allowing Syk to become active. Signals through Syk and Lyn can
further activate the NADPHoxidase, resulting in increased HrOaproduction and spreading of
the signal. During the conversion of ·02- into H202, singlet oxygen (102) is produced that is
reduced by the catalytic activity of Ig (here, mIgM)into H202.This process may help increase
the oxidizingdomain range around the BCR.
from (Reth, 2002)
1.1.6 B lymphocyte maturation
B cells develop from haematopoietic stem cells in the bone marrow. Early
development and commitment to the B-cell lineage depend on several transcription
factors, including early B-cell factor, PU.l, E2A and paired box protein 5 (PAX5).
Successful rearrangement of IgH gene segments in pro-B cells leads to precursor
(pre)-Bcells, which express Ilm; in the pre-B-cell receptor (pre-Bx'R], Ilm provides the
first crucial check-point for B-cell development, which then allows the clonal
expansion and rearrangement of IgL gene segments. The presence of surface IgM is
required to pass the second check-point, which then allows negative selection to
occur (in which tolerance mechanisms delete, anergize or edit autoreactive clones).
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NaiveB220+IgM+B cells that survive negative selection then exit the marrow. B celis
continue their development in the spleen, where they pass through transitional
stages Tl and T2 and are subjected to a further round of negative selection before
becoming fullymature. A small proportion of transitional B celis home to the splenic
marginal zone and remain there as naive non-circulating marginal zone B cells.
However,most B cells in the T2 stage mature into naive long-livedfollicular B celis,
which continue circulating to the follicles in the spleen, to the lymph nodes and to
the bone marrow until they either die or encounter cognate antigen and undergo
further maturation (Shapiro-Shelefand Calame, 2005).
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Fig.! 16 Antigen-independent development of B cells.
B cells develop from pluripotent stem cells in the bone marrow, where full commitment to the
B-cell lineage requires the transcription factor paired box protein 5 (PAX5).Naive B cells that
exit the bone marrow continue to undergo maturation in the spleen to form long-lived naive
follicular B cells and, to a lesser extent, naive marginal-zone B cells. BCR, B-cell receptor; HSC,
haematopoietic stem cell; pre-B cell, precursor B cell; T1, transitional stage 1; T2, transitional
stage 2.
from (Shapiro-SheZeJ and Calame, 2005)
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1.1.7 B cell activation
After antigen encounter, plasma cells can develop from naive marginal-zone B cells
and follicular B cells, from activated germinal-centre B cells and from memory B cells.
Which B-cell subset(s) becomes terminally differentiated depends on the nature of
the antigen, its dose and form, and the location of the encounter. The earliest
antibody response to some pathogens is provided by pre-existing 'natural' antibodies
that are secreted by B1 cells, which differs from conventional B cells (B2) in different
ways (cell surface phenotype, localization, signal transduction pathways). Their BCR
repertoire is skewed towards recognition of T-cell-independent type 2 (TI-2)antigens,
Le. antigens that contain multiple identical epitopes, which crosslink B-cell receptors,
like bacterial lypopolysaccaride (LPS). They are responsible for the production of
'natural' IgM,which forms in response to self-antigens but often recognizes bacterial
antigens and provides the first line of defense by antibodies against such pathogens.
The first B cells to respond to a foreign antigen by differentiating into plasma cells
are marginal-zone B cells. Consistent with this, marginal-zone B cells have a
repertoire that is skewed towards recognition of TI-2 antigens, although some of
these cells recognize T-cell-dependent antigens and therefore present antigen and
provide co-stimulation to T cells. The location of naive marginal-zone B cells, which
do not circulate, facilitates early encounter with blood-borne antigens. A crucial
property of marginal-zone B cells is their inherent ability to respond rapidly to
antigen. They have a lower threshold for antigen activation than follicular B cells and
when stimulated with LPS, proliferate to a greater extent. Circulating mature
follicular B cells that both encounter antigen and receive help from T cells also
respond rapidly (albeit more slowly than marginal-zone B cells), undergoing
proliferation and plasmacytic differentiation to form extrafollicular foci of
plasmablasts and plasma cells. Plasma cells formed by either marginal-zone or
follicular B cells in this early extrafollicular response do not have somatically
mutated immunoglobulin genes and are short-lived, undergoing apoptosis in situ.
The mechanisms leading to apoptosis are matter of particular interest in our
laboratory and will be discussed in details below. However, these cells provide a
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rapid initial response to pathogens. When follicular B cells both encounter antigen
and receive T-cell help, a second developmental possibility is the establishment of a
germinal centre. Germinal centers are specialized areas in the follicle where B cells
undergo rounds of proliferation, which is accompanied by affinity maturation and
class switch recombination (CSR) of immunoglobulin. Antigen-specific T helper cells
and follicular dendritic cells (FOCs) are important for the germinal-centre response.
The germinal-centre response peaks between day 10 and day 14 after immunization
and then diminishes. Plasma cells and memory B cells, which mainly have
somatically mutated, high-affinity BCRs and express switched immunoglobulin
isotypes, exit the germinal centre. Memory B cells have the intrinsic ability to
respond more rapidly than naive B cells, and they show a proliferative burst on
secondary encounter with antigen (Shapiro-Shelef and Calame, 2005).
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Fig. !17 Formation oj plasma cells.
Antibody-secreting cells (ASes) formed from B1 cells secrete natural antibody in the absence
of external antigen, and they also secrete 19A in the gut, in response to pathogens. On
encounter with foreign antigen (indicated by week 1 in figure), naive marginal-zone B cells
differentiate into plasma cells, and subsequently, naive follicular B cells also differentiate into
plasma cells. Most of the extrafollicular plasma cells that are formed in this early response are
short-lived. Some activated follicular B cells form a germinal centre. Post-germinalcentre
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plasma cellsmight progress through a memoryB-cellstage in the primaryresponse or might
developdirectlyfromgerminal-centreB cells. Plasma cells that result froma germinal-centre
reactionmight becomelong-livedif they find survivalniches, which are mainlylocated in the
bonemarrow.CSR, class-switchrecombination.
from (Shapiro-SheleJ and Calame, 2005)
Plasma cells mainly disappear from the spleen within 2 weeks of infection, but they
are present in the bone marrow for up to I year, indicating that the bone marrow is a
site of long-term antibody production. Bone-marrow plasma cells persist in the
absence of DNA synthesis, and in vivo depletion of memory B cells and adoptive
transfer of virus-specific plasma cells show that a substantial proportion of plasma
cells survive and continue to secrete antibody for more than I year in the absence of
detectable memory B cells. So, although there is evidence that some long-term
immunity is derived from continuous differentiation of memory B cells, at least some
persistent antibodies are derived from long-lived plasma cells, independent of
memory B cells and antigen. Although there is evidence that some long-lived plasma
cells are present in the spleen, it is generally agreed that the bone marrow is the
primary site of long-lived plasma cells. The mechanism of survival of long lived
plasma cells is based on competition for survival niches between newly generated
plasmablasts and older plasma cells. Receptors expressed on the cell surface are
important for homing of the plasma cells to the bone marrow. In particular
plasmablasts deficient in the CXC-chemokine receptor CXCR4 are greatly impaired
in their ability to home to the bone marrow, although there are probably alternative
mechanisms of attraction to the bone marrow (Maser et al., 2006; Radbruch et al.,
2006).
1.1.8 Plasma cell dfJ1erentfatfon
The transcriptional repressor BLIMP! is sufficient, when ectopically expressed by B
cells at the appropriate developmental stage, to drive differentiation into plasma cells.
BLIMP! is expressed by splenic and bone-marrow plasma cells and is required for
plasma cell formation and immunoglobulin secretion. BLIMPI initiates cascades of
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gene regulation leading to cessation of the cell cycle (by direct repression of genes
such as myel, repression of genes that are required for the identity of mature and
germinal centre B cells (including genes that regulate signaling through the BCR, T
cell-B cell interactions, CSR and somatic hypermutation) and induction of the
immunoglobulin secretory program. BLIMP! represses the expression of two
transcription factors that are required for germinal-centre reactions, BCL-6 and
PAXS, thereby ensuring that, after plasma cell development is induced, B cells
cannot return to an earlier developmental stage. Repression of PAXS expression is
important not only for inhibiting B-cell functions but also for allowing plasma cell
development by de-repressing expression of the IgH, the IgL, the J chain and XBPl.
BLIMP! is also responsible for the induction of expression of many genes in the
plasma-cell program, such as IRF4 and genes that are involved in immunoglobulin
secretion.
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Fig. ! 18 Transcriptional repression enforces mutually exclusive B-cell and
plasma-cell gene-expression programmes.
Several transcription factors - BCL-6 (B-cell lymphoma 6), MTA3 (metastasis-associated 1
family, member 3), MITF (microphthalmia-associated transcription factor) and PAX5 (paired
box protein 5) - repress plasmacytic development by repressing BLIMP1 (B-Iymphocyte-
induced maturation protein 1), XBP1 (X-box-binding protein 1) and IRF4 (interferon-regulatory
factor 4). In plasma cells, BLIMP! represses B-cell gene-expression programmes. This mutual
repression prevents the unelicited formation of plasma cells in the germinal centre and
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prevents the reversion of plasma cells to a B-cellstage. BCR,B-cell receptor; TLR,Toll-like
receptor.BCL-6,MTA3,PAX5and MITFalso regulate the expressionof genes that are required
for B-celland germinal-centrefunctions, which are outlined in the pink box. BLIMPl,XBPl
and IRF4induce the expressionofgenes that are required forplasma cells,which are outlined
in the blue box.
from (Shapiro-SheZef and Calame, 2005)
XBPl was the first transcription factor that was shown to be uniquely required for
plasmacytic differentiation. XBPl acts downstream of BLIMPl and seems to be the
proximal regulator of the secretory phenotype in plasma cells, topic that will be
discussed in much greater detail below. IRF4 is a transcriptional activator that
seems to function early in plasma cell development because, in addition to being
required for plasma-cell formation, it is required for the initial proliferative burst of
activated B cells, which does not require BLIMPl (Shapiro-Shelef and Calame, 2005).
Recent fmdings demonstrated that the initial steps of plasma cell differentiation is
independent of BLIMP-l, and requires BLIMP -I-independent down regulation of
PAXS. This initial step of plasma-cell differentiation is represented by a newly
identified pre-plasmablast phenotype that is characterized by low immunoglobulin
secretion [Kallies et al., 2007; Klein and Dalla-Favera, 2007).
In addition to relief from repression, plasma cell factors such as BLIMP! might
require activating signals for induction of their expression. Antigen-mediated
signaling through the BCR can result in B cell proliferation, death or differentiation,
and the strength of signal and the presence of varying supplementary signals affect
the outcome. Signals from the BCR lead to degradation of BCL-6, but there is no
evidence of induction of BLIMP! expression. In fact, IgM-specifIc antibodies inhibit
the induction of BLIMP! expression and the differentiation into plasma cells of
mouse splenic B cells in the presence of LPS. In the presence of CD40-specifIc
antibodies, IL-4 and IL-S, multivalent BCR signaling drives plasma cell formation
much more efficiently than standard immunoglobulin-specific antibodies.
Furthermore, the addition of IL-2 and IL-S can overcome the effects of IgM-specifIc
antibodies to drive induction of BLIMP! expression. So, to induce BLIMP! expression,
a strong signal from the BCR or help from cytokine producing cells during signaling
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through the BCR might be required. The cytokines could be derived from dendritic
cells or T cells. In the absence of BCR ligation, the Toll-like receptor 4 (TLR4)ligand
LPS is sufficient to induce the expression of BLIMP! by mouse splenic B cells and
their development into plasma cells (Shapiro-Shelef and Calame, 2005).
1.2 The secretory pathway
1.2.1 The ER
The ER is organized into a netlike labyrinth of branching tubules and flattened sacs
extending throughout the cytosol. The tubules and sacs are all thought to
interconnect, so that the ER membrane forms a continuous sheet enclosing a single
internal space. This highly convoluted space is called the ER lumen. The ER
membrane separates the ER lumen from the cytosol, and it mediates the selective
transfer of molecules between these two compartments. The ER has a central role in
lipid and protein biosynthesis. Its membrane is the site of production of all the
transmembrane proteins and lipids for most of the cell's organelles, including the ER
itself, the Golgiapparatus, lysosomes, endosomes, secretory vesicles, and the plasma
membrane. Almost all of the proteins that will be secreted to the cell exterior, plus
those destined for the lumen of the ER, Golgi apparatus, or lysosomes-are initially
delivered to the ER lumen. Indeed specialized secretory cells like the exocrine
pancreatic cells or the plasma cells share the common feature of a highly developed
rough ER. The ionic and redox conditions found in the ER and downstream
organelles resemble those encountered in the extracellular space (higher [Ca'"] and
oxidized/reduced glutathione -GSSG/GSH- ratio). Therefore, the ER provides
suitable conditions for secretory proteins to attain their three-dimensional structure.
It also provides a test bench to ensure that ligands and receptors attain the very
conformation that allows the proper signals to be transmitted and deciphered.
Indeed, folding and assembly are intimately coupled to a stringent quality control
schedule that restricts transport along the secretory route to native molecules.
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Whilst the basic principles of folding are the same in all cell compartments, secretory
proteins undergo unique covalent modifications, Le. cleavage of the signal sequences,
N-glycosylation, GPI additions and disulfide bond formation. These are catalyzed by a
sophisticated network of specialized chaperones and enzymes spatially distributed
along the various stations of the exocytic route, providing a most efficient assembly,
quality control and transport line. Quality control (QC)mechanisms are active at the
ER-Golgi interface to ensure that non-native molecules are retained in, or retrieved
to, the ER, and eventually dispatched to the cytosol for proteasomal degradation
(Anelliand Sitia, 2008; Ellgaard and Helenius, 2003; Sitia and Braakman, 2003).
1.2.2 Oxidative folding
Disulphide bonds are essential for the folding and assembly of many proteins
synthesized in the ER. They increase stability, an important feature for Ig to
recognize and neutralize foreign elements in the body fluids. Disulfide bond
formation is based on redox reactions in which two cysteines are oxidized by removal
of two electrons forming a covalent bond. Although direct oxidation could also take
place, in living cells oxidative folding utilizes primarily disulfide interchange
reactions in which an oxidized donor molecule (D) transfers the bond to a reduced
acceptor (A)via formation of a transient mixed disulfide intermediate:
D-SS + HS-A-SH - HS-D-SS-A-SH - HS-D-SH + A-SS
Cargo proteins enter reduced in the ER and are rapidly oxidized by protein
disulphide isomerase (POI). POI is then re-oxidized by Ero I flavoproteins. Electrons
are finally transferred to molecular oxygen and possibly to other electron acceptors,
particularly in anaerobic conditions.
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Fig. I 19 Oxidative folding and the generation of ROS.
In eukaryoticcells, oxidativefoldingof cargoproteins is based on serial disulfideinterchange
reactions involvingPDI and Erol molecules. In vitro, yeast Erol is oxidisedby molecular
oxygengenerating H202 in stoichiometricamounts to the disulphide bonds formed.Most
mammaliancellsexpressconstitutivelyErola. If cargois produced in excess,Ero IS is induced
viaUPRpathwaysactivatedby inefficientoxidativefolding.
In yeast, Erolp is an essential gene, whose expression is induced in conditions of ER
stress. Also PDI is essential in yeast, despite the presence of numerous other
oxidoreductases in the ER. The forced expression of some of these can partially
complement the absence of PDI.
This pathway is fundamentally conserved in higher eukaryotes, although some
important differences exist. First, while a single Erol gene exists in Saccharomyces
cereuisiae, two isoforms, Erola and Erolj3, are found in mammals. Both are able to
complement yeast erol mutants, underscoring the conservation of the oxidative
folding pathways. Ero la is induced by hypoxia and PPAR'Yand inhibited by SIRTl.
In contrast, Erolj3 increases during the unfolded protein response (UPR, an ER
stress response that will be discussed shortly below), and is constitutively expressed
at high levels in certain secretory tissues, confrrming that ER stress responses are
important for the acquisition of the secretory phenotype. The reasons underlying the
functional differentiation between Erola and Ero lp in mammals are not yet clear.
Another remarkable difference between yeast and mammalian Era 1 molecules
concerns the mechanisms of sub-cellular localization. A C-terminal tail is present in
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yErolp that mediates membrane association and is essential for function. Neither
Erola nor Ero lp possess this tail. Both are secreted by mammalian cells when over-
expressed, implying saturable retention mechanism(s). It was demonstrated that the
localization of Erola and Erolj3 depends on dynamic interactions with POlar ERp44,
two soluble proteins that despite the presence of ER localization motifs (KOELand
ROEL, respectively) are differentially distributed in the early secretory pathway.
ERp44 accumulates in ERGle and cis-Golgi, distally with respect to PDI. The
dynamic retention of Era 1 may allow the oxidoreductin to distribute in distinct
subcompartments, and provide the oxidative power needed in the sequential steps of
protein folding like, as will be discussed below, in the case of IgMbiogenesis.
References and figure from (Masciarelli and Sitia, 2008), Appendix III
1.2.3 Regulating oxidative power in the ER
As recalled above, Ero1fi is expressed in conditions of ER stress, or in certain tissues
specialised in protein secretion. A mechanism can be hence envisaged that adjusts
oxidative power in the ER. When Erola becomes insufficient, reduced proteins would
accumulate in the ER. The consequent response (UPR) increases Ero 113 thus
generating the required oxidative power. However, cells must also prevent over-
oxidation. In the ER, disulphide bonds must be constantly isomerised for many
proteins to attain their final three-dimensional structure. Furthermore, proteins that
fail to fold or assemble are not allowed to proceed along the secretory pathway and
inter-chain disulphide bonds are reduced prior to their retro-translocation to the
cytosol for degradation during the process defined ER associated degradation (ERAO).
Many POI homologs reside in the ER of mammalian cells (e.g. ERpS7, ERp72, PS,
PDIR, PDIp and ERp27). Since Erol molecules selectively interact with a subset of
them, some members could exert reductase activities. Recent results indicate that
ERdjS, an ER resident protein containing a OnaJ domain and four thioredoxin-like
domains, favours ER associated degradation of certain substrate proteins reducing
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their inter-chain disulfide bonds (Nagata et al. personal communication). An exciting
question that emerges from these fmdings is what maintains ERdj5 in the reduced
state.
Despite the specificity of protein relays allows opposite redox reactions to coexist in
the ER (disulfide bond formation in nascent proteins, reduction in terminally
misfolded ones), Erol activity must be nonetheless tightly controlled. Its main
substrate, POI must remain in part reduced to act as an isomerase and as a redox
sensitive chaperone, catalysing ERAD substrate unfolding before dislocation.
Moreover, in vitro assays demonstrated that Era 1p generates H202 in equimolar
amounts to the number of disulphide bonds formed. H202 can be converted to other
ROS that can be highly detrimental for the cell. Suggestions of a significant
contribution of Era 1 in cellular ROS production in metazoans come from the
observation that down-regulation of Era 1 strongly reduces ROS levels in ER stressed
C. elegans. Since human Era la and ~ can complement yeast defective cells, it would
be extremely important to determine whether oxidative folding generates hydrogen
peroxide also in mammalian cells, and if so in what molar ratio.
Recent findings revealed an in-built mechanism for regulating Erolp activity. The
oxidation of two non-catalytic cysteine pairs, leads to inactivation of the enzyme.
This rapid feedback mechanism could be particularly important in physiological
situations when the requirements for oxidative folding vary transiently and
frequently, as in certain secretory cells. The translocation of reduced substrates into
the ER lumen shifts the redox balance toward reducing conditions, and rapidly
activates pre-existing Era I molecules, thus fulfilling the increased oxidative demand.
If this pool proves insufficient, the transcription of Era I (EroI~ in mammalian cells)
is induced. The two redox isoforms observed in human Eroia (Oxi and Ox2) might
correspond to distinct functional states.
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Fig.120 Post-translational Erol regulation.
The catalyticcysteines are shownas black ovalswith white text and the extendednon-helical
polypeptide containing the shuttle cysteines is colored red. The regulatory cysteines are
depicted as white "SS"-containingovals when oxidized and black thiol "SH" groups when
reduced. By tethering the non-helical loop domain to the protein core, formation of the
regulatorydisulfidesmay restrict mobilityof the shuttle cysteines and decrease Erol activity
under oxidizingER conditions.When the regulatory disulfides are reduced, active Ero1 uses
molecularoxygento facilitatePDI and substrate protein oxidation.
from (Sevier and Kaiser, 2007)
Another redox-sensitive feedback mechanism could operate at the transcriptional
level. Ero l a is regulated by the hypoxia-inducible factor 1 (HIF1). The 02 sensing
subunit of HIF1, HIF1a, has been found at the ER where it is kept silent by 02-
dependent generation of ·OH. The hydroxyl radical is produced by an ER localised
Fenton reaction [H202+Fe2+-+ Fe3++ OH- + ·OH]. It could be speculated that Ero1 is
the source of H202production at the ER.
Mammalian Era la is generally expressed at rather low levels in cultured cell lines
and the assumption is that its catalytic activity is enough to drive multiple POI
oxidation cycles and hence ensure the folding of many substrate molecules. Low
expression would help avoid the risk of oxidative stress. However, data concerning
Ero l p suggest that this model is maybe too simplistic. Ero l S is expressed at high
levels in specific cell types of human stomach and pancreas. It can form homo- and
hetero-dimers with Ero1a. In vivo, the ratio between Ero1j3 monomers and dimers
differs in stomach and pancreas. Even though the biological meaning of Era 113homo-
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and hetero-dimers is not clear, their tissue specific regulation hints to a complex
mode of control of Era 1 activity.
Besides the existence of Erol-centered regulatory mechanisms, ER redox
homeostasis heavily relies on a variety of cellular buffering systems, including
glutathione (GSH) and NADP+/NADPH. The cellular concentration of GSH ranges
from 1 to 10mMbut the ratio between oxidised (GSSG)and reduced (GSH)species is
very different in the cytosol (1:30-100) and in the ER (1:1-3). This has been long
considered the driving force for disulphide bond formation, but the discovery of the
Er01-PDI relays has changed this point of view. It seems now clear that GSH is
crucial in balancing Erol function, avoiding ER hyper-oxidation and formation of
non-native disulphide bonds.
Like the GSH/GSSG couple, NAD+/NADH and NADP+/NADPH have a pivotal role in
protecting the cell against ROS damage, being involved in the main antioxidant
defence systems comprising glutathione peroxidases (Gpx), the thioredoxin-
thioredoxin reductase system (Trx), peroxiredoxins (Prx), glutaredoxins, superoxide
dismutases (SOD), catalases and exogenous micronutrients and vitamins. Open
questions concern the mechanisms that drive the import of GSH, NADHand NADPH
into the ER lumen, and their regulation during differentiation or stress.
References from (Masciarelli and Sitia, 2008), Appendix m
1.2.41gM/olding requires multiple quality control steps
Quality control (QC) mechanisms are active at the ER-Golgi interface to ensure that
non-native molecules are retained in, or retrieved to, the ER, and eventually
dispatched to the cytosol for proteasomaI degradation (Anelli et al., 2007; Ellgaard
and Helenius, 2003; Sitia and Braakman, 2003). QC recognizes different features,
common to unfolded or not completely assembled molecules, such as immature N-
glycans (Helenius and Aebi, 2004), hydrophobic patches (Blond-Elguindi et al., 1993)
or exposed reactive cysteines by thiol-mediated retention (Fra et al., 1993; Sitia et aI.,
1990).
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As discussed in paragraph 1.1.4, IgMpolymers are planar, multimeric proteins. They
consist of 21 or 24 subunits, depending on whether they are secreted as J-chain
containing pentamers ((f.t2~)5-J) or hexamers ((f.t2~)6). In secreted polymers,
individual monomers 1l2L2are assembled via disulfide bonds involving CyS575in the
C-terminal tailpiece of secretory f.t(f.ts)chains (Sitia et al., 1990). Cys575acts also as a
retention and degradation signal for uri-polymerized secretory IgM [thiol-mediated
retention [Fra et al., 1993)). In membrane Il (Ilm)chains, this 20-residue tailpiece is
replaced by a longer hydrophobic segment, essential for membrane insertion and
assembly with B-cell receptor signaling components. The first assembly step (f.t2~
formation), common to both membrane and secreted IgM, is fast and efficient in both
B and plasma cells: its fidelity is checked by BiP. HiP, also called GRP78, is an
abundant chaperone of the hsp70 family, that was first isolated as a protein
associating with unassembled IgH chains (Haas and Wabl, 1983). Most Ilschains are
degraded by proteasomes in H lymphocytes (Shachar et al., 1992), whereas Ilmchains
that negotiated assembly into functional Bscell receptors are transported to the cell
surface (Sitia et al., 1987).
Therefore, secretory IgM biogenesis occurs in at least two sequential and
independently regulated steps, 1l2~ assembly preceding polymerization. We recently
published a study suggesting that a post-ER QC mechanism plays a key role in the
sequential assembly of IgMpolymers (Anelliet al., 2007). An unexpected finding was
that ERp44, a soluble member of the thioredoxin (trx) family, equipped with an RDEL
localization motif (Anelliet al., 2002), accumulates in the ERGICand cis-Golgi.
Of the three trx-like domains of ERp44, only the N-terminal one possesses a catalytic
CRFS motif. It is via this cysteine, (Cys29), that ERp44 forms mixed disulfides with
Erola, Ero ljl, unpolymerized IgM subunits, adiponectin and other substrates of
thiol-dependent protein quality control. ERp44 mediates the thiol-dependent
retention of 1l2~, ilL and other un-polymerized IgM subunits that have already
passed the HiP-dependent checkpoints (Anelli et al., 2003). ERp44 localization partly
depends on interactions with ERGlC-53, which also binds IgM subunits (Mattioli et
al., 2006). As a hexameric membrane-embedded lectin, ERGlC-53 may provide a
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platform for IgM polymerization (Anelli et al., 2007). In the eis-Golgi, ERp44 could
capture un-polymerized IgM subunits and retrieve them via RDEL-dependent
mechanisms. In view of its ability of binding Ero1 (Otsu et al., 2006), ERp44 could
also provide oxidative power to the polymerization machinery. In this scenario, the
compartmentalization of assembly and polymerization in the early secretory pathway
of professional antibody secreting cells may couple QC and transport, thus achieving
high production capacity.
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Fig. I 21 Schematic model of the IgMpolymerization machinery.
The IgM assembly line is schematized in its sequential arrangement. The distribution of
ERp44 in the early secretory pathway (primarily in the ERGlC)is depicted as a gradient of gray.
BiP-dependent control ensures that ID chains do not proceed to the polymerization machinery
unless assembled with L chains [first QC step). ERGlC-53, a hexameric lectin acting in
conjunction with MCFD2 (the latter is not shown) captures m2L2 subunits, likely aligning
them in a planar conformation, suitable for polymerization. ERp44 ensures that
unpolymerized subunits are not secreted, retrieving them into the assembly line (second QC
step). Because of its ability to bind IgM subunits and ERGlC-53, ERp44 may recruit and
locally concentrate m2L2, to stimulate further the polymerization machinery efficacy.
from (Anelli et al., 2007), Appendix II
1.2.5 The unfolded protein response
The flux of newly synthesized proteins into the ER is variable because it can change
rapidly in response to programs of cell differentiation, environmental conditions and
the physiological state of the cell. To handle this dynamic situation, cells adjust the
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protein-folding capacity of the ER according to their requirements, thereby ensuring
that the quality of cell-surface and secreted proteins can be maintained with high
fidelity. Such homeostatic control is achieved through the action of signal
transduction pathways that have sensors facing the ER lumen and effectors that
convey the message to other compartments of the cell. The intracellular signalling
pathway that mediates this regulation is named the unfolded protein response (UPR).
An imbalance (defined ER stress) between the load of unfolded proteins that enter
the ER and the capacity of the cellular machinery that handles this load sets three
main responses in motion, the first two of which are rectifying. First, there is a
reduction in the protein load that enters the ER, which is a transient adaptation that
is achieved by lowering protein synthesis and translocation into the ER. Second,
there is an increase in the capacity of the ER to handle unfolded proteins, which is a
longer-term adaptation that entails transcriptional activation of UPR target genes,
including those that function as part of the ER protein-folding machinery. If
homeostasis cannot be re-established then a third mechanism, cell death, is
triggered, presumably to protect the organism from rogue cells that display misfolded
proteins.
Three different classes of ER stress transducers have been identified. Each class
defines a distinct arm of the UPR that is mediated by inositol-requiring protein-I
(IRE!), activating transcription factor-6 (ATF6)or protein kinase RNA(PKR)-likeER
kinase (PERK).In each case, these are integral membrane proteins that sense the
protein-folding status in the ER lumen and transmit this information across the ER
membrane to the cytosol and the nucleus. Indeed they are constituted by a lumenal
portion that senses the protein-folding environment in the ER, and by a cytoplasmic
effector portion that interacts with the transcriptional or translational apparatus.
The present model to explain UPR activation involves the binding of the major ER
chaperone, BiP, to the lumenal portions of the ER stress sensors, which represses
their activation. In the presence of ER stress BiP releases the receptors to bind
accumulating unfolded proteins, relieving repression (Bertolotti et al., 2000).
However, this model must not be the only means of UPR signaling initiation since it
does not completely explain the fine tuned modulation of UPR activation, as will be
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discussed below.
The firat stress transducer was identified by a screen for mutations that block the
activation of a UPR-inducible reporter in yeast. The gene in question, IREI, encodes
a type I ER-resident transmembrane protein with a novel lumenal domain and a
cytoplasmic portion that contains a protein kinase domain. In response to unfolded
proteins, IREI oligomerizes in the plane of the membrane, allowing for trans-
autophosphorylation of juxtaposed kinase domains. Oligomerization can be triggered
directly by binding of unfolded proteins to the IREI lumenal domain (which bears an
architectural resemblance to the peptide-binding domains of major
histocompatibility complexes) (Zhou et al., 2006), or might involve the release of the
oligomerization-repressing chaperones BiP, or both (Bertolotti et al., 2000). By a
poorly understood mechanism, trans-autophosphorylation of the kinase domain of
IREI activates its unusual effector function, which causes the endonucleolytic
cleavage of the only known substrate: an mRNA that encodes a transcription factor
named Hacl (homologous to ATF/CREBI) in yeast or XBPI (X-boxbinding protein-I)
in metazoans. IREI cuts the precursor Hacl or XBPI mRNA twice, excising an
intervening fragment or intron. The 5' and 3' mRNA fragments are then ligated,
generating a spliced mRNA that encodes an activator of UPR target genes.
Biochemical and genetic evidence indicates that in yeast, ligation of the two ends of
the HACI mRNAis mediated by tRNAligase (Trll). The enzyme(s) responsible for this
reaction in higher eukaryotes have not been identified, but recent evidence for a tight
association of XBPI mRNAwith membranes indicates that, as in yeast, cleavage and
ligation occur in association with the ER. The consequences of this IREI-dependent
splicing event differ in yeast and metazoans. In yeast, the HACI mRNA intron
represses translation and relief of this repression is the key activating event of the
yeast UPR. By contrast, in metazoans both the precursor and spliced form of XBPI
are translated. However, the encoded proteins, which differ markedly in sequence
owing to a splicing-mediated frame shift, have different functional properties. The
form of XBPI encoded in the spliced mRNA (sXBPl) is more stable and works as a
potent activator of UPR target genes, whereas the protein encoded by the precursor
mRNA (uXBPl) is labile and represses UPR target genes. sXBPl up-regulate
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transcription of many genes involved in the secretory pathway (ER chaperones,
members of the ERAD pathway, genes involved in membrane expansion) (Acosta-
Alvearet al., 2007; Shaffer et al., 2004; Sriburi et al., 2007). In metazoan cells, levels
of XBPI mRNAalso increase upon UPR induction and continue to rise as ER stress
declines and IREI is inactivated. Therefore, the new XBPI mRNA remains in its
precursor, unspliced form, which encodes an inhibitor ofXBPI signalling. This might
serve to terminate signaling by a combination of inhibitory heterodimerization with
spliced XBPI and competition for binding sites. Metazoan IREI probably has
signaling functions beyond its nucleolytic activity. For example, mammalian IRE1
activates the stress-induced Jun N-terminal kinase (JNK) and interacts with
components of the cell-death machinery, such as caspase-12, independently of its
RNase activity. However, apart from indirect evidence for a contribution to the death
of ER-stressed cells, the physiological significance of such pathway branches
remains unclear. Analysis of mRNAs expressed in ER-stressed Drosophila
melanogaster cells evidenced widespread IREI-dependent degradation of ER-
associated mRNAs. This process is likely to represent an XBPI-independent post-
transcriptional mechanism for IRE1 control of gene expression that remodels the
repertoire of proteins translated in ER-stressed cells. It is unknown whether the
nuclease that initiates these events is IRE1 itself, functioning in a mode of relative
specificity, or another, yet-to-be-identified nuclease that is recruited or locally
activated by IRE1.
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Fig. !22 Signalling by IREl.
Inositol-requiring protein-l (IREl) oligomerizes in the plane of the endoplasmic reticulum (ER)
membrane in stressed cells. Trans-autophosphorylation in its cytosolic kinase domain
increases the affinity for nucleotides (N),which allosterically activate IRE! and unmask a
dormant endoribonucleolytic activity. IRE!-mediated sequence-specific cleavage of a single
known mRNA (X-box binding protein-l (XBP!) in higher eukaryotes, HAC! (homologous to
ATFjCREBl) in yeast) excises a small RNAfragment (intron). The two ends of the mRNAare
ligated (tRNAligase (Trll) has this role in yeast but the identity of the ligase is unknown in
metazoans), which leads to a frame shift in the coding sequence (shown in the figure as a
colour change from yellow to red after removal of the intron). Spliced XBPI mRNAencodes a
potent transcriptional activator (XBP!s), whereas the unspliced XBPI mRNAencodes XBPlu,
an inhibitor of the unfolded protein response (UPR). In yeast, the Hac1 jXBPl pathway
activates most of the UPR, whereas in mammals, it appears that XBPI regulates a subset of
UPR genes that promote ER-associated degradation (ERAD)of misfolded proteins and ER
biogenesis. IRE! can also act by alternative means. In mammals, recruitment of TRAF2
(tumour necrosis factor receptor (TNFR)-associatedfactor-2) by phosphorylated IREI allows it
to signal to Jun N-terminal kinase (JNK) and alter intracellular signalling (for example,
resulting in insulin resistance). The IREI-TRAF2 complex has also been linked to caspase-12
activation and cell death. In cultured Drosophila melanogaster cells, activated IREI can
promote the cleavage of various ER-localized mRNAs, leading to their degradation. This
reduces the load on the stressed ER and might facilitate reprogramming of the ER-associated
protein synthesis and translocation machinery. It is unknown whether IREl cleaves these
mRNAs directly or whether it promotes their degradation by activating or recruiting other
RNases. JNKK,JNK kinase; JNKKK,JNKKkinase.
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ATF6 is the founding member of a novel class of metazoan-specific ER stress
transducers. These are synthesized as inactive precursors, tethered to the ER
membrane by a transmembrane segment and have a stress-sensing portion into the
ER lumen. Under conditions of ER stress, ATF6 is transported from the ER to the
Golgi apparatus, where it is cleaved by Golgi-resident proteases, first by SIP (site I
protease) and then in an intra-membrane region by S2P (site 2 protease) to release
the cytosolic DNA-binding portion, ATF6f ('f for fragment). From there, ATF6fmoves
to the nucleus to activate gene expression of a subset of UPR genes mostly involved
in improving the secretory capacity of the cell (Haze et al., 1999; Hong et al., 2004;
Nadanaka et al., 2007; Wu et al., 2007; Yamamoto et al., 2007). ATF6 trafficking
from the ER to the Golgi is initiated by accumulation of unfolded proteins in the ER
lumen. As discussed for Ire1 this could be sensed by release of the luminal portion of
ATF6by BiP inhibitory binding or directly. The predicted structures of several other
proteins suggest that they are ER-anchored transcription factors that are related to
ATF6, for example, LZIP (also known as luman or cyclic AMP-responsive element
binding protein-3 (CREB3)), OASIS (also known as CREB3-like-1) and Tisp40
(transcript induced in spermiogenesis-40). One such protein, CREB-hepatocyte
(CREBH),has recently been found to be activated by ER-stress-regulated proteolysis.
However, CREBHdoes not activate genes that enhance the capacity of the secretory
pathway but, rather, links ER stress in the liver to the secretion of serum proteins
that are associated with inflammation (so-called acute-phase responsive proteins).
These observations are an intriguing example of integration of the UPRwith a range
of physiological systems.
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Fig. 123 Signalling by ATF6.
Activating transcription factor-6 (ATF6)and cyclic AMP response element binding protein
hepatocyte (CREBH) are transmembrane proteins with a cytoplasmic portion that, when
liberated from its transmembrane tether, can bind to DNA and activate target genes. In
unstressed cells, ATF6and CREBHreside in the endoplasmic reticulum (ER)membrane. ATF6
trafficking appears to be hindered by binding of the ER chaperone immunoglobulinbinding
protein (BiP) to its lumenal domain. ER stress disrupts BiP binding and ATF6 (and CREBH)
are delivered to the Golgi apparatus. The details of this vesicular transport event remain
unknown. In the Golgi apparatus, these proteins are subject to consecutive cleavage, first by
the lumenal site I protease (SIP) and then the intra-membrane site 2 protease (S2P), which
liberates the cytosolic effector portions of the proteins from the membrane and allows their
import into the nucleus. ATF6probably activates a subset of UPR target genes, although these
remain to be characterized, whereas CREBH activates acute-phase response genes that
encode secreted proteins involved in inflammation.
The third ER stress transducer, PERK, superficially resembles IREl. Both are ER-
localized type I transmembrane proteins with lumenal stress-sensing domains that
are phylogenetically related, similar in structure and function, and experimentally
interchangeable. The cytoplasmic portion of PERK also contains a protein kinase
domain, which undergoes activating trans-autophosphorylation by oligomerization in
ER-stressed cells; however, unlike IREl, for which the only substrate is itself, PERK
phosphorylates the a-subunit of eukaryotic translation initiation factor-2 (eIF2a) at
SerS!. This phosphorylation inhibits the guanine nucleotide exchange factor eIF2B,
a pentameric complex that recycles eIF2 to its active GTP-bound form. Lower levels
of active eIF2 result in lower levels of translation initiation, globally reducing the load
of newly synthesized proteins, many of which are destined to enter the already
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stressed ER lumen. In addition to decreasing global protein synthesis to reduce the
ER load, PERK-mediated eIF2a phosphorylation also contributes to transcriptional
activation in the UPR. Expression profiling in ER-stressed PERK knockout cells
showed the defective induction of numerous mRNAs that are responsible for the
normal UPR.A similar defect in stress-induced gene expression was also observed in
cells with a Ser51Ala mutation in eIF2a that prevents the regulatory phosphorylation
event but does not otherwise affect eIF2 function. Furthermore, most genes that are
down regulated in PERK-knockout cells were induced by the directed activation of
PERK (in an experimental system that is uncoupled from ER stress). Most
importantly, the entire range of the PERK-dependent gene expression program
requires eIF2a phosphorylation as it was blocked by the SerSlAla mutation. eIF2a
phosphorylation leads to translational up regulation of the transcription factor ATF4.
The S'-untranslated region of ATF4contains short, inhibitory upstream open reading
frames (uORFs) that prevent translation of the downstream ATF4-encoding ORF in
unstressed cells. Conditions that limit eIF2 activity (due to eIF2a phosphorylation)
lead to ribosomes skipping the inhibitory uORFs so that the ATF4 ORF can be
translated. As different types of stress converge on eIF2a phosphorylation, like
starvation, the presence of double stranded RNAand heme deficiency, respectively
mediated by the eIF2a kinases GCN2, PKR and HRI, this branch of the UPR is also
termed integrated §tress response (ISR) (Harding et al., 2003). General translation
inhibition is quickly reversed by a negative feedback loop. Phosphorylation of eIF2a
and the consequent decrease in initiation complexes availability that selectively
promotes translation of the transcription factor ATF4mRNAleads to up-regulation of
genes involved in amino-acid transport, genes that protect against oxidative stress
(Lu et al., 2004; Marciniak et al., 2004; Ron and Walter, 2007) and of gadd34, a
regulatory subunit of the PPI phosphatase which dephosphorylates eIF2a shutting
down the signalling (Novoaet al., 2001).
Among the genes whose expression is induced by eIOa phosphorylation there is the
member of the C/EBP family of transcription factors CHOP. CHOP is mostly
recognized as a pro-apoptotic factor, especially when induced by the UPR (Marciniak
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et al., 2004; Oyadomari and Mori, 2004). CHOP role and mechanisms of up
regulation, in the UPR, and elsewhere, will be the main topic throughout this work.
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Fig. I 24 Signalling by PERK to the translational machinery.
In response to endoplasmic reticulum (ER) stress, protein kinase RNA(PKR)-likeER kinase
(PERK), similar to inositol-requiring protein-l (IREl), oligomerizes in the plane of the
membrane and is activated by trans-autophosphorylation of its activation loop. Extensive
further phosphorylation of the large kinase insert loop facilitates substrate recruitment.
Phosphorylation of a single known substrate, the a subunit of eukaryotic translation initiation
factor-2 (eIF2) on SerSl, inhibits the pentameric guanine nucleotide exchange factor eIF2B
from recycling eIF2 to its active GTP-bound form. The resulting reduced activities of eIF2B and
the eIF2 complex account for all of the important consequences of PERK activity. Because
other eIF2 kinases (PKR, haem-regulated inhibitor kinase (HRI) and general control non-
derepressible-2 (GCN2))can activate this pathway independently of ER stress, this portion of
the unfolded protein response (UPR)is termed the integrated stress response (ISR). Lower
global protein synthesis reduces ER unfolded protein load but also affects gene transcription.
For example, translation of the activating transcription factor-4 (ATF4)is increased under
conditions of limiting eIF2, whereas nuclear factor ICB(NFICB)is activated post-translationally.
The ISR activates genes that encode amino-acid transporters and genes that protect against
oxidative stress, and it contributes to the transcriptional activation of XBPI. The transcription
factor CHOP (C/EBPhomologous protein) is also activated transcriptionally by ATF4 and its
target genes include GADD34 (growth arrest and DNA damage-inducible protein-34), a
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regulatory subunit of phosphatase PPl that dephosphorylates eIF2a and terminates signalling
in the ISR, and ER oxidase-l (ERGl), which is required for disulphide bond formation in
protein folding. A constitutive phosphatase CReP (constitutive repressor of eIF2a
phosphorylation) assists GADD34in this task.
Although the three UPR pathways are distinct there is a considerable degree of cross-
talking (Ron and Walter, 2007). Indeed ATF-6 increases transcription of xbp-l (Leeet
al., 2002) and ATF-6 and sXBP-1 act cooperatively on various targets via the ER
stress responsive element (ERSE) and the UPR element (UPRE). Whereas ATF6
activates transcription only via the ERSE, sXBP1 can recognize both ERSE and
UPRE elemens (Wuet al., 2007; Yamamoto et al., 2007; Yamamoto et al., 2004). Also
ATF4 (which activates transcription via the C/EBP-ATF composite site) and ATF6
cooperate in the activation of some UPR genes, as will be discussed in further details
(Ma et al., 2002; Ma and Hendershot, 2004). sXBP-l up-regulate the expression of
p58lPK which inhibits PERK signalling (Lee et al., 2003; van Huizen et al., 2003; Yan
et al., 2002). Depending on the duration and the strength of the stress the UPR can
mediate recovery and adaptation or apoptosis (Lin et al., 2007; Rutkowski and
Kaufman, 2007). In particular IRE1 and PERK are involved in activation of various
pathways leading to apoptosis in a manner that is not fully elucidated (Meares et al.,
2008; Puthalakath et al., 2007; Szegezdi et al., 2006).
Clarification of the UPR pathways was mainly obtained by heavy perturbation of the
ER homeostasis obtained by drugs that led to the coordinate activation of all the
branches of the UPR. For this reason the UPR was initially considered as an "all or
nothing" response. It then became clear on the contrary that different types of
secretory cells, which undergo physiological levels of ER stress, selectively exploit the
various UPR branches (Brewer and Hendershot, 2005; Wu and Kaufman, 2006). For
example whilst PERK pathway is essential for survival of insulin secreting ~ cells
(Harding et al., 2001), IRE1/XBP-l and ATF6 pathways are activated during plasma
cell differentiation but PERKis not (Gass et al., 2002; Gass et al., 2008; Zhang et al.,
2005). Indeed XBP-I-I- B lymphocytes cannot differentiate into plasma cells
(Iwakoshi et al., 2003a; Reimold et al., 2001) but PERK-I-B cell differentiation is not
impaired (Gass et al., 2008).
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Unless stated otherwise references and figures are from (Ron and Walter, 2007)
1.3 Regulation of immunoglobuUn secretion
1.3.1 The UPRin plasma cell differentiation
Ig are co-translationally translocated in the ER where they attain their proper
quaternary structure, mature into the Golgi and proceed along the exocytotic
pathway to be secreted. Indeed the most dramatic transformation when a B
lymphocyte differentiates into a plasma cell concerns the ER expansion accompanied
by an enlargement of the Golgi complex (Lewiset al., 1985; Rush et al., 1991; Shohat
et al., 1973; Wiest et al., 1990) which are necessary to accommodate the increase in
Ig synthesis. This transformation is accomplished by the interplay between B
lineage-specific transcriptional programs that control plasma cell differentiation and
the unfolded protein response.
The extensive secretory pathway in plasma cells is appropriately equipped for
enhanced protein biosynthesis. In fact, it is specifically the ribosome-studded rough
ER that is most drastically expanded, and this correlates well with the robust
escalation of immunoglobulin translation. As differentiation proceeds, a large cohort
of ER-resident proteins that constitute critical components of the protein folding
machinery is up regulated. These proteins include molecular chaperones such as BiP
that promote proper protein maturation and enzymes such as protein PDI and Ero 1
that facilitate oxidative protein folding. Therefore, the enlarged ER is populated with
the full complement of factors needed to efficiently accommodate the increased load
of nascent immunoglobulin chains (Romijn et al., 2005; van Anken et al., 2003). The
increased immunoglobulin synthesis is further managed by parallel enhancement of
mechanisms that ensure fidelity in immunoglobulin secretion. For example, the
amount of ERp44 and ERGle-53 rise sharply during the differentiation process
(Anelli et al., 2007). This observation fits well with the fact that plasma cells
generally do not secrete incompletely assembled immunoglobulin molecules (Reddy
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and Corley, 1999). Thus, quality is not sacrificed for quantity as B cells transition
into high-rate antibody production.
The augmented flow of nascent immunoglobulin chains into the secretory pathway
increases the demand placed on the protein folding capacity of the ER. Given its
various roles in regulating ER homeostasis, it follows that the UPR would be
intimately involved in the conversion of B cells into antibody factories. The essential
connection between the UPR and plasma cell development was revealed by key
studies from Glimcher and co-workers regarding the XBPI transcription factor.
Deletion of mouse xbpl induces an embryonic lethal phenotype owing to hypoplasia
of the liver (Reimoldet al., 2000). When xbpl-null ES cells were used to reconstitute
recombination activating gene-2 (rag-2) deficient mice, the chimeric animals
produced normal numbers of mature B cells in all compartments. The B cells were
able to proliferate and form germinal centers in response to antigen but were unable
to differentiate into plasma cells (Reimold et al., 2001). Plasma cell differentiation
and the UPR then crossed when XBPI mRNAwas shown to be spliced during LPS-
induced plasma cell differentiation (Calfon et al., 2002). Indeed, sXBPl is capable of
restoring differentiation potential to XBP-l deficient B cells, whereas the uXBPl is
not (Iwakoshi et al., 2003b).
sXBPl can orchestrate expansion of intracellular organelles. Enforced expression of
sXBPl in a B cell line was shown to be sufficient to amplify the abundance of ER,
Golgi, mitochondria and lysosomes (Shaffer et al., 2004). Thus, sXBPI can direct
events that expand the compartments where antibodies are made while
concomitantly increasing the quantities of the organelle that supplies the energy
required for massive immunoglobulin biosynthesis. Organelle expansion in cells
overexpressing sXBPI is accompanied by elevated expression of many genes
encoding secretory-pathway components. These include proteins that target and
translocate nascent polypeptides into the ER, chaperones and their cofactors that
promote protein folding and assembly, oxidoreductases that regulate oxidative
protein folding, glycosylation enzymes, regulators of vesicular trafficking, and
proteins implicated in ER associated degradation (ERAD).Notably, many of these
same genes are up regulated in differentiating B cells in an sXBPI-dependent
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fashion. These data strongly suggest that sXBPI mediates a broad program of gene
expression during differentiation that upgrades the entire secretory apparatus,
thereby enhancing antibody production while ensuring retention of assembly
intermediates and disposal of excess or misfolded immunoglobulin subunits by
ERAD. Perturbation of UPR-mediated gene expression in differentiating B cells
compromised quality control, resulting in improper secretion of IgM assembly
intermediates (Gunn et al., 2004).
A growing body of data indicates that the UPR activation profile is likely to vary
among different types of specialized secretory cells. For example, the IREI-XBP-l
branch of the UPR is clearly active in differentiating B cells (Calfon et al., 2002;
Iwakoshi et al., 2003b), and sXBPl is essential for successful plasma cell
development. ATF6 pathway is activated as well during plasma cell differentiation
(Gass et al., 2008) even though a role for ATF6 in developing plasma cells has not
been established. It is certainly possible that this factor contributes to the induction
ofXBPI as well as many genes encoding ER chaperones and folding enzymes. PERK,
in contrast, is not activated in the normal course of terminal B cell differentiation
(Gass et al., 2008; Zhang et al., 2005). Notably, the PERK arm of the response is
functional in B cells, as evidenced by potent induction of CHOP, a PERK-dependent
UPRtarget gene, in response to ER stress agents, as will be shown in this work. This
raises an interesting point, because PERK seems to be essential for maximal
induction of ER chaperones during ER stress (Harding et al., 2000; Novoa et al.,
2003), and chaperones are highly up regulated during plasma cell differentiation. In
sharp contrast to differentiating B cells, pancreatic tissue shows high constitutive
activity of both PERK and Irel (Harding et al., 2001). PERK is essential for proper
control of insulin biosynthesis, ~ islet cell survival, and normal function of pancreatic
acinar cells.
What is the mechanistic basis for UPR variation? One possibility is that the three
transducers-IRE 1, ATF6 and PERK-have different thresholds for activation. To
date, there is no evidence supporting this idea, but it is conceivable that such
differences may not have been apparent when strong ER stress-inducing agents were
used to study the response. If such a hierarchy exists, it must vary by tissue given
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the dissimilarity between PERKactivity in B cells versus the pancreas. Another idea
is that there are alternative mechanisms to activate the individual transducers
independent of the load of unfolded proteins and the abundance of BiP. Although no
other means of activating the transducers have been elucidated, this hypothesis
remains an intriguing possibility. In the case of UPR activation in differentiating B
cells, expression of immunoglobulin heavy chains is required for optimal synthesis of
sXBPI (Iwakoshi et al., 2003b). These data fit well with the idea that the UPR is
triggered when BiP is needed to accommodate an increased flux of nascent
polypeptides. It is worth noting, however, that u-chain deficient B cells did show low,
but detectable, amounts of sXBPI when stimulated with LPS. Moreover, a kinetic
analysis found that synthesis of sXBPI precedes the massive increase in
immunoglobulin translation during differentiation of the CH12 B cell lymphoma
(Gass et al., 2002). Thus, the nature of the signals that can elicit the UPR in
physiologic settings may not yet be fully understood.
A final possibility is that various arms of the UPR can be specifically suppressed or
activated. Flexibility is likely to be a key feature of the physiologic UPR, allowing the
response to appropriately fit the situation. For example, pancreatic cells must rapidly
modulate protein synthesis according to sudden fluctuations in circulating glucose
concentrations. As a result, the ~ islet and acinar cells must cope with episodic high-
rate synthesis of secretory-pathway proteins. It follows, therefore, that these cell
types might be especially reliant on the ability of PERKto rapidly regulate translation.
However, as B cells terminally differentiate, they initiate and accelerate antibody
secretion, presumably to an optimal level, and then continue in this capacity until
death. Moreover, the differentiation process prepares the cell for high-rate secretion
by up regulating a wide array of metabolic processes and initiating expansion of the
secretory pathway before the point of greatest immunoglobulin synthesis (Romijn et
al., 2005; van Anken et al., 2003). Thus, a UPR-initiated, PERK-mediated repression
of protein synthesis would be counterproductive for cells that are designed to
maximally synthesize and secrete immunoglobulins. One could regard the PERK-
mediated attenuation of translation as an 'emergency brake' that, in certain cell
types under specific conditions, slows the flow of nascent polypeptides into the
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secretory pathway, thereby guarding against the potentially catastrophic effects of an
overloaded ER. This translation 'brake' might be deliberately not in use when there is
no need to balance high-rate protein production with long-term survival, as would be
the case for short-lived plasma cells.
Interestingly we have previously reported that the UPR player CHOP (Q/EBP
homologous Qrotein) is up regulated during differentiation of the B lymphoma cell
line 1.291-l+(Cenci et al., 2006). CHOP belongs to the C/EBP family of transcription
factors and is also called C/EBPl;, GADD153 (Q.rowth ~est and DNA Qamage
inducible gene 153) and ddit3 (DNA-damage-inducible transcript 3) (Marciniak et al.,
2004; Oyadomari and Mori, 2004). It heterodimerizes with other members of C/EBPs
family (Ron and Habener, 1992; Ubeda et al., 1996) and also with different bZip
transcription factors, like those belonging to the ATF/CREB family (Chen et al.,
1996). However, CHOP contains proline and glycine substitutions in the basic region
that disrupt its DNA-binding activity. Consequently, CHOP-C/EBP heterodimers
cannot bind to canonical C/EBP sites. On the other hand, CHOP-C/EBP
heterodimers can bind to another unique site (A/G) (A/G) (A/G)TGCAAT(A/ClCCCto
activate target genes. Furthermore, CHOP can enhance the transcriptional activation
of AP-1 by tethering to the AP-1 complex without direct binding of DNA.Thus, CHOP
has a dual role both as an inhibitor of C/EBPs function and as an activator of other
genes (Oyadomari and Mori, 2004).
ER stress is the strongest inducer of CHOP, downstream of ATF6, Ire1 and PERK
pathways, where it mostly plays a proapototic role (Ma et al., 2002; Oyadomari and
Mori, 2004). However, it is also involved in many different stress responses and
physiological processes and it was originally described as a gene involved in the
response to DNA damage (Eizirik et al., 1993; Fornace et al., 1988; Luethy and
Holbrook, 1992; Oyadomari and Mori, 2004). CHOP is up regulated in response to
accumulation of misfolded proteins in the mitochondria (mtUPR) (Horibe and
Hoogenraad, 2007), upon amino-acid starvation (Averous et al., 2004; Bruhat et al.,
2000) and upon exposure to oxidative stress (Guyton et al., 1996; Tang et al., 2002).
Importantly CHOP plays a role in the differentiation of a variety of cell types, like
adipocytes (Huang et al., 2005; Li et al., 2006; Tang and Lane, 2000), keratinocytes
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(Maytin and Habener, 1998) and osteoblasts (Pereira et al., 2006; Shirakawa et al.,
2006), together with different members of the C/EBP family of transcription factors.
Expression of the XBP1 gene in B cells is controlled by the interplay of several
transcriptional regulators. The BCL6 transcription factor is required for normal
function of mature B cells and is a repressor of BLIMP1 (see paragraph 1.1.8).
Signaling through the B cell antigen receptor (BCR) induces phosphorylation and
ubiquitination of BCL6, thereby targeting it for degradation (Niu et al., 1998) and
allowing induction of BLIMPI. Recent gene array studies have shown that BLIMPI is
upstream of a complex program of gene expression that involves both down and up
regulation of transcription (Kallieset al., 2007; Klein and Dalla-Favera, 2007; Shaffer
et al., 2004). In particular, Blimp-1 directly represses BCL6 and PAX5, a
transcriptional regulator required for B lineage commitment and a repressor both of
immunoglobulin and J chain genes and of XBPI (Reimold et al., 1996). In keeping
with these data, induction of XBP1 is dependent on BLIMP1 (Shaffer et al., 2004).
XBP1 is not the only essential target downstream of BLIMPl, as enforced sXBPl
expression in bZimpl-deficient cells is not sufficient to restore immunoglobulin
secretion (Shapiro-Shelef et al., 2003). BLIMPl regulates expression of several gene
products that control cell cycle progression, thereby halting proliferation of
terminally differentiating B cells. A number of cell surface proteins, such as major
histocompatibility class II molecules, components required for BCR signaling and
factors that control the germinal center reaction, are also downregulated by BLIMPl
(Brewer and Hendershot, 2005). These modulations in gene expression fit well with
the fact that cells devoted to antibody secretion no longer need to communicate with
T cells, respond to antigen or undergo affmity maturation. Furthermore, BLIMPl,
perhaps via indirect mechanisms, augments the transcription of genes encoding the
structural components of antibody molecules, including the immunoglobulin heavy
and light chains and the J chain. It is also required for the switch to the production
of mRNA encoding secretory rather than membrane-bound IgH chains (Shapiro-
Shelef et al., 2003). Therefore, BLIMPl functions as a master regulator of plasma cell
differentiation by facilitating induction of XBPl, shutting down unnecessary cellular
processes and enhancing immunoglobulin expression. Increased immunoglobulin
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expression is, as discussed earlier, also linked to optimal induction of sXBPl.
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Fig. I 25 Interplay between transcriptional programs during plasma cell
differentiation.
Signaling through the BCRor LPS stimulation leads to a loss of Bc16(blue box), which relieves
the repression on Blimpl. In turn, Blimp-l represses Bcl6 transcription to maintain its own
expression, blocks proliferation by repressing Myc and E2fl and inducing the cyclin-
dependent kinase inhibitor p18 (also known as Cdkn2c), and induces switching to the
secretory form of immunoglobulin heavy chain. Additionally, Blimp-l represses PaxS, which
relieves the repression on the immunoglobulin genes, allowing their upregulation. Bcl6 and
PaxS thus directly repress genes involved in plasma cell differentiation (red lines). In addition,
the Blimp-I-mediated loss of Pax5 relieves the repression on Xbpl, resulting in larger
amounts of unspliced XBP1(U) mRNA, as does ATF6 activation via the UPR (purple box
denotes potential overlap between these two pathways). Activation of Irel (via UPR; orange
box) induces processing of the XBP-I mRNA to produce the remodeled form of the XBP-l
protein, XBP-I(S), which drives many of the requirements for high-level secretion. Only the
PERKcomponent of the UPR seems to remain inactive (yellowbox), and this regulation might
also be linked to XBP-I(S).
from (Brewer and Hendershot, 2005)
1.3.2 Ending the antibody response
After few days of intense Ig secretion most plasma cells die (Moser et al., 2006;
Radbruch et al., 2006). Their short lifespan is probably important to limit the
immune response. If the antigen is not yet defeated, new specific B lymphocytes,
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meanwhile expanded in numbers and equipped with better receptors by affmity
maturation and isotype switching in germinal centers, will be activated. What causes
apoptosis of plasma cells? Ig production itself could cause death via different
mechanisms. One could be a prolonged UPR sustained by continuous Ig production.
The UPR can lead to apoptosis through multiple pathways (Breckenridge et al., 2003;
Scheuner et al., 2006; Szegezdi et al., 2006; Xu et al., 2005): activation of ER stress
specific caspases (caspase 4 in human, 12 in mouse), mitochondrial activation by ER
Car' release, activation of JNK via IRE1, and suppression of anti-apoptotic bc1-2 and
sensitization to ROS via the transcription factor CHOP (downstream of the PERK
branch of the UPR). However, recent data exclude a role for PERK and the
downstream factor CHOPin plasma cell apoptosis ((Gass et al., 2008) and this work).
A recent study supports a direct role of Bax, caspase 4 and the ER in plasma cell
apoptosis (Pelletier et al., 2006), though autocrine or paracrine loops involving the
death ligand TRAIL may also be important (Ursini-Siegel et al., 2002).
In all likelihood, different factors concur in rendering plasma cells susceptible to
apoptosis. One predisposing factor could be the chaperone overload that might arise
at the high rate of protein synthesis achieved by plasma cells (Soti et al., 2003;
Sreedhar and Csermely, 2004). In addition, we recently showed that in the late
phases of differentiation, when antibody production becomes maximal, proteasomal
activity decreases. This correlates with parallel increased sensitivity to proteasome
inhibitors, and stabilization of endogenous proteasomal substrates, including IK-Ba,
and the proapoptotic factors Bim and Bax ((Cenci et al., 2006), appendix I).
Aminoacid supply and energy production could also become limiting as Ig synthesis
becomes preponderant, further lowering the threshold for apoptotic commitment
(Cenci and Sitia, 2007).
Perturbation of the redox homeostasis could be yet another factor leading to plasma
cell death. On the basis of the present knowledge about oxidative folding, the
massive production and assembly of Ig could generate abundant ROS in
differentiating plasma cells (paragraphs 1.2.2 and 1.2.3). The production of 103 IgM
per second, each containing 102 disulfides, implies that 105 bonds be formed solely
to satisfy the requirements of antibody production, explaining the increase in Ero1a
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and ~. If O2is the ultimate acceptor also in living mammalian cells, up to 105 H202
molecules per second could be generated as a byproduct of oxidative folding in IgM
secreting cells.
Besides oxidative folding, additional processes could contribute to ROS production. It
has been estimated that nearly 2% of the total oxygen consumed by mitochondria
leaks from mitochondrial respiratory chain in a partially reduced form (Ames et al.,
1993). It is reasonable to imagine that the higher metabolic requirements in plasma
cells would cause a corresponding increase in mitochondrial ROS generation. Such
mechanism has been proposed to explain the increase in ROS upon T lymphocytes
activation (Hildeman et al., 2003).
A regulated source of ROS in differentiating B cells could be NADPHoxidases. These
are complex enzymes known to generate superoxide in phagocytes during
inflammatory processes (Babior, 2002). Different isoforms of NADPHoxidase (NOX)
and dual oxidase (DUOX)have been described in non-phagocytic cells to generate
ROS in a regulated manner, with important consequences upon signalling (Bedard
and Krause, 2007; Lambeth, 2004). B lymphocytes express NOX2 and DUOXI
(Bedard and Krause, 2007; Reth, 2002; Singh et al., 2005). Intriguingly, I found
increased expression of NOXA2(p67phox) transcripts in murine ASC with respect to
un-stimulated B lymphocytes (transcriptional expression profiling described in this
work). These preliminary findings deserve further analyses, especially since previous
reports failed to detect NOXA2in plasma cells (lnanami et al., 1998).
Although formal evidence of ROS generation during plasma cell differentiation
remains to be gathered, many are the indications that plasma cells undergo oxidative
stress. The up regulation of different enzymes involved in thiol redox balance upon
stimulation of 1.29~+with LPS has been described in different proteomic analysis
studies (Romijn et al., 2005; van Anken et al., 2003). Prxl expression was detected
by immunoistochemistry in human plasma cells but not in B lymphocytes infiltrating
inflammatory tissue of the oral cavity, independently of the inflammation-inducing
agent (Demasi et al., 2007). An ER resident oxidoreductase (plasma cell-Trx related
protein, PC-TRP)is specifically expressed in murine primary plasma cells (Wrammert
et al., 2004). Trx! expression is higher in human cell lines with plasma cell-like
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features than earlier stages of differentiation, even though immortalized lines could
be selected for stronger anti-oxidant responses (Nilsson et al., 2004).
Further indication of ongoing oxidative stress in ASC comes from the observation
that differentiating B lymphoma cells trigger a Nrf2-dependent anti-oxidant response
(S. Nerini Molteni, S. Cozza and R.Sitia, unpublished data). Nrf-2 is a redox sensitive
transcription factor that mediates the induction of glutathione S-transferase,
glutamyl cysteine ligase (GCLM/GCLC, the limiting enzymes for GSH synthesis),
heme oxigenase-I (HO-I), phase II detoxifying enzymes and other anti-oxidant
factors (Zhang, 2006).
The above observations indicate that oxidative stress could contribute to limit
plasma cell lifespan, in a fashion possibly dependent on the rate and intensity of
antibody secretion. Proteasomal insufficiency, a chronic UPR and ROS production
could hence cooperate in inducing death when enough antibodies have been
produced. It is worth recalling that the UPR and ROS share a common apoptotic
pathway through the apoptosis signal-regulated kinase 1 (ASKI) (Bishopric and
Webster, 2002; Kadowaki et al., 2005; Nagai et al., 2007). Activated IRE! recruits the
TNF receptor associated factor 2 (TRAF2),which in turn binds to ASK! leading to
apoptosis via JNK activation. ASK! deficient cells are unable to activate JNK and are
much more resistant to ER stress-dependent death (Nishitoh et al., 2002). ASKI is
negatively regulated by reduced Trx l (Fujino et al., 2007; Nadeau et al., 2007). Ig
synthesis could hence activate the ASK1/ JNK apoptotic cascade, via the different
mechanisms elicited by UPR/IRE1 pathway and ROS. Furthermore, the pro-
apoptotic activity of JNK is executed via the bc1-2 family members, known to be
involved in plasma cell death. JNK can inhibit bc1-2 (Yamamoto et al., 1999) and
mcl-l and activate Bax , Bim and Bmf (Inoshita et al., 2002; Lei and Davis, 2003;
Putcha et al., 2003; Tsuruta et al., 2004). Recent studies point to a direct proapototic
role for Bax in human plasma cells: Bax is recruited at the ER and contributes to
caspase 4 cleavage before the release of mitochondrial apoptotic factors (Pelletier et
al., 2006). Bax is stabilised and accumulates in differentiating B lymphoma cells
whilst the level of bcl-2 expression remains constant (Cenci et al., 2006). An
additional link among ER stress, ROS generation and Bax proaptotic activity comes
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from studies regarding pharmacologically induced UPR and apoptosis. The ER
resident protein Bax inhibitor 1 (BI-l) regulates ER stress associated ROS generation
via up-regulation of HO-l through Nrf-2 and protects cells from UPR induced
apoptosis (Lee et al., 2007). Increased ROS could favour plasma cell apoptosis also
perturbing Ca' ' homeostasis. The activity of both sarcoplasmic/endoplasmic
reticulum calcium ATPases (SERCA2b in particular) and IP3 Receptors type 1 are
regulated in a redox dependent manner (Higo et al., 2005). In turn, ER Cat" release
potentiates mitochondria-dependent apoptosis (Gorlach et al., 2006).
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2. Aims of the work
Plasma cell differentiation entails profound metabolic and morphological changes. In
order to achieve the required levels of immunoglobulin production, assembly and
secretion, B cells need to increase their secretory capacity by expanding the ER and
the Golgi. Such transformation is obtained by the interplay between the B cell
lineage specific transcriptional program and a stress response named Unfolded
Protein Response (UPR). The UPR consists in a group of signaling pathways
emanating from the ER when it undergoes stress, due to increased demands in the
folding capacity or to disruption of its homeostasis. The UPR aims to re-establish ER
homeostasis by augmenting the ER membrane and protein components. When ER
stress is too strong or too prolonged the UPR switches from its adaptive nature to
promoting apoptosis. For many years it has been considered as a uniform response,
with the various branches activated altogether in the presence of ER stress. The
main reason for this belief is that the elucidation of the response has been obtained
mainly with drugs that dramatically disrupt the ER homeostasis, circumstances in
which generally all the UPR arms are indeed set off. Studies on physiologically
induced ER stress due to pathological conditions (like expression of mutant proteins)
or to increased demand for secretory capacity (as in the case of secretory cells
differentiation) showed on the contrary that different cell types selectively exploit
various elements of the UPR. Indeed only certain components of the UPR are
necessary for plasma cell differentiation.
My studies aimed mainly to the identification of elements of the UPR involved in
plasma cell differentiation and to the characterization of their role. I indeed describe
here the involvement of a UPR player, the transcription factor CHOP. Unexpectedly
though, my data suggest that during this process CHOP is expressed independently
of the UPR. The characterization of its role in plasma cell differentiation evidenced
that CHOPexpression is not essential but led to the identification of a novel role for
this transcription factor in the ER homeostasis, likely cell-type specific. I furthermore
identified a novel gene downstream of CHOP, the transcription factor ATFSwhose
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role in plasma cell differentiation and in the UPRmust be further analyzed.
Characterization of plasma cell molecular physiology being extensively studied in our
laboratory. I collaborated with my colleagues in an effort to elucidate the mechanism
regulating plasma cell life span (appendix I). In particular I utilized a murine
lymphoma cell line and a mouse model to support our fmdings indicating that
inefficient proteasomal capacity with respect to the increased load challenging ASCis
one of the elements leading to plasma cell apoptosis. In the same context, in
collaboration with a colleague, I recently set out to study the redox homeostasis
during plasma cell differentiation. Our preliminary findings indicate that ASC
undergo increased levels of oxidative stress when producing the maximum amount of
IgM.
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3. Results
3.1 Identification of a novel role for CHOPin the secretory pathway of
antibody secreting cells
3.1.1 The transcription factor CHOPis expressed in 1.29p+,a model cell line to
study antibody secreting cell differentiation
1.291l+is a murine lymphoma cell line that can be induced to differentiate to plasma
cell-like antibody secreting cells (ASC)by exposure to bacterial lipopolysaccharide
(LPS)(Romijnet al., 2005; van Anken et al., 2003). Differentiation can be assessed by
analysing various parameters that 1.291l+share with their primary counterpart, such
as for instance the expression on their plasma membrane of the heparan sulphate
proteoglycan syndecan-l (CD138) (Fig.1 A). Upon LPS stimulation it is possible to
observe the switch between the expression of the membrane isoform of Il chain (Ilm,
part of the BCR) and the secretory one (Ils), together with highly increased levels of
IgM expression and secretion (Fig.! B). The UPR transcription factor XBP-l is
essential for plasma cell differentiation and indeed differentiated 1.291l+increase the
expression of the active, spliced isoform sXBP! (Fig.I Cl. The life span of
differentiating B cell is short, almost half of the cells die 4 days after LPS stimulation
(Fig.! Cl.
In a search for UPR players up regulated during 1.291l+differentiation I found that
these cells increase CHOP expression shortly after LPS stimulation (Fig.! D). I then
asked if CHOP induction could be observed also in differentiating primary B
lymphocytes.
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Fig. 1 1.29f.l+up regulate CHOPexpression during differentiation to ASC
The murine lymphoma line I.291t+was induced to differentiate to ASCwith 20 Ilg/ml LPS. At
the indicated time points differentiation was followed by checking various parameters. A
Surface expression of the plasma cell marker CD138/syndecan-l was measured by flow
cytometry, staining the cells with an anti-CD138 antibody PE-conjugated. B Protein extracts
from differentiating cells (lysate) and culture media (secretion) were treated with the enzyme
PNGase F to remove glycans and separated by SDS-PAGE.The blotted filters were probed with
an anti-It antibody to follow the expression levels of the membrane (11m) and secreted (Ils)It
chain isoforms. C Filters prepared as in B were probed with antibodies specific to XBP-l and
CHOP. Only the region of the blot corresponding to molecular weight of the spliced form of
XBP-l is shown. Actin expression level was used as loading control. D Apoptosis was
measured by propidium iodide (PI)staining followedby flowcytometry analysis.
3.1.2 CHOP is transiently induced during primary antibody secreting cell
differentiation but its absence does not impede it
Mouse mature primary splenic B cells can be readily induced to undergo terminal
differentiation in vitro by LPS treatment, providing an optimal tool to study
differentiation of antibody secreting cells (Iwakoshi et al., 2003b; Shaffer et al., 2004).
I found that the transcription factor CHOP is transiently up regulated early during
ASC differentiation: in the experiment shown in figure 2A CHOP transcript
expression level peaked at day 1 upon LPS stimulation and became barely detectable
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thereafter. In other experiments, CHOPtranscription and synthesis peaked at day 2,
but I never observed CHOPin the nucleus at day 3 or after (Fig.2B]. As a control for
CHOPinduction I treated B lymphocytes and ASCwith the ER stress inducing agent
thapsigargin (Tg),which depletes ER Ca2+ stores heavily affecting protein folding. An
increase in CHOP nuclear levels was observed in both lymphocytes and ASC
indicating that CHOPsilencing in the later phases of differentiation is not irreversible.
Since CHOP is up regulated in response to various types of stress, including
oxidative stress, and isolation and in vitro differentiation of primary B lymphocytes
expose the cells to a much higher p02 with respect of that found in vivo, I checked if
the same pattern of CHOP expression could be observed in in vivo differentiated
plasma cells. To this aim wt mice were challenged with an intra-peritoneum injection
of LPSand plasma cells were isolated at the indicated time points (Fig.2Cl. Real time
PCR analysis of mRNApurified from plasma cells confirmed that chop messenger is
up-regulated at the early time points of B cell differentiation. On the basis of my
experience, I believe that the diversity in the fold of increase between the experiments
shown in figure 2A and 2C depends on the variability observed among mice and not
on the different experimental settings.
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Fig. 2 Differentiating primary B lymphocytes transiently increase CHOPmRNA
and protein
B lymphocytes (CD19+) isolated from wt and chop-r- mouse spleens were induced to
differentiate into antibody secreting cells (ASC)by incubation in vitro with 20 I1g/mlLPS for the
indicated time points. A CHOP mRNAexpression pattern during differentiation was followed
by relative real time PCR-The fold increase at each time point with respect to day 0 wt was
calculated by the aaCt method, using histone 3 as reference gene. Error bars represent the
SEMfor the average of PCRtriplicates of the same samples. B CHOPprotein up regulation was
detected by Western blot of nuclear extracts of differentiating B cells decorated with an anti-
CHOP antibody. B cells at day 0 or day 3 after LPS stimulation were treated for 3hrs with 2
I1g/mlof the ER stress inducer thapsigargin (Tg)and the nuclear protein extracts were used as
positive controls for CHOP induction. Ponceau staining of the nitrocellulose filter is shown as
loading control. C c57/BL6 mice were injected intra-peritoneum with LPS only at the starting
point of the experiment (dayO).After LPS injection 3 mice for each time point were sacrificed
and differentiating B cells were purified and mixed to extract total RNA.CHOP transcript was
detected as in A (error bars represent the SEM for the average of PCR triplicates of the same
samples).
In order to investigate the role of CHOP in plasma cells I turned to the analysis of
chop-null mice. These are viable and fertile and show no obvious phenotype
(Oyadomari et al., 2002; Zinszner et al., 1998). Accordingly, B and T lymphocytes
were present in the same percentage in spleens and lymph nodes of wt or chop t:
mice (Fig.3 A).Spleens from chop:': mice showed the same gross morphology as those
harvested from wt littermates, and a comparable number of CD19+cells could be
purified from spleens of either genotype (data not shown). These observations
indicate that CHOP is not essential for B cell development. However, the transient
appearance of CHOP in the nucleus might reflect a functional role for this
transcription factor in ASC differentiation. Therefore, I stimulated B splenocytes from
chop:': mice or controllittermates with LPS and analyzed numerous parameters of
ASC differentiation (Figures 3 and 4). The percentage of cells expressing on their
surface the plasma cell marker CD138 was alike in wt and chop:': cultures (Fig.3 B).
After an initial phase of intense proliferation ASC start dying and after 4-5 days of
LPS stimulation around 40%-50% of cells undergo apoptosis. The patterns of
proliferation and death were similar in wt and chop:t: differentiating B cells (Fig.3 C
and results not shown) indicating that CHOP plays no essential role in
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differentiation-related apoptosis. The strong increase in expression and synthesis of
IgMsubunits was unaffected in chop/: ASCas well (Fig.3D and El.
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Fig. 3 CHOP deletion does not affect the normal pattern of B cell
differentiation
A The totality of cells harvested from lymph nodes and spleens were stained with FITC-
conjugated antibodies against the B lymphocytemarkers CD38and BCR11m chain and the T
lymphocyte'sone TCRa chain and analyzedby flowcytometry (n=3;error bars represent the
SEMof the average).B·E B lymphocytesisolated fromwt and chopv: spleenswere incubated in
the presence of LPS and differentiationprogression was analyzed by various parameters. B
Surface expression of the plasma cell marker CDI38/syndecan-l was measured by flow
cytometryafter staining the cellswith an anti-CD138antibody PE-conjugated(n=3;error bars
represent the SEMof the average).C Growthcurve (top panel) was obtained culturing the cells
at the initial density of 105 cells/ml and measuring the cell density at the indicated time
points. The percentage of dead cells (bottom panel) was measured by staining the cells with
propidiumiodide (PI)followedby flowcytometryanalysis (n=3;error bars represent the SEMof
the average)To confirm death by apoptosis the experiments were repeated performing the
TUNELassay, obtaining the same results (data not shown).D IgMsubunits 11and J chains
transcript levels were measured by relative real-time PeR performed as in Fig. 2 A E IgM
subunits J, K and 11chains protein expression was assessed by western blot, sequentially
probing the filter with specific antibodies. Ponceau staining of the nitrocellulose filter is
presented as loadingcontrol.
I then checked if components of the UPR, normally activated during plasma cell
differentiation, were mis-regulated in chop-t- ASCs. Hence, I assessed the induction
of ATF6/IRElpathways and found that these were normal. Up regulation and
splicing of xbpl mRNA and sXBPl protein appearance showed the same dynamics in
wt and in chop t: cells (Fig.4 A, B and C). Consistently with the similar levels of
sXBPl, the mRNA levels of its targets edem and ERdj4 (Kanemoto et al., 2005; Lee et
al., 2003; Yoshida et al., 2003), displayed indistinguishable kinetics of activation in
wt and chop«: cells (Fig.4 OJ.Also the levels of ERdj3, another target of sXBPl during
ER stress and PC differentiation (Shen and Hendershot, 2007) were the same after 3
and 4 days of LPS stimulation (Fig.4 C). Particularly important was to study the
expression pattern of HERP in ASC differentiation, because together with CHOP is
the only mown UPR target dually regulated by the ATF6-XBPl and by the
PERK/ATF4 pathways, via ERSE and C/EBP-ATF composite element respectively
(Ma and Hendershot, 2004). HERP is an ER localized protein involved in the ER
associated degradation (ERAD) and protects against ER stress-induced apoptosis
(Liang et al., 2006; Okuda-Shimizu and Hendershot, 2007). I found that HERP is
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strongly up regulated in wt as well as in chap:l: ASC at the latest days of
differentiation, as the other UPR players (FigA C].
From the analysis of chop/: B cell I reckon that CHOP is dispensable for plasma cell
differentiation.
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Fig. 4 UPR signaling is intact in chop-I· ASC
B lymphocytes isolated from wt and chop«: spleens were incubated in the presence of LPS and
at the indicated time points RNAand protein extracts were obtained to study the expression
pattern of various components of the UPRA The amount of XBPI transcript was measured by
relative real-time peR as in Fig.2 A. B Activation of XBPI pathway was assessed by RT-PCR
with primers specific for the un-spliced (uXBPI) and the spliced (sXBPl) forms of XBPI mRNA.
RNApurified from 1.29!l+cells treated with the ER stress inducer tunicamycin was used as
positive control (Tm). C Protein levels of sXBPI, ERdj3 and HERP were measured by western
blot with the corresponding antibodies. Actin was used as loading control. D EDEM and ERdj4
mRNAlevels were quantified by relative real time PRC as in Fig.2 A.
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3.1.3 CHOP expression is important for efficient IgM polymerization and
secretion
The most important feature of plasma cells is their ability of efficiently producing,
assembling and secreting very high amounts of Ig. As shown above, the increase in
the synthesis ofigM subunit was similar in wt and chop t: Ase cells (Fig.3 D and E).
However, a subtle phenotype became evident when we compared IgM assembly by
non-reducing western blotting. As shown in figure SA, chop t: ASC accumulated more
high molecular weight (HMW) species than the wt cells at the latest days of
differentiation, namely after three to five days upon LPS stimulation depending on
the experiment (Fig.SA and not shown). These high molecular weight species
contained J, K and ~ chains and consisted of disulphide-bonded aggregates, as they
were no longer detectable after boiling in DIT (data not shown). Densitometric
analyses confirmed that the chop": Ase accumulated significantly more HMW
complexes while similarly assembling the other IgMspecies (Fig.SB).
As these data suggested impairment of the secretory pathway and protein
aggregation, performed electron microscopy analysis to detect possible
morphological alterations in the ER. Whilst wt ASe's cytoplasm was mostly filled by
regular stacks of ER cisternae, many chop t: cells presented deformed, very enlarged
cisternae supporting the previous observations pointing to protein aggregation (Fig.S
Cl·
Since HMW aggregates are retained intracellularly, I reasoned that chop-I- ASe
should secrete fewer IgMwith respect to the wt cells. I thus quantified IgM secretion
in wt and chop l: Ase cultures by ELISA. The results indicated that chap t: cells
secrete less IgM polymers (Fig.S D). Accordingly, different concentrations of the
reducing agent 2ME were necessary to increase secretion of unpolymerized IgM
(Alberini et al., 1990) in chop«: rather than in wt ASe (Fig.S E). At lower
concentrations, 2ME promoted secretion in ko as well as in wt cultures. On the
contrary, higher concentrations of 2ME allowed the release of the more abundant
IgMaggregates in the chop t: cells but negatively affected the wt cells, where IgMare
assembled and secreted with higher efficiency and there is less aggregation. At high
71
concentrations, 2ME impairs IgM secretion and promotes I.l chain degradation in
hybridoma cells (Shachar et al., 1994), likely because it disturbs oxidative folding of
nascent Igs (Valetti and Sitia, 1994). When I measured IgG concentrations in the
culture media I found that secretion of this isotype was impaired as well in chop":
Ase (Fig.S D). However 2ME inhibited IgG secretion at the same rate in both
genotypes pointing to a cause of reduced IgG secretion other than covalent
aggregation (Fig.S El.
Since eHOP is involved also in oxidative stress responses it was important to exclude
that the phenotype observed in chop t : Ase were related to altered redox equilibrium.
Thus I investigated if chop:': plasma cells exhibit the same defect at physiological p02.
In order to verify if chop I plasma cells secrete sub-optimal amounts of IgM also in
vivo, and if such defect extends to other Ig isotypes, wt and chop t mice were
immunized sub-cutaneously with ovalbumin. Blood samples were taken at the
indicated time points and sera levels of ovalbumin-specific IgM and IgG were
assessed by ELISA.To normalize for the variability of Ig concentration in the pre-
immune sera the data were analyzed as the ratio between the absorbance values
obtained at a given time point and the earliest time point of the assay (Le. day 0 for
IgMand day 4 for IgG), as detailed in figure SF. In keeping with the data obtained in
vitro, I found that upon immunization the increase in IgM sera concentrations was
lower in chop t: than in wt mice. On the contrary there was no difference in IgG
increase. This observation is in contrast with the results I obtained with ASe
differentiated in vitro. Together with the data obtained with the 2ME treatment this
fact supports the idea that the impairment of IgG secretion in vitro in chop«: culture
is due to a different mechanism than that affecting IgM folding. The in vivo analysis
leads to the conclusion that IgG secretion is normal in chopr plasma cells.
In summary, I conclude that even though CHOP is not essential for plasma cell
differentiation, it allows optimal functionality of the IgM assembly machinery and
consequently higher levels oflgM secretion.
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Fig.5 CHOPpromotes optimal assembly and secretion oj 19M
A IgMpolymerization was analyzed by non-reducing western blots. Total protein extracts from
wt and cnop ': B cells after 3 and 4 days of LPS stimulation were subjected to SDS-PAGEin
non-reducing conditions, in order to preserve disulphide bonds among the IgM subunits and
blotted. The nitrocellulose filter was incubated with anti-u chain antibodies and the main IgM
assembly intermediates were identified. B Quantification of the relative amount of each IgM
species in chop/: ASC with respect to the wt. The percentage of each prevalent IgM species
(HMWcomplexes, 1!21.2, I!L, I!) relative to the sum of all the species was calculated after
densitometry analysis of non-reducing western blots as shown in A.The histogram reports the
average of the ratio between the percentages of each IgM species in chopr: samples to that
found in the wt samples from four independent experiments (n=9; error bars represent the
SEMof the average). Depending on the experiment the analysis was performed at 3 to 5 days
after induction of differentiation. C Morphology of wt and chop-': ASCat day 4 of differentiation
was studied by transmission electron microscopy. N, nuclei; m, mitochondria; white
arrowheads indicate rough ER tubules. wt: 77% (n=13); ko: 50% (n=14) of cells with regular
ER. D Secretion efficiency of wt and chop-I- ASC 3 days after LPS stimulation was tested by
EUSA measurement of IgM and IgG concentrations in medium of cultures at 1()6cella/ml
incubated for 4hrs. The histograms report the average concentrations obtained in two
independent experiments (n=4; error bars represent the SEM of the average). E Effects of the
reducing agent 2-mercaptoethanol (2-ME)on IgMsecretion. Secretion assay was performed as
described in Dafter 5 days upon LPS stimulation in the absence or in the presence of the
indicated concentrations of 2-ME. IgMand IgG concentrations in the media were measured by
EUSA. Data are reported as the ratio between the absorbance measured in the presence of the
indicated concentrations of 2-ME and that measured in the absence (n=4, error bars represent
the SEM of the average, * indicates a p value < 0.05 (Student's T test)). 11' Ovalbumin-specific
IgMand IgG titers in mouse sera upon ovalbumin immunization. Mice were immunized with
by sub-cutaneous injection of ovalbumin and sera were collected at 0, 4, 13 and 22 days post-
immunization. IgMand IgG sera concentration were measured by EUSA. Data are reported as
the ratio between the absorbance measured at the indicated time point and the earliest time
point in each assay (dO for IgM and d4 for IgG) (n..5; error bars represent the SEM of the
average, * indicates a p value < 0.05 (Student's T test)).
3.1.4 CHOP absence lowers the expression oj Btl' and ERp44, ER chaperones
involved in IgMpolymerization
The observation that chop«: ASC are more prone to generate IgM aggregates
prompted me to investigate the levels of expression of the ER chaperones involved in
IgM polymerization. IgM polymerization is a stepwise process under the control of a
strict quality control system. BiP (originally known as GRP78), one of the main ER
chaperones, is involved in the earliest step of IgM polymerization binding 1.1 chain
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thus avoiding its aggregation or secretion until it is joined to the light chain
(Hendershot and Kearney, 1988; Vanhove et al., 2001). ERp44 has a main role in the
thiol-mediated retention system, blocking secretion of un-polymerized IgM and
recently we proposed that ERp44 collaborates with ERGICp53 favoring IgM
polymerization (Anelli et al., 2007). Another player likely involved in IgM
polymerization is the ER oxidoreductase Ero1a: Ig and in particular IgM, are rich in
disulphide bonds and Ero 1 proteins are essential for their formation. When I
analyzed the levels of expression of this set of chaperones I found, as expected, that
all of them were up regulated during ASC differentiation (Fig. 6). BiP up-regulation
was slightly reduced in the differentiating chop": cells, both at the mRNAand at the
protein level (Fig.6 A and B)_ERGICp53 expression pattern was the same in wt and
ko cells while I found a difference in the amount of ERp44 protein that was slightly
less in the chop-null ASCcompared to the wt (Fig.6 C). Immunofluorescence analysis
of ASC indicates as well that ERp44 is less expressed and/ or differentially localized
in chop/: ASC (Fig.6 D). Unfortunately, at this moment, variability among different
experiments does not allow me to draw definitive conclusions about the
transcriptional regulation of ERp44 in chop-null cells. Previous studies from Ron and
colleagues (Marciniak et al., 2004) showed that eroIa expression is regulated by
CHOP in mouse embryonic fibroblasts as chop-null MEF show strongly decreased
up-regulation of Erola upon UPR induction. They also showed by ChIP assays that
such regulation is directly exerted on Erola promoter. I found no differences between
the two genotypes in the up-regulation of Erola protein during B cell differentiation
(Fig.6 B]. Analysis of the expression pattern of the mRNAhowever, indicates that at
the time points in which CHOP is expressed during ASC differentiation Erola mRNA
amount is less in the ko cells than in wt (Fig.6AI.A compensation mechanism seems
to increase the amount of Ero la messenger in the chop-null cells in the following
hours, when CHOP expression is shut down. This observation could explain why I do
not detect differences in the protein amounts between wt and chop«: cells.
In summary, among the chaperones involved in IgM polymerization that I analyzed, I
found that BiP and ERp44 proteins are still increased during differentiation of CMp-/-
B cells but to a lesser extent with respect to the wt ones, pointing to the presence of
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alterations in the IgM polymerization machinery and quality control system. Indeed
we recently showed that ERp44 down-regulation by RNAiin a reconstituted system
of IgM polymerization in HeLa. cells decreases polymers formation ((Anelli et al.,
2007) appendix II). From my present data I are not able to assess how these
observations are related with the tendency of chop': ASC to form IgMaggregates and
this will be matter of further investigation. However, my results suggest that among
CHOP targets during B cells differentiation there is one or more factor(s) whose
expression allows full up-regulation of BiP and ERp44. It is indeed unlikely that
CHOPdirectly regulates SiP and ERp44 expression since its transient up regulation
terminates much before they reach the maximal levels of expression (compare Fig. 2
and 6)
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Fig.6 CHOPI- ASC up regulate BiP and ERp44 to a lesser extent than wt cells
B splenocytes differentiated in vitrowere analyzed for the expression of chaperones involved in
IgM polymerization. A Relative real time PCR as in Fig.2 A was performed to quantify BiP and
Erola transcript levels (error bars represent the SEM of the average among PCR triplicates of
the same samples; .... p value < 0.005, .. P value < 0.01 (Student's T test)). B-C Erola, BiP,
ERp44 and ERGICpS3 protein expression was analyzed by western blot with specific
antibodies. Actin was used as loading control (top panels). Densitometric analysis of western
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blots as shown in the top panels (bottom panels). Data are reported as fold increase relative to
the protein amounts measured at dayO, normalized to actin (error bars represent the SEM of
the average fold increase in four independent samples for each genotype). D Expression level
and localization of ERp44 (green) was analyzed by immunofluorescence staining of wt and
chop«: cells 3 days after LPS stimulation. ERGle and ER compartments are labeled by the
resident proteins p115 and calreticulin respectively (red).
3.1.5 CHOPI·ASC express lower levels of ERtijS, Cl newly identified ER resident
reductase
Very recently Prof. K. Nagata and his collaborators described for the first time the
existence of an ER resident protein with a specific thiol-reductase activity, ERdj5
(personal communication, Ushioda et al. manuscript in preparation). ERdj5 was first
identified in our laboratory as a chaperone expressed in secretory cells and induced
during ER stress (Cunnea et al., 2003). It belongs to the ERdj family, which
comprises ER proteins containing a DnaJ domain, by which they can interact with
hsp70 family proteins like BiP. Among the five identified members of the ERdj family
only ERdj5 possesses also a thioredoxin-like domain CXXC.Nagata and colleagues
demonstrated that ERdj5 exerts reductase activity that requires its CXXCmotifs and
that it enhances ER associated degradation (ERAD) of misfolded proteins by
preventing the formation of disulfide-bound aggregates. Furthermore they showed
that it interacts with EDEM, a fundamental component of the ERADmachinery and
that in order to promote degradation of misfolded proteins it must also have an
intact DnaJ domain to associate with BiP.
These observations prompted me to investigate the expression pattern of ERdj5
during B cell differentiation, wondering if that could have a role in minimizing IgM
aggregation.
I found strong up-regulation of ERdj5 protein during ASC differentiation, suggesting
that it could play an important role. Surprisingly its levels of expression were
significantly reduced in chop": cells (Fig.7 A). As discussed for BiP and ERp44, it is
unlikely that CHOP directly activates ERdj5 expression: however it could induce the
expression of one or more factor(s) that then enhance ERdj5 promoter activation. I
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hypothesize that reduced amounts of ERdj5 in chop-null cells could generate over-
oxidizing conditions in the ER and explain the increased tendency to generate IgM
aggregates.
In order to prove this theory I would need on the one hand to knock-down Erdj5 in
wt ASCand on the other to over-express it in chap": cells. If the hypothesis is correct
then I should observe enhanced IgM aggregation in the first case and reduced
aggregation in the second one. Since, for unclear reasons, transfection of B cells is
not easily achieved, alternative strategies are being considered as discussed below.
While setting up the appropriate tools, I turned to other systems to start
investigating the role of ERdj5 in IgM polymerization. Non-B cell types are able to
assemble different IgM intermediates when transfected with cDNAsencoding for the
various subunits. Diverse epithelial cell lines show differential efficiency in
assembling higher order IgM intermediates. I exploited HEK293FT (293) to
reconstitute IgM polymerization with or without simultaneous over-expression of
ERdj5, in order to study the influence of this chaperone on IgMpolymers formation
(Fig.7 B). My results show that when 293 are simultaneously transfected with 1-1 and
A they form various IgMintermediates species and I identified the main ones as I-1A,
1-12A2 and polymers. When also J is transfected together with 1-1 and A the polymers
molecular weight is increased since they comprise the J chain, as expected. ERdj5
over-expression reduced the amount of polymers in both JI-1A and I-1A transfectants to
the advantage of lower degree IgMassembly, 1-12A2, I-1A and 1-1.
Taken together my data point to the involvement of ERdj5 in IgM polymerization
during which it exerts reductase activity.
79
A
+/+ -t- *15 -O-wl
~
ERdj5 10
5
actin
0
...
LPS dO dl d2 d3 d4
(days)
LPS
B
J~l). ~l).
ERdj5 - + - +
polymers
CII
o
ERdj5
• ~l)_
o ~l)_,
L pol
J~l/_
*
Fig.7 The ER resident reductase ERdj5 is involved in IgM polymerization and
is expressed at lower levels in chop-I-ASC
A ERdjS protein expression during in vitro differentiation of wt and chop·l· B cells was analyzed
by western blot- Actin was used as loading control (left pane~. Densitometric analysis of
western blots as shown in the left panel (right panel). Data are reported as fold increase
relative to the protein amounts measured at dayO, normalized to actin (error bars represent
the SEM of the average fold increase in four independent samples for each genotype; * p value
<0.05 (Student's T test)). B HEK293FT cells were transfected with plasmids encoding for the
IgM subunits u, A and J chains, as indicated, with or without an additional plasmid expressing
ERdjS. 48 hrs after transfection protein extracts were separated by SDS-PAGE in non-
reducing conditions to preserve disulphide bonds and blotted. The nitrocellulose filter was
probed with anti-u antibodies to individuate IgM polymerization intermediates (left pane~. The
asterisk indicate an aspecific band. Densitometric analysis of the western blot shown in the
left panel (right paneQ. Data presented in the left side histograms report the percentage of each
IgM intermediate relative to the total amount of Il in the lane. In the right side histograms are
plotted the ratios between the percentage of each IgM intermediate in the presence of ERdjS to
that in the absence.
80
3.1.6 CHOP/· B cells (but not T cells) are more sensitive to ER stress-induced
death
It is well accepted that during the UPR CHOP mainly plays a pro-apoptotic role
(Marciniak et al., 2004; Oyadomari et al., 2002; Oyadomari and Mori, 2004). The
downstream pathways are not fully elucidated yet but chop/: MEF are more resistant
than wt to ER-stress induced death and chop-null mice show a lower degree of
kidney damage relatively to wt siblings when systemically treated with the ER stress
inducer tunicamycin (Marciniak et al., 2004). The same study indicated that CHOP
deletion exerts a protective effect by reducing the load of client proteins in the ER
and by altering the ER redox equilibrium toward reducing conditions. However, in
one study on a physiological system of ER stress induction in oligodendrocytes
CHOPwas found to have an anti-apoptotic role, since oligodendrocytes from chop:':
mice were more resistant to death induced by over-expression of a mutant protein
(Southwood et al., 2002). Furthermore a stably transfected clone of the myeloma line
NSO,was protected from UPR-induced death when CHOP was down-regulated by
siRNA (Cudna and Dickson, 2006). I thus wondered how CHOP deletion affected B
cells sensitivity to ER stress-induced death. I incubated purified B and T cells with
tunicamycin (Tm), which induces ER stress by inhibiting glycosylation of de-novo
synthesized proteins impairing their folding. I found that chop": B cells were
consistently more sensitive to ER stress when compared to wt cells, whereas T cells
did not show a significantly different sensitivity (Fig.8 A). The same results were
obtained when I tested the sensitivity of chop-null ASC compared to wt (Fig.8 B).
Thus I show that even though B cells up regulate CHOP during the UPR (Fig.2 B) its
deletion worsens the effects of ER stress, in contrast to observations in MEF or
pancreatic ~ cells for example. T cells do not seem to be affected. My fmdings,
together with the numerous published studies, suggest a cell type specific role in ER
stress-induced apoptosis for this transcription factor.
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Fig.S ChOJTI· B lymphoblasts and ASC are more sensitive to ER stress·induced
apoptosis
Sensivity to ER stress was assessed by measuring the percentage of propidium iodide positive
cells by flow cytometry analysis after treatment with the ER stress inducer tunicamycin. A T
and B lymphocytes were purified from the same preparation of wt and chop-I· splenocytes and
cultured in the presence of LPS to reduce spontaneous apoptosis. 2 Ilg/m1 Tm were added 8
hrs after cell purification. After additional 16hrs the cells were harvested, stained with PI and
analyzed by flowcytometry (n=3; error bars represent the SEM of the average; p value < 0.005).
BASe at day3 of differentiation were treated and analyzed as in A. Tm concentration was
reduced to 0.5 Ilg/m1 to avoid excessive death rate (n=2; error bars represent the SEM of the
average; p value < 0.005 (Student's T test)).
3.1.7 Transcriptional profiling analysis of wt and chop-1- differentiating B
cells
In the attempt to identify CHOP target genes during B cell differentiation, I performed
microarray transcriptional profiling analysis.
I analyzed the total mRNA expression profile in wt and chopr: purified B splenocytes
after 1,2 and 3 days upon LPS exposure. I did not use the RNApurified from freshly
isolated splenocytes before LPS stimulation and after 4 days since the quality of the
RNAwas not good enough; in the first case because magnetic separation is known to
cause a stress from which the cells must recover before obtaining the RNAand in the
second one because at day 4 of differentiation the percentage of dead cells is high
(see Fig.3 C). Firstly I concentrated on expression profile changes in wt B cells. While
in the literature it is possible to find various expression profiles of B cell lines and
normal or myeloma plasma cell performed by lymphocyte-specific chips, as far as we
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are aware no study has been published in which the entire mouse genome was
probed (Peterson, 2007). I selected the genes whose levels significantly raised at day2
and day3 with respect to dayl and analyzed them with the microarray analysis tool
L2L (Newman and Weiner, 2005). I thus identified the biological processes that were
up regulated during B cell differentiation. As expected from the present lmowledge
about B cell differentiation I found profound differences between the two time points.
It is clear, comparing figure 9 and 10, that after 2 days of LPS exposure most of the
processes up regulated relative to day 1 belong to cell cycle control and
metabolism/molecular biosynthesis groups, as well as to the secretory pathway/UPR
one. After 3 days, most of these transcriptional groups are down-regulated to leave
high rates of expression of genes related to the secretory/UPR pathway and to
immunological functions (for example interferon and interleukin signaling). As
already described by proteomic analysis of 1.291l+cells (Romijn et al., 2005; van
Anken et al., 2003), I conclude as well that before starting massive Ig secretion
primary B cells get ready by increasing their metabolic and secretory capacity. These
fmdings add further consistence to the model I used to study plasma cell
differentiation but especially provide a valuable set of data that we can exploit for
whatever biological process, or single gene we want to follow during B cell
differentiation (Fig.IOB).
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Fig.9 Transcriptional profiling of murine ABC: biological processes up
regulated at differentiation day2 relatively to dayl
Transcriptional profiles ofwt B cells at dayl and day2 after LPS stimulation were analyzed by
Affymetrixmouse 430 2.0 chip, containing probes recognizing the entire mouse genome.
Significant changes in the expression level of each transcript at day2 relatively to dayl were
identified by Affymetrix software. The probes whose complementary transcripts resulted
significantly increased were selected and subjected to further analysis by the microarray
analysis tool L2L (Newman and Weiner, 2005) which grouped them on the basis of the
biological process they belong to as classified by the Gene Ontology (GO) consortium
(Ashburner et al., 2000). Comparison of our data with the software databases indicated which
biological process groups were "enriched" in our dataset, Le. contained a higher number of
probes than expected. The results of this comparison are reported in the figure as fold
enrichment for each group. Since the set of probes analyzed were those increasing at day2
versus dayl such analysis reports which processes are up regulated at day2. The groups were
further assigned to four main processes (cell cycle, energy metabolism/macromolecules
biosynthesis, secretory pathway /UPR, immune response) evidenced by color code. The insets
report the total number of probes belonging to a particular group and some of the most
significant genes they corresponded to.
Fig.10 Transcriptional profiling of murine ABC: biological processes up
regulated at differentiation day3 relatively to dayl
ATranscriptional profiling of wt B cells at dayl and day3 after LPSstimulation, analyzed and
reported as in Fig.9 B Examples of the expression pattern of single genes of interest. The
fluorescence signals emitted by the different microarray probes corresponding to a single gene
were averaged for each time point and plotted in histograms.
From the comparison of the expression profiles of wt versus chop/: ASC at day 2 and
day 3 of differentiation we selected 19 and 17 genes, respectively. either up- or down-
regulated in the chop-null cells, which passed very strict statistical criteria (Table 1),
obviously besides CHOP itself. We were not able to identify a particular biological
process affected in the ko cells, if not maybe the mis-regulation of more than one
gene involved in small OTPases signaling pathways. However, this was not un-
expected considering the mildness of chop": ASC phenotype. Furthermore, the same
kind of analysis, comparing wt and chop«: MEF after ER stress stimuli identified only
26 genes that were never induced in the ko cells, despite a more evident phenotype
(Marciniak et al., 2004). Microarray data regarding single genes always need to be
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verified by real-time peR analysis. We began the screening and then we focused on
one gene that was definitively repressed in the chop-null cells, at all the time points
analyzed: ATF5.The remaining data presented in table 1 still need proper validation .
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Table 1 Genes differently expressed in chop/- ASC
The table lists the genes that were either up (positivefold change) or down (negative fold
change) regulated in chop/: ASCat day2 and day3 after LPSstimulation relativelyto wt cells
at the correspondingtime point. Analysiswas performedby Affymetrixanalysis software and
onlygenes that showedat least two-foldchangewere considered.
3.1.81dentijication of the transcriptionfactorATFS as a novel CHOPpathway
target gene during B cell differentiation and in the UPR
ATFS is a member of the Activating Transcription Factor family. Relative real-time
PCR confrrmed that ATFS mRNA expression is down regulated in chop/: B
lymphocytes and ASCwhen compared to wt (Fig.I I A). Obviously, since there is still
an increase in chop/: ASCwith respect to undifferentiated cells, ATFScan be induced
also by CHOP-independent pathways. CHOP control during B cell differentiation
however seems to playa role (though in other experiments ATFS increase in chop/:
cells is somewhat higher). The first question that I decided to answer to was if CHOP
activates ATFS expression also during the UPR. Treatment of unfractionated
splenocytes with Tm increased the expression of ATFS mRNA (Fig.I I B). However,
chop/: splenocytes had lower levels of ATFS to start with and its up-regulation in
response to the UPR was minor in comparison with wt cells. Therefore CHOP is
required for full expression of ATFS in B cell differentiation and in the UPR. To
assess if CHOP directly binds the ATFS regulatory sequences I will need to perform
chromatin immunoprecipitation assays. As explained in the discussion below
however, I do not think this is the case.
Since the above data suggest that the role of CHOP is quite specific in B cells, I next
asked if CHOP-dependent ATFS activation in the UPR was characteristic of this cell
type only. To start answering this question I treated a mouse fibroblast (NIH3T3)and
a B cell line (1.291-1-+),with Tm in order to obtain comparable levels of CHOP
expression (Fig.I I C). ATFS up-regulation by the UPR in 3T3 was the same, if not
higher with respect to 1.291-1-+.From this experiment I draw the important conclusion
that ATFS is generally up regulated by the UPR. I cannot however claim if also in
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fibroblasts its up-regulation depends on CHOP. ER-stress induction in wt and chop/:
fibroblast will allow elucidating the last point.
The finding that ATFS expression is activated by the UPR, likely downstream of
CHOP raises very exciting questions. Despite the clear involvement of CHOP in ER
stress-induced apoptosis, the exact pathways leading to cell death are still obscure.
The literature regarding ATFS is quite scarce. This transcription factor has been
involved in neural cell differentiation, in response to starvation and very interestingly
in apoptosis. The most intriguing point is that, depending on the cell type, ATFS
either promotes or prevents apoptosis induced by various means, a behavior
reminiscent of CHOP. I wondered if ATFS could be a member of the pathway(s)
downstream of CHOPleading to ER stress-induced death. By generating ER stress in
3T3 cells previously transfected with siRNAagainst ATFSor against the control gene
luciferase, I obtained preliminary data supporting this hypothesis. In the
experimental settings used, the cells transfected with ATFS siRNAwere resistant to
ER stress-induced apoptosis, unlike the cells transfected with siRNA targeting the
luciferase gene sequence (Fig.11D). This experiment unfortunately lacked analysis of
ATFSmRNA, so even though the siRNAsequences used were published and tested
by the authors (Angelastro et al., 2006), I cannot attribute with certainty the
observed effects to ATFSdown regulation.
The role ofATFSin the UPRclearly needs further investigations.
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Fig.ll ATFS expression is impaired in chop« cells
A B lymphocytes isolated from wt and chop/: mouse spleens were induced to differentiate by
incubation with LPS for the indicated time points. ATF5 mRNA expression pattern during
differentiation was followed by relative real time PCR as in Fig.2 A (error bars represent the
SEM of the average of PCR triplicates of the same samples). B The totality of cells harvested
from wt and chop": spleens was cultured in the presence of 20 J.lg/mlTm for 4hrs to induce
UPR. After the incubation time total RNAwas purified and analyzed by real time peR as in A
to follow the expression of CHOP and ATF5 transcripts (error bars represent the SEM of the
average of PCR triplicates of the same samples). C ER stress was induced in 1.291!+and 3T3
cells by 4hrs incubation with 10 Ilg/ml Tm. Then RNAwas purified and analyzed by real time
PCR as in A to follow the expression of CHOP and ATF5 transcripts (error bars represent the
SEMof the average of PCR triplicates of the same samples). D 3T3 cells were transfected with
20 J.lMduplex RNA oligonucleotides targeting ATF5 or luciferase transcripts. 36hrs after
transfection cells were incubated with 250nM thapsigargin (Tg)for 4hrs and then analyzed by
flow cytometry. The percentage of apoptotic cells was identified by forward/side scatter
physical parameters analysis (n=3; error bars represent the SEM of the average; p value=
0.082 (Student's T test))
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3.2 Differentiating B cells suffer proteo-toxic and oxidative stress
3.2.1 Proteasomal capacity is impaired during plasma cell differentiation
While a minority of plasma cells home to the bone marrow and live longer, the vast
majority, particularly those producing IgM, die by apoptosis after a few days of
intense Ig secretion. Although extrinsic factors are crucial to shape the proper
environment for long-lived plasma cells (Maser et al., 2006; Radbruch et al., 2006),
little is known of the molecular events that cause apoptosis of short-lived Ig secretors.
A considerable fraction of secretory u-chame are degraded also in hybridoma cells
(Fra et al., 1993; Sitia et al., 1990) via ERAD, probably owing to the inefficient
assembly of IgM polymers. As discussed and shown above (FigA C and D), some
ERAD components are highly up regulated during plasma cell differentiation,
presumably in order to cope with the increased load of proteins to be degraded. The
terminal executers of ERAD are the cytosolic proteasomes. Since myeloma cells are
particularly sensitive to treatments with proteasome inhibitors, we reasoned that the
abundant production of IgM that characterizes activated B cells could represent a
load on the protein degradation machinery. We thus asked if such load could be a
source of stress rendering plasma cells particularly prone to apoptosis. Answering
this question was the result of a collaborative effort of the laboratory in which I was
involved. We demonstrated that in the late phases of plasma cell differentiation,
when antibody production becomes maximal, proteasomal activity decreases ((Cenci
et al., 2006), appendix I). In particular, I showed that I.29~+ cells accumulate poly-
ubiquitinated proteins and consequently have decreased amounts of free ubiquitin in
the later phases of differentiation (Fig.12 A) suggesting impairment of proteasomal
activity. To provide further evidence of proteasomal insufficiency during B-cell
differentiation, I then analyzed transgenic mice expressing a chimerical, un-cleavable
ubiquitin-GFP (UbG76VGFP) that is rapidly degraded by proteasomes (Dantuma et al.,
2000). A short exposure to the proteasome inhibitor MG132 caused a strong
accumulation of the reporter in un-stimulated CD19+B cells (Fig.12 B, top). After 3
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days ofLPS stimulation in vitro, differentiating B cells accumulated the GFP reporter
even in the absence ofMG132 (Fig.12B, bottom).
These data, together with many others produced and published in our laboratory
demonstrate that a built-in plasma cell developmental program impairs the
ubiquitin-proteasome disposal system and lead us to propose that the progressive
impairment of proteasomal capacity is one of the mechanisms that contribute in
limiting plasma cell lifespan, linking it to antibody production (Cascio et al., 2008;
Cenci et al., 2006).
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Fig.12 Differentiating B cells accumulate poly-ubiquitinated proteins
A The murine lymphoma line I.291l+was induced to differentiate to ASC by addition of 20
!kg/ml LPS. At the indicated time points protein extracts were separated by SDS-PAGEand
after blotting the filters were probed with anti-ubiquitin antibodies. The HMW poly-
ubiquitinated proteins and the 7KD ubiquitin monomer were separated with 6% and 15%
polyacrylamide gels respectively. B B lymphocytes were purified from spleens of UbG76VGFP
mice and wt littermates and cultured in the presence of LPS for 3 days. At the indicated time
points cells were treated with the proteasome inhibitor MG132, 1.5 !kMfor 2.5hrs. UbG76VGFP
accumulation was followedby flowcytometry analysis.
3.2.2 Differentiating antibody secreting cells experience increasing oxidative
stress
Perturbation of the redox homeostasis could be yet another factor leading to plasma
cell death. Recent evidences prove that the process of oxidative folding can generate
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H202that can then be converted in other reactive oxygen species (ROS)(paragraphs
1.2.2 and 1.2.3). Owing to the reactivity of H202 and the existence of many buffering
systems in living cells (catalase and peroxiredoxins for instance), a quantitative
measurement of peroxides is likely to be a difficult task. Nonetheless the sharp
increase in IgMbiosynthesis might lead a related increase in H202, should O2be the
electron acceptor during oxidative folding. The increased loads of H202 produced
could represent an intracellular signal (Gross et al., 2006; Liu et al., 2005; Tu and
Weissman, 2004). Hence I utilized an H202-specific dye (PG1) (Miller et al., 2007) to
measure the concentration of hydrogen peroxide during ASC differentiation. If the
hypothesis were correct I would expect an augmentation of H202 concentration in
correspondence with increased IgM synthesis and polymerization. Using primary
splenic B cells, I observed a strong increase in H202 concentration only at day 5 of
differentiation, that is after the first wave of apoptosis, clearly detectable at days 3
and 4 of differentiation (Fig.13 A). I did not follow differentiation at later days yet, to
understand if the increase in H202 observed at day 5 will coincide with a further
peak of death at day 6. Interestingly however the raise in H202 concentration
corresponded to increased accumulation of IgM HMW species (Fig.13 B).
Furthermore chop/ :ASC, which experience higher degree of aggregation, present a
slight, but statistically significant higher concentration of hydrogen peroxide at day
5. These observations suggest a correlation between oxidative folding and H202
accumulation. However, a significant increase in IgM synthesis and folding occurs
already at earlier time points, after 3 or 4 days upon LPS stimulation. If it is true
that oxidative folding generates H202, a possible explanation for the delayed increase
in H202concentration could be found in the regulation of scavenging systems. I thus
began addressing this point by investigating the pattern of expression of the
peroxiredoxins family members, thiol-specific antioxidant proteins also termed
thioredoxin peroxidases. Six members of the family have been identified in
mammalian cells that differ for the sub-cellular localization and for the recycling
mechanisms. I found that PrxI, III and IV expression levels increase during
differentiation (Fig.13 C). PrxI is localized in the cytosol, PrxIII is mitochondrial
whereas PrxIV is an ER resident protein. It is worthy of note that, whereas PrxIV
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continues increasing until day 4, PrxI and III reach a peak of expression at day 2 and
3 then decrease. Prxs are not the sole cellular peroxidases and these data are still
preliminary. Nonetheless my fmdings open to the possibility that H202 levels could
be controlled by up regulation of scavenging systems in the first days of
differentiation and then reduction of the buffering capacity would determine
increased oxidative stress. Continuous up-regulation of PrxIV in the ER could help
maintaining the Ig folding compartment as efficient as possible until the cell dies.
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Fig.13 Differentiating B cells undergo oxidative stress
B lymphocytes isolated from wt and chop«: mouse spleens were induced to differentiate by
incubation with LPS_AAt the indicated time points cells were analyzed by flowcytometry after
staining with the H202 specific dye PG1 (Median Fluorescence Intensity) or with propidium
iodide (percentage positive cells) to followapoptosis. (n=4; error bars represent the SEM of the
average; * p value < 0.02 (Student's T test)). B IgM polymerization of wt ASCat day4 and dayS
of differentiation was analyzed by western blot as described in Fig.S A. C The pattern of
expression of the Peroxiredoxin family proteins (Prx I-VI) during B cell differentiation was
followedby western blot analysis of protein extracts obtained by wt cells (left panel). Actin was
used as loading control. Densitometric analysis of western blots as shown in the left panel
(right panel). Data are reported as fold increase relative to the protein amounts measured at
dayO, normalized to actin. (error bars represent the SEM of the average fold increase in four
independent samples).
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4 Discussion
4.1 Plasma cell differentiation
4.1.1 Preparing for secretion
Plasma cells, specialists in antibody production, represent an ideal model to
investigate the cellular dynamics of proteosynthetic stress. Their differentiation from
small resting B lymphocytes into Ig secreting cells entails a series of genetic and
functional changes, finalized to producing specific antibodies in adequate amounts
at the proper time. Upon encounter with antigen, long-lived B lymphocytes activate a
profound functional and structural metamorphosis that, in few days, leads to
differentiation into a mature plasma cell, a terminally differentiated element capable
of secreting enormous amounts of Ig. This process entails augmenting the secretory
organelles and the proteins that populate them, up regulating their energy and
translation potentials, and increasing the quality control systems. This
transformation is accomplished by the interplay between B lineage-specific
transcriptional programs that control plasma cell differentiation, the unfolded
protein response and possibly redox homeostasis variations and other signaling
pathways. The high rate of antibody production requires efficient folding and quality
control machineries. Primary plasma cells produce large amounts of IgM (about
103/cell/s). It follows that up to 105disulfides are formed per second in each plasma
cell, solely to sustain IgMproduction. Eight x·l 06 aminoacids must be synthesized or
imported each second to compensate for IgM secretion. IgM being planar disks 36
nm wide and 4 nm thick, an impressive number of vesicles must be produced to
warrant their transport, and as many to recycle the intracellular membrane
compartments. To satisfy the increased demand for oxidative folding, more Era In
and ~ are produced. If the increased levels of Era Iu and ~ satisfies the redox demand,
ASC differentiation needs to solve the problem of assembling thousands of IgMper
second. These planar molecules are linked by disulphide bonds in their C-terminal
96
tails. Our recent work suggest that ERp44 and ERGle-53 concur in IgM
polymerization. Hexameric ERGle-53 may provide a planar platform that
concentrates 1-l2k subunits and favors their ordered assembly, avoiding formation of
larger polymers (de Lalla et al., 1998). However, human patients with various
deficiencies in the ERGle-53 mediated transport machinery show impaired secretion
only of the coagulation factors V and VIII, thus presenting bleeding problems
(Neerman-Arbez et al., 1999; Nichols et al., 1998). Undergoing studies in our
laboratory are investigating possible alterations of ERGle-53 null patients plasma
cell 19 secretion. Yet these patients do not show major immunological defects and
have normal IgMtiters though consistently in the lowest percentile. Preliminary work
on in vitro PBL from FVFVIIIpatients suggests a delay in the onset of IgMpolymers
secretion. These observations point to the existence of redundant mechanisms for
efficient IgMpolymerization and secretion in cells of the B lineage, underscoring the
importance of this process.
4.1.2 Dying
The vast majority of plasma cells are short-lived so as to limit the antibody response.
The mechanisms leading to programmed death of plasma cells are still unclear.
However, different stress factors, related to the high rate of protein synthesis concur
in rendering plasma cells more susceptible to apoptosis. The system could be based
on a "timer" or a "counter". In principle, the latter may result in better tuning of
antibody responses, but how to count secreted molecules that are no longer there?
An intracellular sensor of the work accomplished could transduce intrinsic stimuli
and start apoptosis when a functional threshold is met. Proteasomal inhibition in the
later stages of plasma cell differentiation could function as a bottleneck in an
otherwise efficient quality control strategy dedicated to Ig folding and assembly. This
could be a mechanism evolved by plasma cells to count the work accomplished, and
predispose themselves to die on the basis of accumulated stress (proteo-toxic,
oxidative and so forth). Selective accumulation of certain protein species, like the
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pro-apoptotic Bcl-2 relative Bax, or the NF-kB counteractor IkBa, could play an
important role in cells sensitized by the likely ensuing oxidative stress, UPR, ER
calcium release, etc. Together, they may provide plasma cells with a powerful
redundancy of apoptotic stimuli, and ensure apoptosis.
4.2 CHOPexhibits a B cell-specific role during ASC differentiation and
in response to ER stress
Mystudy revealed an unexpected role for CHOPin the secretory pathway of antibody
secreting cells where it contributes to the full expression of elements of the folding
and quality control machinery. Furthermore my findings point to a cell-type specific
role for this transcription factor during the UPR. Indeed CHOP seems to protect B
cells from ER stress induced apoptosis, unlike what is observed in other cell types.
4.2.1 CHOPis induced independently of the UPRduring B cell differentiation
I found that CHOP is induced during B cell differentiation while looking for UPR
players involved in this process. Surprisingly however, together with the existing
literature discussed below, my data on the activation of elements of the UPR in ASC
point to an UPR-independent regulation of CHOP during ASCdifferentiation. Zhang
and colleagues concluded some time ago that the PERK pathway is not activated
during ASC cell differentiation. Furthermore they excluded an essential role in
plasma cell differentiation for the cascade downstream eIF2a phosphorylation by
showing that knock-in mice expressing a mutant of eIF2a that cannot be
phosphorylated (eIF2aSer51Ala)achieved the same Ig titer as wt mice upon
immunization (Zhang et al., 2005). Recently such conclusions were further
demonstrated by Gass and colleagues who confirmed that PERKis not activated in in
vitro B cell differentiation and showed that PERK-I- B cells can differentiate normally
(Gass et al., 2008). Thus, if chop transcription were induced by activation of the UPR
in ASC differentiation, then it should be via one of the ERSE (ER stress responsive
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element) present in its promoter, recognized by ATF6 and/or XBPl. However, CHOP
induction upon ER stress is completely abolished in PERK-/- and in eIF2aSer51Ala
knock-in MEF and over-expression of ATF4 cannot restore CHOP induction in PERK-
/- cells indicating the requirement of a signal downstream eIF2a phosphorylation,
other than ATF4 (Harding et al., 2000; Scheuner et al., 2001). Although it cannot be
excluded that, some other kinase(s) could phosphorylate eIF2a (e.g. GCN2 or PKR),
since PERK pathway is disposable for ASC differentiation, it is reasonable to
conclude that CHOP regulation in ASC cell is UPR independent. Another
consideration suggesting that CHOP is expressed independently of PERK/eIF2a
phosphorylation pathway consists in the fact that PERK-/-ASC seems to secrete the
same amount of IgMas wt as assessed by in vitro secretion assay (Gass et al., 2008)
and sera levels of IgMin eIF2aSer51Alamice were the same if not higher, even though
the analysis was performed at much longer time points with respect to my
experiments (Zhang et al., 2005). The idea of an UPR-independent CHOP regulation
in differentiating B cells is supported by the very different kinetics of CHOP
expression with respect of all the other UPR elements that I studied. particularly
interesting is the difference between CHOP and HERP expression pattern in ASC.
Both CHOP and HERP promoters have ERSE1, ERSE2 and ATF/C/EBP composite
site regulatory elements and are dually regulated during the UPR by ATF6-XBP1(via
ERSE) and by PERK/ATF4 (via ATF/C/EBP composite element) pathways. Both can
still be induced in the absence ofATF4upon ER stress, although at a lower level, but
not upon amino acid starvation, thus showing a very similar pattern of regulation
(Ma and Hendershot, 2004). HERP expression, however, can be induced also by an
ER resident transcription factor, LUMAN/CREB3, which is activated by proteolytic
cleavage by SP1 protease as ATF6 and, like sXBP-1, can bind and activate
transcription via UPRE and ERSE elements (Liang et al., 2006). LUMANregulates
herp transcription via the ERSE2; the clwp promoter contains an ERSE2 as well but
I could not find published data about a possible regulation of cnop by this
transcription factor. Interestingly LUMAN is activated during the UPR only in
response to certain ER stress-inducing agents maybe providing a fine tuned
regulation of the response depending on the kind of ER stress. It can be speculated
99
that LUMAN,or another yet to be identified factor activation mediates the differential
regulation of CHOPand HERP during ASC differentiation. These observations further
underline the differences between a UPR pharmacologically induced and
physiological responses to changing protein loads in which only certain elements are
activated, likely depending on the nature of the cargo proteins and cell types.
4.2.2 What drives CHOPexpression during B cell differentiation?
The pathway(s) upstream to CHOPinduction in ASC remains to be elucidated. CHOP
is up regulated in response to a variety of stimuli and examples of various cell- and
stress-specific regulatory pathways have been described. For example, cell type
specific control over chop transcription has been recently found in pancreatic j3 cells.
MafA, a transcription factor expressed only in tissues involved in eye development
and in j3 cells, inhibits or induces chop transcription downstream of the MAPKs
ERKI/2, depending on glucose concentration in the culture medium (Lawrence et al.,
2007). Chop transcription is activated during mitochondrial UPR through an API
element present in the promoter, possibly via the MEK/JNK2 pathway and the
PI3K/PKCb pathway seems to be involved in CHOP up regulation in response to
oxidative stress (Oh-Hashi et al., 2004; Scott and Loo, 2007). In these studies eIF2a
phophorylation was not analyzed so it is not clear if CHOP expression, promoted by
different pathways, is dependent also on eIF2a phosphorylation. Nevertheless a
recent study, demonstrated that insulin promoted CHOP expression in the absence
of eIF2a phosphorylation in mature adipocytes (Miyata et al., 2008).
4.2.3 CHOP is involved in the dUTerentiation oJ a variety 0/ cell types
An important role for CHOP in cellular differentiation has been described in
adipocytes, osteoblasts and keratinocytes. Different lines of evidence indicate that
CHOP plays an inhibitory role in adipocyte differentiation. In the preadipocyte cell
line 3T3Ll CHOP is up regulated in the early phases of differentiation while the cells
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undergo mitotic clonal expansion. In this phase CHOP dimerizes with C/EBPfl
inhibiting its DNA binding activity thus blocking the expression of the key
transcription factors that drive adipocytes differentiation. When cells exit the mitotic
clonal expansion, CHOP is down regulated and C/EBPfl activates transcription and
the following steps of differentiation (Liet al., 2006). The inhibitory role of CHOP in
differentiation of preadipocytes to adipocytes was confirmed in primary cultures:
overexpression of CHOPinhibited differentiation. Furthermore the same study shows
that the physiological fat decrease associated with aging correlates with higher levels
of CHOP expression in older rat preadipocytes with respect to cells from middle-age
or young animals and that such up regulation is due to increased secretion of TNFa
(Tchkonia et al., 2007). In vivo no effects of chop deletion were observed in male mice
either when fed by standard or by high fat diet whereas chop/: females showed
increased body weight already when fed by standard diet. Even though the authors
do not draw definitive conclusions about the cause of the observed phenotype, they
report mis-regulation of C/EBP family members in female chop-null fat cells and
lower levels of estrogens in the sera, an hormonal alteration that can cause obesity
(Ariyama et al., 2007). While inhibiting adipogenesis CHOP promotes
osteoblastogenesis. Pereiera and colleagues showed that in 8T-2 murine stromal cells,
the levels of CHOP transcripts rise as the cells differentiate toward osteoblasts, and
that overexpression of CHOP accelerates osteoblastic cell differentiation and
suppresses adipogenesis. The effects of CHOPdeletion in vivo are less clear: the same
authors found that chop-null mice have impaired osteoblastic cell function but the
skeleton revealed no abnormalities and bone mineral density was normal (Pereira et
al., 2006). Indeed another study evidenced a very complex role for CHOP in
osteoblast differentiation depending on the commitment of the cells analyzed and on
the stimuli that induced differentiation. 8hirakawa and others showed that CHOPis
expressed in bone as well as in mesenchymal progenitors and primary osteoblasts
and that chop-deficient osteoblasts differentiate more strongly than their wild-type
counterparts, suggesting that endogenous CHOP plays an important role in the
inhibition of osteoblast differentiation. At the same time though they found that
endogenous CHOP induces differentiation of calvarial osteoblasts upon bone
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morphogenetic protein (BMP) treatment. They also demonstrated that, as in
adipocytes, also in osteoblasts CHOP forms heterodimers with C/EBpt\ and inhibits
its DNA-binding activity thus blocking transcription of osteoblast-specific genes.
These fmdings indicate that CHOPacts as a dominant negative inhibitor of C/EBpt\
and prevents osteoblast differentiation but promotes BMP signaling in a cell-type-
dependent manner. Thus, they conclude that endogenous CHOPmay have dual roles
in regulating osteoblast differentiation and bone formation (Shirakawa et al., 2006).
C/EBPs (a, ~ and CHOP) are involved also in keratinocytes differentiation.
Keratinocyte differentiation followsa temporally and spatially well-defmed program of
stratification. As cells migrate upward from the proliferative basal layer, they first
undergo growth-arrest, then sequentially express a series of unique gene products,
among which secreted keratin, and finally die by apoptosis to form the dead barrier
layer. This program of differentiation can be reproduced in vitro by culturing a
keratinocyte cell line in high calcium conditions. In fact when induced to differentiate
these cells undergo growth arrest within 24-48 hrs, start expressing keratinocyte
specific genes beginning at 24 hrs and after 48 hrs start undergoing apoptosis,
closely reminding B cell differentiation. In a keratinocyte model Maytin and Habener
analyzed the pattern of expression of C/EBPa, J:l and CHOP. They described that
C/EBPa increases at day 1 and 2 and remains elevated, C/EBpt\ raises at day 2 and
4 and gradually falls and CHOP raises at day 1 and then returns rapidly to baseline
(Maytin and Habener, 1998). I could not find more recent studies about C/EBPs, in
particular CHOP,role in keratinocyte differentiation.
Idid not investigate properly the pattern of expression of the C/EBP family members
in plasma cell differentiation. However the transcriptional profiling analyses indicate
that C/EBpt\ and C/EBPy transcripts rise at day2 and day3 relatively to dayl, with
different kinetics (Fig. 121), whereas CHOP mRNA and protein levels decrease from
dayl to day3 (Fig.2 and 121). Furthermore, a study conducted to followthe pattern of
expression of C/EBP transcription factors in different stages of B cell differentiation
showed that C/EBpt\ and C/EBPy were differentially regulated in splenic B cells
differentiated in vitro by LPS and that tranScriptional activity from a C/EBP minimal
promoter was found only in cell line models of later stages of B cell differentiation
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(Cooper et al., 1994). It is worth to point out that CjEBP binding sites have been
shown to be functionally important in Ig heavy chain variable region promoters, the
H chain intronic enhancer and the K chain intronic enhancer . These considerations
raise the hypothesis that CHOP's role during B cell differentiation could be via the
interplay with CjEBPI3and CjEBPy and that these transcription factors could playa
role in activating a differentiation-related transcriptional program, as observed in
other cell types.
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Fig. Jll Members of the C/EBP transcription factor family are up regulated
during ASC differentiation
Expression pattern of C/EBP~, C/EBPy and CHOP as measured by microarray analysis. The
fluorescence signals emitted by the different probes corresponding to a single gene were
averaged for each time point and plotted in histograms.
4.2.4 How could CHOPdeficiency during plasma cell differentiation affect the
expression of chaperones involved in 19Mpolymerization?
A similar mechanism could explain why chop-null ASC phenotype consists in
alterations of the foldingmachinery, whose components are part of the differentiation
program. On the basis of this purely speculative hypothesis I analyzed about 1500
bp up-stream the transcriptional starting site of the chaperones whose expression is
affected by chop deletion and indeed I could find various CjEBP binding sites (Table
2) (http://alqqen.lsi.upe.es/eqi-bin/promo v3/promo/promoinit.cqi?dirDB=TF 8. ~
(Farre et al., 2003; Messeguer et al., 2002). It is worth pointing out that by the
analysis performed I identified CHOPbinding sites (Oyadomari and Mori, 2004) only
in Er01a regulatory region, but not in those of BiP, ERp44 or ERdj5. Anyway, other
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considerations point to the idea that CHOP does not directly regulate these genes. In
fact, CHOPis already back at basal level at the time points in which BiP, ERp44 and
ERdj5 start rising and/or reach their maximal level of expression. The interplay with
other members of the C/EBP family could justify such phenomenon. Among the
many possible explanations, it could be imagined that CHOP/C/EBP complexes
induce (or inhibit) the expression of some factor(s) that in turn activate the
chaperones. Alternatively CHOP, alone or interacting with other factors could
determine epi-genetic modifications that facilitate the expression of certain genes at
later time points. ATF5 peak of expression on the contrary perfectly correlates with
CHOP expression; however, when CHOP goes back to basal levels ATF5 remains
highly expressed (compare figure 2 and 11 A). Furthermore, ATF5 mRNA level is
lower in un-stimulated splenocytes suggesting that CHOP basal levels of expression
are necessary to maintain normal ATF5 activation (Fig.11 B). When we analyzed the
2000 bp upstream the transcription initiation site we found many binding sites for
the C/EBP family members but not for CHOP (Table 2).
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oene position sequence C/ESPa C/ESPtl C/EBf'y_ CHOP % dissimilarity_
-1075 TGCAAT X 0
-1541 TGCAAT X 0
-559 TTGCTG X 0
-777 GAGCAA X 0
Erola -834 TGTTGC X 0
-1312 TGTTGC X 0
-210 GCGCAA X 0.58
-559 TTGCTC X 0.39
-777 GAGCAA X 0.39
-559 TTGCTCAA X 1.25 J-558 ATTGCTCAAT X 6.05
-155 AGTTGC X 0.36
-168 TAGCAA X 0.86
-1392 AGTTGC X 0.86
SiP -153 TTGCGG X 2.3
-168 TAGCAA X 1.79
-75 CTTCACCAAT X 7.06
-108 ATGGACCAAT X 11.86
-1392 TTGCTACA X 3.64
-860 TTGCTT X 0.64
-1301 GCAACA X 0
-860 TTGCnCA X 6.91
ERp44 -1032 TTGCAT X 0.76
-1058 TTGCACA X 0
-179 TTAAGCAA X 0.11
-860 TTGCTTCA X 2.5 J
-467 GCAACA X 0
-732 TTTCCTCAAT X 10
ERdjS -882 ATGCAA X 0.76
-1332 GTGCAA X 0
-471 TTTAGCAA X 1.25 J-1473 TTAAGCAA X 0.11
-81 TTGCCT X 2.96
-279 TTGCCCA X 3.2
-359 GCAACC X 0.36
-279 TTGCCACC X 13.4
ATF5 -318 TGGCGCAA X 6.39
-355 GGCAGCAA X 12.95
-81 TTGCCT X 1.59
-279 TTGCCACC X 2.24
-320 GCGCAA X 0.58
Table 2
Table 2 CjEBPtranscription factor binding sites are present in the promoters
of Erola, BiP, ERp44, ERdjS and ATFS
Putative binding sites for transcription factors belonging to the C/EBP family have been
identified by PROMOanalysis of about 1500-2000bp upstream the transcription initiation site
(http://alqqen.lsi.upc.es/caibin/promo v3/promo/promoinit.cqi?dirDB=TF 8.3). Only the sites
with the highest similarity and closest to the transcription initiation site are listed in the table.
Sites marked in bold are completely or partially overlapping for more than one transcription
factor.
4.2.5 Chop-l- plasma cells do not exhibit increased levels of ER stress
These data led me to surmise that down regulation of components of the IgMfolding
machinery, in particular ERdj5, could explain the chopv': ASC higher tendency to
form HWMIgM aggregates. Such phenotype should give rise to intensified levels of
ER stress in chap/: ASC leading to an anticipated or stronger UPR that instead we
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did not observe (Fig.4). There are two reasons to expect increased ER stress in the
chop-null cells. The first is the 20% of IgM retained intracellularly in form of
aggregates relatively to the wt (Fig.5 A and B), which likely determines the observed
morphological alterations of the ER (Fig.5 C). Secondly, down regulation of BiP
should reduce the amount of unfolded proteins accumulating in the ER required in
order to free and thus activate, Ire1a and ATF6, especially in cells that retain higher
amounts of secretory proteins than normal. However, cases of accumulation of
aggregated misfolded proteins that do not induce UPR have already been described
(Hidvegi et al., 2005; Mattioli et al., 2006). Regarding the BiP issue different
considerations must be taken into account. Accordingly to many published studies
and to the data presented in this work, it is clear that UPR activation is not easily
confined into the model that described it until recently, based on the competition for
BiP binding among the UPR sensors and the accumulating misfolded proteins
(Bertolotti et al., 2000). As already discussed in the introduction, misfolded proteins
could directly bind and activate Ire lo (Credle et al., 2005; Zhou et al., 2006) and
physiological models of UPR, the one described in this work first of all, indicate that
selected elements can be activated while others kept silent (Brewer and Hendershot,
2005; Gass et al., 2008; Zhang et al., 2005). Furthermore the analysis of BiP
heterozygous mice (grp78 +,-) indicated that lower levels of BiP can be tolerated by
the cells and by the entire organism. Whereas grp78 -,-mice are lethal at the earliest
stages of embryogenesis (E3.5) underscoring the essential role of this ER chaperone,
grp7B +/- mice, which express about half of the wt levels of BiP proteins, are viable
and show no general defects. Moreover grp7B +,- MEF show no basal up-regulation of
the UPR, even though they express higher levels of POI and grp94, and can still
respond to ER stress with full expression of sXBP-l and CHOP (Luo et al., 2006).
Altogether these findings are compatible with the my observations showing that
chop-null ASC, which express slightly lower levels of BiP, activate the UPR at the
same extent as wt cells.
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4.2.6 Lower sera IgM titers do not affect the immunological response of chop-I'
mice to a T dependent antigen
I showed that IgM titers after immunization with a T cell-dependent antigen are lower
in chop": mice with respect to that of wt littermates. This finding is in accord to the
results obtained testing in vitro differentiated ASC. This was not the case for IgG,
whose sera levels were as high in chop-null as in wt mice, but that were secreted with
lower efficiency in in vitro experiments. At the present I do not know how to explain
the discrepancy between the data obtained in viuo and in vitro. I can hypothesize that
in viuo the interactions with other cellular populations can compensate CHOP
deficiency sufficiently to rescue the ability of properly assembling and secreting IgG
but not IgM, a more complex molecule that requires further steps of assembly and
must pass more quality control check points. Further investigation is required to
address this point.
Chop-null mice show no obvious immunological phenotype. However, I did not
perform experiments aimed at testing the mice's immunological competence nor
could I fmd any published study. Ehrenstein and colleagues created mice that,
although harboring a normal number of B cells expressing surface IgM, completely
lacked serum IgM while retaining the other Ig isotypes, by targeting the ~.
polyadenylation site. These mice retained a generally normal B lymphocyte
distribution but exhibited substantial delays in mounting affmity-matured IgG
responses to T cell-dependent antigens. The T cell-independent response, however,
was augmented. The authors concluded that the IgM present before antigen
challenge (as well, possibly, as that elicited immediately after immunization)
accelerates maturation of the primary response, presumably by complexing with the
antigen and facilitating lymphocyte activation and or antigen trapping (Ehrenstein et
al., 1998). The same authors also showed that while deficiency in serum IgM leads to
diminished responsiveness to foreign antigens at the same time causes increased
responsiveness to self-antigens (Ehrenstein et al., 2000). I did not observe a delayed
or reduced primary response, in terms of total IgG titer, upon T cell-dependent
immunization. Since only at later time points I observed a reduced IgM titer in chop-
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null mice sera relatively to wt, it is likely that the amount of IgMproduced by chop/:
mice is sufficient to guarantee enough natural, as well as affinity-matured,
antibodies to promote an efficient primary response.
4.2.7 Chop-I' B cells are more sensitive to ER stress
Likely, the most striking phenotype I observed in chop-null B cells is their higher
sensitivity to ER stress-induced apoptosis. To my knowledge only one study
described CHOPexpression during the UPR as protective from apoptosis (Southwood
et al., 2002). Southwood and colleagues studied mice models of a pediatric
neurodegenerative disease that exhibits different degrees of severity depending on
which kind of mutation of the plp l gene causes it. They found that some mutants
induced UPR in oligodendrocytes, leading to CHOP expression. In this context CHOP
played a protective role, since the same mutation that caused a mild disease and
normal life span in wt background led to development of severe symptoms and very
precocious death, due to strongly increased oligodendrocyte apoptosis rate, in chop-
null background. Target genes up regulated by CHOP in MEFs treated with Tm were
not induced in this model of physiological UPR. As the authors point out such
difference could be due either to a cell type-specific set of C/EBP and more generally
bZIP transcription factors that CHOP associates with, or to the different stimuli that
induced UPR, a physiological, persistent stress due to the expression of a mutant
protein versus acute, strong, drug-induced UPR. However, CHOP manifested pro-
apototic activity in many other mouse models of physiological UPR. The Akita mouse
develops diabetes because of pancreatic fl cell apoptosis induced by expression of
misfolded mutant insulin. Chop-null mice harboring a single allele encoding for
mutant insulin developed hyperglycemia at later age and had a minor number of
apoptotic fl cells relatively to those observed in a wt background. Yet, when both
insulin alleles are mutated no difference was observed in the onset or in the severity
of diabetes (Oyadomari et al., 2002). My data suggest that B cells, at different stages
of differentiation, are another cell type in which CHOP induction during the UPR
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exerts a protective role from ER stress induced apoptosis. Importantly my
conclusions are based on acute, drug-induced UPR. I cannot exclude that LPS
stimulation is part of the causes of the major sensitivity to ER stress of chop/: cells.
Indeed, in order to avoid spontaneous apoptosis due to culturing isolated
lymphocytes (Souvannavong et al., 2004), I performed the experiments in the
presence of LPS also when assessing the sensitivity of freshly isolated splenocytes.
However, a study conducted in the myeloma cell line NSO supports my findings.
Stably transfected subclones of NSO, lacking or overexpressing CHOP, were
generated and their sensitivity to ER stress-induced apoptosis was tested by
induction of UPR by Tm. The clone with undetectable levels of CHOP expression
exhibited increased sensitivity to Tm treatment relative to the parental cells; on the
contrary the clone over-expressing CHOP showed a slightly increased resistance
(Cudna and Dickson, 2006).
Altogether these considerations point to a B cell-specific role for CHOP during the
UPR. It will be interesting to identify CHOP targets in B cell UPR and compare them
with those already identified in MEFs (Marciniak et al., 2004). As well, it will be
important to identify CHOP heterodimerization partners in the different cell types
(MEFs, B cells, oligodendrocytes) to shed light on the eclectic role of CHOP in
response to ER stress.
4.2.8Identijication of AT'S CI8 a new UPRplayer downstream o/CHOP
My attempt to single out CHOP targets during B cell differentiation led to the
recognition of the transcription factor ATFSas one of these. I indeed found that ATFS
expression is partially dependent on CHOP both during B cell differentiation and
upon UPR induction in B lymphocytes. Furthermore ATF5 transcript is up regulated
also in the fibroblast cell line NIH3T3upon UPR induction (Fig.11). While I obtained
these results Zhou and colleagues published their work showing that ATFSprotein is
up regulated upon induction of ER and oxidative stress and following proteasomal
inhibition (Zhou et al., 2008). The responses to these different stresses lead via,
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activation of diverse kinases, to phosphorylation of eIF2a and ATF4 and CHOP
induction. They demonstrated that elF2a phosphorylation is necessary to induce
ATFS protein in all these stress conditions since the phosphorylation-incompetent
elF2aSerSlAiaMEFs failed to up regulate ATF5 protein. They describe a post-
transcriptional mechanism of regulation for ATF5mRNAvery similar to that driving
ATF4 translation upon elF2a phosphorylation, based on the presence of inhibitory
ORFs upstream the coding region. In contrast with what I observed, this study
reported that whereas oxidative stress induced increased ATF5 transcription,
blocked in atf4-1- MEFs, ER stress did not. They thus concluded that upon oxidative
stress ATFS is regulated both at the transcriptional and translational levels,
depending on ATF4 and elF2a phosphorylation respectively, whereas in ER stress
conditions only post-transcriptional regulatory mechanisms dictate ATF5 induction.
ATFSRNAbasal levels where in any case lower in atf4-1- MEFs suggesting that basal
levels of ATF4 activation guarantee steady state transcription of ATF5, accordingly
with my observations in chop«: cells (Fig.I I B). I did not checked ATF5 protein
expression levels yet, but I observed increased ATF5 mRNA expression upon
induction of ER stress in primary splenocytes and in the cell lines 1.291l+and NIH3T3
(Fig.I I B and C). A possible explanation for this discrepancy could be found in the
different drugs used to induce ER stress. I used the inhibitor of protein glycosylation
tunicamycin while Zhou and colleagues used the inhibitor of the SERCACat" pump
thapsigargin.
Anyway, my data add to those published by Zhou and colleagues and pose ATFSup
regulation during the UPR downstream of the PERK/eIF2a/ATF4/CHOP pathway.
What will be important to determine is the role played by ATF5 in the UPR. ATF5has
been involved in apoptosis mainly with an anti-apoptotic role. There are findings
indicating that ATF5 is down regulated in a variety of cells undergoing apoptosis
following growth factor deprivation. When stably expressed in an interleukin 3-
dependent cell line, ATFS suppressed apoptosis resulting from cytokine deprivation.
Conversely, a dominant-negative ATF5mutant induced apoptosis of cells cultured in
the presence of growth factors suggesting an anti-apototic role for this transcription
factor (Persengiev et al., 2002). Involvement of ATF5 as an anti-apoptotic factor has
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been described also in cell lines subjected to heat shock. In fact ATFSpromoted cell
survival during heat shock stress via heat shock protein 27 (Hsp27) up regulation,
and ectopic expression of ATFS increased cell tolerance to elevated temperature.
ATFSup regulated Hsp27 gene promoter activity and inhibition of Hsp27 expression
by RNAi could increase apoptosis in cells ectopically expressing ATFS, indicating
Hsp27 involvement in ATFSmediated cell survival (Wang et al., 2007). Accordingly
with the anti-apoptotic function of this transcription factor ATFSis highly expressed
in tumors, like glioblastoma multiforme and in rat and human glioma cell lines.
Interference with ATFS function or expression in glioma cell lines caused marked
apoptotic cell death whereas such manipulations did not affect survival of ATFS-
expressing cultured astrocytes or of several other cell types that express this protein.
Moreover retroviral delivery of a function-blocking mutant form of ATFS into a rat
glioma model evoked death of the infected tumor cells, but not of infected brain cells
outside the tumors (Angelastro et al., 2006). Finally, loss of ATFS function caused
significant apoptotic death of neoplastic breast cell lines, but not of non-neoplastic
breast cell lines (Monaco et al., 2007). However, a case of pro-apototic function of
ATFShas also been reported. The ectopic expression of ATFSin HeLa cells increased
cisplatin-induced apoptosis and the cleavage of Caspase-3, and induced Cyelin D3
mRNA expression via cooperation with E2Fl transcription factor. Moreover, the
interference of Cyclln 03 expression by transfection with Cyclin D3 RNAiprotected
cells from ATFS-mediated apoptosis induced by cisplatin, indicating the contribution
of Cyclln D3 in ATFS-mediated apoptosis (Weiet al., 2006). Taking into account the
fact that ATFS is downstream of CHOP in the UPR and given its involvement in
apoptosis, it is tempting to hypothesize that ATFS could be one of the mediators of
the apoptotic functions of CHOP. In contrast with this idea there is the observation
that CHOP is mainly pro-apoptotic whereas ATFS is mainly anti-apoptotic in the
models that have been studied. However, I have already discussed that both
transcription factors can exert opposite functions. In particular, chop-null MEFs are
more resistant to ER stress-induced apoptosis, whereas chop-null lymphoblasts are
more sensitive. Thus these two different cell types could provide suitable models to
shed light not only on the function of ATFSin the UPR but also on its relation with
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CHOP. If indeed ATF5 is downstream of CHOP in the pathways leading to or
protecting from apoptosis, then down regulation of ATF5 in MEFs could result in
higher resistance to ER stress while interfering with ATF5 expression in B cells could
lead to higher sensitivity. The preliminary data I obtained support this hypothesis
(Fig.II D): the use of RNA oligonucleotides targeted to ATF5 transcript exerted a
protective role from ER stress-induced apoptosis in the fibroblast cell line NIH3T3.
A different issue concerns the role of ATF5 during plasma cell differentiation. ATF5 is
a member of the ATF/CREB family of bZip proteins, often involved in cellular
differentiation. Neural progenitor/stem cells in the developing brain express high
levels of ATF5 and it must be downregulated to permit neural progenitor cells to
differentiate into neurons and glia (Angelastro et al., 2006; Angelastro et al., 2005;
Mason et al., 2005). The findings that ATF5 transcript is up regulated during ASC
differentiation but no major phenotype is observed in chop/: cells, in which ATF5
expression is strongly inhibited, point to the conclusion that, as CHOP, ATF5 play no
essential role in B cell differentiation. Nonetheless, it must be considered that a
certain increase in ATF5 transcript can still be detected in chop-null cells and it
could be sufficient to perform the required activity; furthermore it cannot be
excluded that full ATF5 depletion in wt background would lead to different
conclusions.
4.2.9 CHOProle fn B cells: concluding remarks
In conclusion, I showed that chop/: B lymphocytes undergo broadly normal
differentiation, exhibiting a mild phenotype consisting in increased IgM aggregation
that leads to slightly decreased IgM secretion relatively to wt plasma cells. I propose
an explanation to this phenotype with the observation that the expression level of
important factors involved in IgM folding and assembly, BiP, ERp44 and ERdj5, is
lower in chop-null ASC. Despite its mildness, the phenotype described in cnop/ ASC
is open to interesting speculations, yet to be proven, that could add information
regarding the multi-faceted role of this transcription factor. Indeed I propose that
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CHOP expression during differentiation is not related to UPR induction but it is part
of the differentiation program. Furthermore I speculate that the interaction between
CHOP and other bZip transcription factors (particularly those belonging to the
C/EBP family) could regulate the expression of differentiation-related genes, like
those involved in the secretory pathway.
Very likely CHOP belongs to a group of redundant pathways. I described its
involvement in plasma cell differentiation yet I found a very mild phenotype, both in
vitro and in vivo. Furthermore, even though the analysis of the transcriptional
profiling showed that the data obtained are in line with the knowledge about plasma
cell differentiation and thus validates them, I found very few genes that where
differentially regulated in chop/: ASC relatively to the wt cells. My observations are in
accordance with those obtained in the study of osteoblast, adipocyte and
keratinocytes differentiation. Although a role for CHOP was defined in vitro, chop-null
mice show no major phenotype.
In my opinion, one of the most interesting findings I show concerns the peculiar role
of CHOP in ER stress-induced apoptosis in B cells, relatively to those described up to
now in other cell types, like MEFs, pancreatic ~ cells and epithelial kidney cells. The
most likely hypothesis to explain the cell type-specific role of CHOP in B cells is that
these express a different set of CHOP dimerization partners, thus leading to
activation of diverse target genes with respect to MEFs, for example.
Finally, the study of chop'': B cell differentiation brought me to the discovery of the
ATF/CREB family member ATFS as a novel CHOP target in B cell differentiation and
in the UPR.
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Fig. J!2 CHOP role in B cells
A chop:t: B splenocytes undergo broadly normal differentiation, showing increased IgM
aggregation, an altered ER morphology and decreased efficiency of IgM secretion. B During B
cell differentiation CHOP is induced by pathways still to be identified. CHOP could interact
with other members of the C/EBP family or with members of the ATF family of transcription
factors. Such interaction could trigger pathways leading to full expression of genes related to
plasma cell functions. C CHOP, induced by ER stress in different cell types, like MEF or B cell,
could interact with diverse heterodimerization partners and depending on these interaction it
could promote or antagonize apoptosis.
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4.3 Manipulating gene expression in B cells
It is evident that some of the conclusions I draw are purely speculative and need
further experimentation to be proven. For example it would be important to down
regulate ERdj5 in wt ASC to undoubtedly assess a role for this chaperone in IgM
assembly. Understanding the role of ATF5during the UPRwill require modulation of
its expression in MEFs and in B cells, as discussed above. B cells are not transfected
by traditional liposomal carriers but good enough levels of exogenous DNA
expression can be achieved by the usage of viral vectors. At the moment we are
working on the development of such vectors in order to be able to over express or
down regulate by RNAinterference whatever gene we are interested in and answer to
some of the many questions we left open. Apart from viral vectors, we plan to use
another tool to prove the role of the genes we are interested in, the cell line DT40.
These are bursal-stage chicken B cells, expressing IgM on their surface. DT40
targeting system has been proven to be a valid model for plasma cell differentiation
studies (Alinikula et al., 2006; Nera et al., 2006). The most obvious benefit of the
DT40 cell line over other B cell lines is the ease of accomplishing a true knockout.
Small interfering RNAsdecrease the expression at best to a low level, whereas with
conventional disruption methods in the DT40 cell line the expression of a functional
protein is totally lost.
4.4 Limitation of plasma cell life span: a matter of mUltiple cellular
processes failure?
The short lifespan of the majority of plasma cells is important to limit antibody
responses. However, some of them home in the bone marrow where they find
conditions for longer survival, which maintains protective Ig titers in the blood
(Maser et al., 2006; Radbruch et al., 2006). While it is clear that extrinsic factors
such as cytokines and contacts with stromal cells play important roles in shaping
the environmental niche that promotes survival of long-lived plasma cells, little is
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known about the mechanisms inducing the death of short-lived ones. In particular,
the existence of intrinsic factors regulating plasma cell lifespan has been proposed,
but never demonstrated.
4.4.1 Proteasomal capacity is impaired during plasma cell differentiation
Our findings reveal that in differentiating 1.29~+and primary spleen B cells, the
proteasomal capacity decreases despite the higher demand imposed by the high
rates of protein production (Fig.12 and appendix I). As an efficient ERAD is
important for folding and secretion capacity, it was surprising to observe that the
enzymatic activities and the relative abundance of proteasomes decreased during
differentiation of both 1.29~+lymphoma cells and primary splenocytes. This could
represent a distinctive feature of short-lived plasma cells, as dendritic cells
upregulate proteasomal subunits in response to LPS (Macagno et al., 2001). No
changes in proteasome activity were induced by LPS in a monocytic line, implying
that TLR4 triggering per se is not sufficient to cause proteasome down regulation.
Whilst polyubiquitinated proteins accumulated in activated B cells, the pool of free
ubiquitin decreased. Either the latter or the relative number of proteasomes could
limit degradation. As a consequence, endogenous proteasomal substrates were
stabilized in differentiating 1.29~+cells, and the reporter of the ubiqutin-proteasome
pathway GFpG76Vaccumulated in LPS-activated GFpG76V-transgenicsplenocytes
(Fig.12B). Weobserved stabilization of endogenous proteasomal substrates like IKI3a
and Bax that might meet certain functional requirements of plasma cells.
Accumulation of death factors may predispose to the apoptotic program. In this
scenario, plasma cell death would be linked to Ig production, thus contributing to
end humoral responses. Hence, we propose that the progressive impairment of
proteasomal capacity is one of the mechanisms that contribute in limiting plasma
cell lifespan, linking it to antibody production ((Cenciet al., 2006), appendix I).
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4.4.2 Plasma cell differentiation entails oxidative stress and the activation of
antioxidant responses
In all likelihood, different factors concur in rendering ASCs susceptible to apoptosis.
Perturbation of the redox homeostasis could be one of these. Oxidative folding, Le.
intra- and inter-molecular disulphide bond formation, could be a source of reactive
oxygen species (paragraphs 1.2.2 and 1.2.3). My preliminary findings exclude a
determinant role for H202accumulation in initiating the apoptotic program of ASC. I
did measure highly increased concentration of H202 but only after the apoptotic
program already began (Fig.l3 Al. Nonetheless, this does not exclude that the rise in
hydrogen peroxide could contribute at later time points as a further apoptotic signal.
Interestingly I could not detect accumulation of H202 in correspondence with the
initiation of massive Ig production, after 3 and 4 days upon LPS stimulation, but
only later, at dayS. In vitro assays demonstrated that yeast Erol generates H202in
equimolar amounts to the number of disulphide bonds formed. Since the pathway is
highly conserved in higher eukaryotes, it will be important to assess if H202 is
generated in mammalian cells as well, and we are investigating the issue.
Suggestions of a significant contribution of Ero 1 in cellular ROS production in
metazoans come from the observation that down-regulation of Ero 1 strongly reduces
ROS levels in ER stressed C. elegans (Harding et al., 2003). Ifwe assume that H202is
indeed generated by oxidative folding, the missing correlation between the increase
in Ig production and the rise in H202concentration could be explained by the up
regulation of the peroxiredoxins I, III and IV (Fig.13 C). Increased Prxs activity
between day 2 and 3 could be sufficient to eliminate high amounts of hydrogen
peroxide. Importantly, the cytosolic Prx I and the mitochondrial Prx III expression
levels decrease at day 4, before the H202rise observed at day 5. On the contrary Prx
IV expression steadily increases during differentiation, at least until day 4, the last
time point I analyzed. I hypothesize that Prx IV increase could reflect the need of
keeping the Ig folding compartment as efficient as possible until cell death. As part of
a collaboration in the laboratory, we are targeting an engineered YFP reporter of
hydrogen peroxide concentration to the ER. Commercial versions of this reporter are
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already available, targeted to cytosol or to mitochondria compartments (Belousov et
al., 2006). We hope that such tools will allow discrimination of the site of H202
production and accumulation in differentiating B cells.
Lastly, it could be worth pointing out that in correspondence with increased levels of
H202HMW aggregates accumulate in higher measure (Fig.13 B) and chop/: ASC,
which exhibit increased aggregation of IgM relatively to wt cells, present slight, but
statistically significant, higher amounts of hydrogen peroxide. The open question is
who came flrst: when folding is impaired multiple cycles of misoxidation, reduction
and reoxidation could increase the levels of oxidative stress; viceversa, unbalance
toward oxidizing conditions in the ER could affect chaperones activity and impair the
folding capacity of the ER.
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5. Materials and Methods
5.1 Mouse strains, cell cultures and spleen B cell isolation
chop t: mice were kindly provided by Dr. David Ron (Zinszner et al., 1998) while
UbG76Vwere provided by Dr. NicoDantuma (Dantuma et al., 2000).
1.29J.l+murine lymphoma cells and purified B splenocytes were cultured in RPMIwith
10% FCS endotoxin-free, 100U/ml Pen/Strep, ImM sodium-pyruvate, 2mM N-
glutamine (G1BCO) and 50J.lM 2-mercaptoethanol (SIGMA) and induced to
differentiate to ASC by addition of 20 J.lg/ml LPS (SIGMA). Purification of B
lymphocytes from mouse spleen was performed by magnetic isolation with anti-CD 19
beads (Miltenyi Biotec) and LS+ MACS separation columns following the
manufacturer instructions. Primary B cells were seeded at an initial cell density of
106/ml. Cells were never allowed to reach a cell density higher than 2-3*106/ml to
avoid risk of starvation. The cultures were diluted with complete medium.
Treatments with the ER stressors tunicamycin and thapsigargin were performed as
described in the figure legends. For the RT-PCR reported in Fig.4 B 1.29 cells were
treated with 1 J.lg/mlTm O/N. The drugs were added at the indicated concentrations
to the culture media.
For the LPS immunization experiment 3 mice/point were injected intra-peritoneum
with 3SJ.lg/gLPS (L2637 SIGMA)and B cells were purified as described (Cascio et al.,
2008). For the ovalbumin immunization experiment 5 mice for each genotype were
injected sub-cutaneously with 100J.Llof PBS/0.5mg ovalbumin/75J.lg LPS as adjuvant.
5.2 now cytometry
2*105 to 5*105 1.29J.l+or differentiating B cells were washed in PBS/O.5% BSA and
stained with each of the following reagents: 0.5J.lg/ml propidium iodide, SmM PG1
(peroxy-Green) 1:200 anti-CD138 PE-conjugated (BD Pharmingen), 1:200 anti-CD38
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FITC-conjugated (BD Pharmingen), 1:10.000 anti-u chain (Cappel) FITC-conjugated
and 1:200 anti-a chain FITC-conjugated (BD Pharmingen).
Samples were read at the Cytomics FC500 flow cytometer (Beckman Coulter) and
data analyzed by the FCS express analysis software.
5.3 Relative real time peR
Total RNA was isolated from cells by the Trizol reagent (Invitrogen) following the
manufacturer instructions and quality of the purified RNAwas checked by OD 260-
280 readings and by electrophoresis separation. 0.5-1 J.lgof total RNA was retro-
transcribed by the Super-Script II kit (Invitrogen) in a final volume of 10J.ll.0.5-1 ul of
these were used in each PCR reaction. Real time PCR was performed with Sybr Green
Master Mix (Applied Biosystems) in a final volume of 25J.lI by the ABI7900 HT
thermal cycler (Applied Biosystems). Data were analyzed by the SDS 2.0 software.
The increase of each transcript at a certain time point of differentiation relatively to
dayO was calculated by the dACt method using histone 3 and/ or ~-actin as reference
genes. The following primers were used for PCR. The following primers were used:
CHOP - FW: GCG ACAGAG CCA GAATAACA RW: ACC AGG TTC TGC TTT CAG GT;
BiP - FW: TAT TGG AGG TGG GCA AAC CAAG RW: CGC TGG GCA TCA TTG AAG
TAAG; Ero1a - FW: CCG AAAAACTGA TCG CAAAT RW: CCG TCC TCC TCA GTG
AACAT; XBPI splicing - FW: GGA GTG GAG TAAGGC TGG TG RW: CCA GAATGC
CCAAAAGGATA; XBPI total - FW: TTT GGG CATTCT GGA CAAGT RW: AAAGGG
AGG CTG GTAAGG AA;EDEM - FW: ACTGATTCC AAACAG CCC TT RW: GGA TCC
CTG TCT TGG TGT TT; ERdj4 - FW: GCC ATG AAGTAC CAC CCT GA RW: CTT TCC
GAC TAT TGG CAT CC; ATF5 - FW: GGCTGGCTCGTAGACTATGG RW:
CAGCCTGGACCTGTACCCTA.
5.4 We.tem blot
Total celllysates (to detect IgM assembly intermediates) were prepared by lysis of the
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cells in a buffer containing 2SmM Tris, 100 mM NaCI, 3mM EOTA, 2% SOS plus
freshly added protease inhibitors (Roche Complete protease inhibitor cocktail,
following manufacturer instructions) and 10mM NEM (N-ethyl maleimide) at room
temperature, followed by sonication to remove DNAand boiling IOta 15 mins. Post
nuclear supernatants (to detect ERdj3, HERP, BiP, ERp44, ERGICpS3, ERdjS, Erol0,
Prx I-VI)were prepared by lysis in 10mM Tris HCI pH 7.4, lS0mM NaCI, 1% NP40
plus freshly added protease inhibitors (Roche Complete protease inhibitor cocktail,
followingmanufacturer instructions) and 10mM NEMfor 15 mins on ice, followed by
centrifugation at 17.000xg for 15 mins at 4°C to remove nuclei. Nuclear extracts (to
detect CHOP and sXBPI) were prepared by lysing the cells in harvest buffer (IOmM
HEPES, SOmMNaCI, O.SM sucrose, O.lmM EOTA, 0.5% Triton X-lOO plus freshly
added lmM OTT and protease inhibitors - as above-], and lysing the nuclear pellet,
obtained by centrifugation of the lysates at 17.000xg for 15 mins at 4°C, in nuclei
buffer (10mM HEPES, SOOmMNaCI, O.lmM EOTA, O.lmM EGTA. 0.I%NP40 plus
freshly added 1mMOTTand protease inhibitors).
To detect IgM assembly intermediates total cell lysates were separated on gradient
polyacrylamide running gels (2-14%) with 2.5% stacking gels. Stacking gels were
blotted too since high molecular weight IgM aggregates were found mostly there.
Total lysates of HEK293FT after transfection with 11, ). and J chains plus or minus
ERdjS were separated by pre-casted Bis-Tris 4-10% gels (Invitrogen) following
manufacturer instructions.
To detect all the other proteins conventional SOS-PAGEwas performed.
Transfer of the proteins on nitrocellulose filter was performed in wet conditions
(Pharmacia Biotech transfer tank) with transfer buffer [Ix tris-glycin buffer)
containing 20% methanol overnight at 4°C. After transfer filters were blocked with
5%milk in PBS/a. I% tween 20 buffer for 1hr at r.t.
Anti-BiP and anti-HERP rabbit sera and anti-ERdj3 antibody were kindly provided by
Dr. Linda Hendershot (St. Jude Children's research hospital, Memphis, TN, USA).
Anti-ERp44 and anti-Erola monoclonal antibodies were produced by hybridoma cell
cultures (anti-ERp44 (39ES) published in Anelli 2007, supplementary material
appendix II; anti-Ero l a Bergamelli et al. submitted). The anti-ERGICpS3 rabbit
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serum was kindly provided by Dr. HP Hauri (Basel, Switzerland). The monoclonal
anti-ERdj5 was kindly provided by K. Nagata (Kyoto, Japan). XBPI and CHOP
antibodies were from Santa Cruz biotechnology. Anti-Prx I-VI polyclonal antibodies
were from AB frontier. Anti-u rabbit serum was from Zymed. Anti-s antibody was
from Southern Biotechnology and anti-J antibody was a polyclonal serum produced
by PRIMM(Milan, Italy). Anti-actin was from SIGMA.Primary antibodies were diluted
in PBS/O.l% tween buffer containing 5% milk, all at 1:1000 but XBP and CHOP that
were diluted at 1:400. Incubation with all the primary antibodies was performed for
Ihr at r.t, followed by 3 washes for 15' in PBS/O.l% Tween. Secondary antibodies,
anti-mouse or anti-rabbit HRP conjugated (Southern Biotechnology) were diluted at
1:2000 in PBS/O.l% tween and filter incubated for Lhr at r.t. Filters were then
washed 3x in PBS/O.l% Tween for 15 mins and signal was detected with Amersham
ECL substrate. When indicated filters were stripped with 100mM glycin pH 2.5 for
30' at r.t. followed by 2 washes in PBS for 15' at r.t. and then blocked and re-probed
as described above.
Western blot images were acquired with the Chemidoc-it Imaging System (UVP,
Upland, CA) and processed with Adobe Photoshop 7.0 (Adobe Systems Inc.).
Densitometric analysis was performed by the Image Quant 5.2 software (Molecular
Dynamics).
5.5 Secretion assay and ELISA
Differentiating B cells were washed twice in PBS and cultured in Optimem (GIBCO)
in the absence of FCS for 4 hrs at a cell density of 106/ml. Protease inhibitors and
10mM NEMwere added to the media at the end of the incubation period and the
cells were discarded by sequential centrifugation at 300xg firat and at 17.000xg
afterwards. 10~1 of media or mice sera diluted 1:500 were analyzed by ELISA.
Analysis of IgM secreted in the culture medium was performed as follow: the ELISA
plate was coated with 1:200 anti-u rabbit serum (Zymed) OIN at 4°C, blocked with
3% milk in PBS/0.05% Tween 20 for Ihr at r.t and media were incubated OIN at 4°C.
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To detect IgG coating was performed with 1:200 anti- y specific antibody (Southern
Biotechnology) followed by the same steps as for IgM detection. After washing (3x
with PBS/tween) a secondary anti-K-HRP 1:1000 (Southern Biotechnology) was
incubated for lhr at r.t. After washing (3xwith PBS/tween) the assay was developed
with SIGMAOPD fast read and the plate read at 4S0nm. To detect IgM and IgG in
the sera the plate was coated with ovalbumin conjugated to BSA (20 ~g/ml) O/N at
4°C, blocked with 3% milk in PBS/O.OS%Tween 20 for lhr at r.t and sera were
incubated O/N at 4°C. After washing (3x with PBS/tween) anti-y-HRP 1:1000
(Southern Biotechnology) or anti-u-Hfd> 1:1000 (Southern Biotechnology) was
incubated for 1hr at r.t. After washing (3xwith PBS/tween) the assay was developed
with SIGMAOPD fast read and the plate read at 4S0nm. All the antibodies were
diluted in PBS/O.OS%tween 20.
5.6 Transrection
HEK293FT were cultured in DMEM with 10% FCS, lOOU/ml Pen/Strep, lmM
sodium-pyruvate, 2mM N-glutamine (everything from GlBCO). 2xl()6 cells were
plated in 10cm Petri the day before transfection. Transfection was performed with a
mix of 120 ~g PEl plus 12~g DNA in PBSlx added to 6 ml of media O/N. Plasmid
transfected were based on PCDNA3.1 (-)where the cDNAsequences of J, f... and ~
chains were cloned. ERdjS plasmid was a kind gift of Prof. K. Nagata (Kyoto,Japan).
The following day cells were cultured in normal medium and harvested for lysis
48hrs after transfection.
5.7 Immunofluorescence and electron microscopy
Lymphoid cells were incubated on poly-L-lysine-coated cover-slips for 20 min at 37°C
on 10-mm2 cover-slips. Cells were fixed in 3% paraformaldehyde and permeabilized
with 0.1% TXIOO.Cells were then decorated with the indicated antibodies diluted in
PBS 1:1, Ihr at r.t (anti-ERp44 monoclonal described in S.4; rabbit anti-p l IS was
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kindly provided by Dr. M. A. De Matteis (Chieti, IT);rabbit anti-calreticulin was from
Stressgen (Victoria, BC Canada)) and washed 3x with PBS. After staining with the
appropriate secondary antibodies (Alexa Fluor 488 Goat anti-mouse IgG (H+L) or
Alexa Fluor 564 Goat anti-rabbit IgG (H+L)from Molecular Probes (Oregon, USA))
diluted 1:200 cells and 3 washes in PBS cells were stained with Hoechst (1:1000 at
r.t. for 51, and then samples were mounted in Mowiol.
Slides were analyzed on an Olympus inverted fluorescence microscope (model IX70j
with DeltaVision RT Deconvolution System (Alembic, HSR, Milano). After
deconvolution, images were processed with Adobe Photoshop 7.0 (Adobe Systems
Inc.).
B splenocyte pellets obtained by centrifugation at 300xg at r.t. for 5' were fixed for 1
hour at 4 QCwith 4% paraformaldehyde and 2,5% glutaraldehyde in 125 mM
phosphate buffer. The pellet was postfixed (1 hour) with 1% Os04 in125 mM
phosphate buffer, washed, dehydrated and embedded in Epon. Conventional thin
sections parallel to pellet surface, were collected on uncoated grids, stained with
uranil and lead citrate and examined in a Leo912 electron microscope.
5.8 Expression profiling analyses
Total RNAwas isolated from cells by the Trizol reagent (Invitrogen) following the
manufacturer instructions and quality of the purified RNAwas checked by OD 260-
280 readings and by electrophoresis separation. The RNA was analyzed by Dr.
GeoffreyNeale, at the Hartwell Center for Bioinformatics and Biotechnology, St. Jude
Children's Research Hospital, Memphis, Tennessee, USA. The analysis was
performed using pairwise comparison in the Affymetrix GCOS software. The LogRatio
was calculated, and a Change Call (Increase/Decrease, No Change) was provided in
the data output. The probesets with >2-fold difference plus a change call at each of
the three tirnepoints were selected. Further analysis of the data was performed by
myself as described in chapter 3.1.7.
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